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ABSTRACT 
Campylobacter jejuni is a common cause of human gastrointestinal infections. Invasion 
of host epithelial cells is believed to be an important virulence mechanism of this 
bacterium. C. jejuni strains vary in their ability to invade the human epithelial cells and 
some of the strains are hyperinvasive. The aim of this work was to find the molecular 
basis of this hyperinvasive phenotype. The previously studied hyperinvasive phenotype 
of C. jejuni 01/51 in INT-407 cells was verified using Caco-2 cell based invasion assay 
and the assay was set up at Nottingham Trent University by selecting blood agar for 48 
hours as the pre-assay bacterial growth conditions and 100 multiplicity of infection as 
the starting inoculum. Seven hundred and sixty eight mutants generated in this strain by 
random transposon insertional mutagenesis were screened for their ability to invade 
human intestinal epithelial cells in an in vitro model and 174 mutants were selected for 
further studies. The motility of selected mutants was determined and 40 mutants that 
showed more than 75% motility compared to wildtype strain, with a very low level of 
invasion were selected for reconfirmation of this reduced invasion phenotype using 
standard INT-407 and Caco-2 cells based invasion assays. Localisation of the 
transposon insertion site by plasmid rescue was attempted in 15 mutants that showed 
very low levels of invasion in both eukaryotic cell lines. Preliminary DNA sequencing 
data from these mutants has identified, amongst others: cipA; an anion-uptake ABC-
transport system permease; a glycosyltransferase; a membrane protein; a capsule 
polysaccharide biosynthesis protein, a putative histidine triad (HIT) family protein; a 
putative restriction modification enzyme; a putA; a putative cytochrome C and 2 
hypothetical proteins. DNA sequence from one mutant had no database match. Targeted 
mutagenesis was done in 6 genes to verify the reduced invasion phenotype observed in 
the transposon mutants and Caco-2 cell-based adhesion and invasion assays were 
performed. All the six targeted mutants showed reduced invasion of Caco-2 cells 
compared to the wildtype strain but interestingly adhesion was variable. 
Complementation of 4 mutated genes partially restored the reduced invasion phenotype 
in the mutants. The reduced invasion of the mutants into human intestinal epithelial 
cells was not due to a reduction in their growth, motility, atmospheric air survival, 
culture media or intracellular survival of the mutants. The Cj1136 mutant showed 
significantly reduced ability to colonise the chick gut and the gene was also found to be 
crucial for lipooligosaccharides biosynthesis in C. jejuni. 
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1. INTRODUCTION 
 
1.1 General description 
Campylobacters are small (0.2 – 0.9 µm wide and 0.2 – 5.0 µm long), curved or spiral 
shaped non-sporulating rod-shaped, Gram-negative bacteria that exhibit rapid darting 
and spinning motility. They generally are microaerophilic, growing best in an 
atmosphere containing 3 - 13% CO2 and 3 - 5% O2 though some grows under aerobic 
and anaerobic conditions. Most Campylobacters have a rather narrow temperature range 
for growth with a maximum temperature of ~46oC and a minimum of 30oC and are 
classified as thermophiles.  Campylobacters have a low G + C content and are unable to 
ferment or oxidise carbohydrates due to the absence of a key glycolytic enzyme 6-
phosphofructokinase, instead the main carbon sources used by Campylobacters are 
amino acids especially serine; pyruvate and tricarboxylic acid cycle intermediates can 
also be utilised as the sources of carbon (Guccione et al., 2008; Kelly, 2005; Wright et 
al., 2009).  
 
1.2 Historical Perspectives 
Although Campylobacters were not recognised as human pathogens until the 1970s, 
they probably caused illness in man for centuries. In 1886, Escherich published a series 
of articles describing microscopical examinations suggesting the presence of non-
culturable spiral bacteria in the colon of infants who died of what he called “cholera 
infantum” as well as the stool of infants suffering from diarrhoea (Escherich, 1886).  
Campylobacter has been recognised as a cause of disease in animals particularly in 
bovines and ovines. In 1909, McFadyean and Stockman reported the presence of an 
unknown vibrio-like bacterium that was frequently isolated from aborted foetuses in 
ovines (McFadyean and Stockman, 1913).  In 1919, Smith who was investigating 
infectious abortions in the bovine also identified the spiral shaped bacteria, spirallum 
(Smith, 1919). Later, Smith became acquainted with the work of McFaydean and 
Stockman, and assumed they had been studying the same bacteria and proposed the 
name “Vibrio fetus” for this bacteria (Smith and Taylor, 1919). In 1931, winter 
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dysentery in calves was attributed by Jones et al. to infection with a ‘vibrio’ that was 
called Vibrio jejuni (Jones et al., 1931), and in 1944 Doyle described a similar organism 
associated with swine dysentery (Doyle, 1944). The pathogenic role of V. fetus 
venerealis in enzootic sterility in cows was demonstrated in 1949 (Stegenga and 
Terpstra, 1949). In 1959, Florent was able to distinguish two types of V. fetus by their 
biochemical and pathogenic characteristics, namely V. fetus venerealis and V. fetus 
intestinalis (Florent, 1959). 
Campylobacter was not isolated from human blood until the 1940s; in 1946 the Vibrio-
like bacteria were isolated from human cases which involved a milk-borne outbreak of 
diarrhoea (Levy, 1946) and a year later Vinzent et al. isolated V. fetus from the blood of 
three pregnant women having raised temperature (Vinzent et al., 1947). In 1957, King 
described a vibrio with several features in common with the agents described by 
Vinzent and termed the organism as “related vibrio” (King, 1957) which was later 
renamed as Campylobacter (Sebald and Véron, 1963). The isolation of Campylobacter 
from faeces was accomplished in 1972 using a filtration technique (Dekeyser et al., 
1972). In 1977, Skirrow described a simpler technique of culturing C. jejuni and C. coli 
from stool specimens (Skirrow, 1977) and later, the development of selective media 
brought the isolation of Campylobacter into the realm of routine microbiology (Bolton 
et al., 1984; Butzler et al., 1983; Endtz et al., 1991; Goossens et al., 1989; Karmali et 
al., 1986). 
 
1.3 Taxonomy of campylobacters 
The taxonomy of Campylobacter has changed significantly since its inception in 1963. 
The vibrio-related organisms Vibrio fetus and V. bubulus were classified into the novel 
genus Campylobacter by Sebald and Vernon in 1963 (Sebald and Véron, 1963). In a 
comprehensive study on taxonomy of the microaerophilic Vibrio-like organisms four 
distinct species were described in the genus Campylobacter: C. jejuni, C. coli, C. fetus 
and C. sputorum. Since the acceptance of divergence in 16S rRNA gene sequences as a 
model for determining phylogenetic relationships between bacteria in the 1980s, several 
studies of 16S rRNA gene sequence divergence in Campylobacter demonstrated the 
diversity of the genus (Lau et al., 1987; Romaniuk et al., 1987). On the basis of 16S 
rRNA gene sequence, cellular fatty acid composition and flagella morphology two 
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Campylobacter species, C. pylori and C. mustelae, were assigned to a new genus 
Helicobacter (Goodwin et al., 1989). The 16S rRNA sequence divergence, protein 
profiling and immunotyping data was the basis of reclassifying the so-called 
aerotolerant campylobacters under new genus Arcobacter, as A. nitrofigilis and A. 
cryaerophilus (Vandamme et al., 1991; Vandamme et al., 1992). Using the 16S rRNA 
sequence divergence two oral anaerobic species Wolinella curva and Wolinella recta 
were also shown to belong to genus Campylobacter. Finally the genera Arcobacter and 
Campylobacter, Sulfurospirillum and Bacteroides ureolyticus were accommodated in 
the new bacterial family Campylobacteraceae (Vandamme and De Ley, 1991). All the 
above taxa form a distinct but diverse phylogenetic group referred to as rRNA 
superfamily VI (Vandamme et al., 1991), the epsilon division of the Proteobacteria or 
the Epsilobacteria (Cavalier-Smith, 2002). Recently, whole-genome sequences of 
species belonging to the family Campylobacteraceae are becoming available; whole-
genome comparison using 25 complete and incomplete genome sequences of 15 species 
from Campylobacteraceae generated a phylogenetic tree similar to that generated using 
16S rRNA gene sequences, although whole-genome comparison gave more resolution 
between closely related species like C. jejuni subspecies jejuni, C. jejuni subspecies 
doylei and C. coli (Debruyne et al., 2008). 
 There are currently 17 species and 6 subspecies within the Campylobacter genus and 
the number of species has continued to rise (Debruyne et al., 2008). Currently well 
known Campylobacter species are C. jejuni, C. coli, C. fetus, C. hyointestinalis, C. 
upsaliensis, and C. lari. C. jejuni comprises two subspecies: subsp. jejuni and subsp. 
doylei. C. jejuni subsp. jejuni represents the taxon first described by Jones et al. as 
Vibrio jejuni (Jones et al., 1931) from bovine intestinal contents and commonly occurs 
as a commensal in a wide range of animal hosts. On the other hand, no animal host has 
been found for C. jejuni subsp. doylei (Steele and Owen, 1988) although it has been 
found in human cases of gastroenteritis and septicaemia (Lastovica and Skirrow, 2000).  
Subspecies doylei differ biochemically from subsp. jejuni by the absence of nitrate 
reduction, cephalothin susceptibility and this subspecies also fails to grow at 42oC. 
Many molecular-based methods are not suitable for subspeciation (On and Jordan, 
2003), but recently a multiplex PCR based on the nap locus was proposed for C. jejuni 
subspecies differentiation (Miller et al., 2007). 
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1.4 Typing of Campylobacter 
Detection and diagnosis of Campylobacter infections is based upon culturing on 
selective media, Gram’s stain and phenotyping (e.g. biochemical tests, fatty acid and/or 
protein profiles) or genotyping (e.g. DNA fingerprints, sequences, PCR). 
1.4.1 Phenotyping  
In the absence of the carbohydrate fermentation ability in Campylobacter, most 
phenotyping schemes are focused on differentiating Campylobacter according to 
production of catalase, growth at 42oC or 25oC and resistance to nalidixic acid or 
cephalothin. The hippurate hydrolysis test is used to distinguish C. jejuni from C. coli as 
the latter is generally unable to hydrolyse hippurate (On, 1996). The tolerance of C. 
fetus to glycine and the ability to produce hydrogen sulphide distinguishes this organism 
from the rest of the taxa. Other typical biochemical characteristics of Campylobacter 
species are reduction of fumarate to succinate; negative methyl red reaction and acetoin 
and indole production; and for most species, reduction of nitrate, and presence of 
oxidase activity. A computerised scheme of nearly 70 biochemical tests readily 
differentiated virtually all Campylobacter species (On and Holmes, 1995; On, 1996). 
Cellular fatty acid and protein profiling, and mass spectrometry have also been used for 
the identification of bacterial organisms including Campylobacter (Costas et al., 1990; 
Mandrell et al., 2005; Steinbrueckner et al., 1998).  
1.4.2 Serotypting 
Serotyping is a type of phenotyping and mainly three serotyping schemes are used for 
Campylobacter species, the Penner, Lior and LEP schemes. The Penner and LEP 
schemes are based on the soluble heat stable (HS) antigens while the Lior scheme is 
based on heat labile antigens of Campylobacter. The Penner serotyping scheme (Penner 
and Hennessy, 1980) involves the passive haemagglutination of the erythrocytes 
sensitised with the supernatant of a boiled Campylobacter cell suspension; sensitised 
erythrocytes are then mixed with antisera to demonstrate agglutination. Penner serotype 
by means of microarrays have revealed that the capsule is the likely Penner 
serodeterminant (Dorrell et al., 2001). This scheme recognises 65 serotypes and 
comprises 47 antisera for C. jejuni and 15 antisera for C. coli (Penner et al., 1983). The 
Lior scheme, a slide agglutination technique, can recognise up to 130 serotypes of C. 
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jejuni, C. coli and C. lari (Lior et al., 1982). A Penner serotyping scheme based LEP 
(Laboratory of Enteric Pathogens) serotyping scheme was described by Frost et al. in 
which passive haemagglutination used in the Penner scheme was replaced by detection 
of heat-stable antigens by direct bacterial agglutination using absorbed antisera (Frost et 
al., 1998). This was not proven to be any better than the Penner scheme, with cross 
reacting isolates still a problem (Oza et al., 2002). The sensitivity of serotyping is poor 
with over 20% of human strains and 40% of veterinary strains still non-typable (Newell 
et al., 2000). 
1.4.3 Phage typing 
The other typing scheme commonly used for Campylobacter is phage typing. The phage 
particles bind to the phase-variable surface structures including capsular polysaccharide 
and flagella of Campylobacter to enter the bacterial cells (Coward et al., 2006) and 
elicit bacterial cell lysis. Phage typing relies on the lytic reaction patterns of an isolate to 
different virulent typing bacteriophages. Different phage typing schemes have been 
used in the USA, Canada and UK, however, 76 defined phage types have been 
recognised using the UK scheme (Frost, 2001). A simple phage type is defined as two 
or more unrelated isolates that have the same bacteriophage pattern reaction (Frost et 
al., 1999). Phage typing is often used in conjunction with heat stable antigen based 
serotyping. 
1.4.4 Molecular typing 
Molecular typing or genotyping schemes mainly rely on nucleotide sequence 
differences between strains. Numerous molecular typing systems have been developed 
in recent years such as PCR based techniques including restriction fragment length 
polymorphism, nucleotide sequencing, restriction endonuclease analysis, ribotyping, 
pulsed-field gel electrophoresis of restricted chromosomal fragments and amplified 
fragment length polymorphism (Newell et al., 2000).  
Restriction fragment length polymorphism (RFLP) is a PCR based method that detects 
variation in a particular locus e.g. flagellin (fla typing) through amplification and 
subsequent digestion with one or more restriction enzymes (fla-RFLP) or direct 
sequencing (fla-amplified short variable regions [fla-SVR]) (On et al., 2008b). 
Amplified fragment-length polymorphism (AFLP) is a RFLP related method. 
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Conventional AFLP profiling involves digesting DNA with two enzymes and ligation of  
specific adaptors, which allow PCR amplification of a subset of DNA fragments using 
fluorescent-labelled primer pairs (On et al., 2008b). Comparative studies of molecular 
typing techniques suggest that AFLP is equally as discriminatory as pulsed-field gel 
electrophoresis and multi-locus sequence typing (Lindstedt et al., 2000; Miller et al., 
2005; Siemer et al., 2005). Random amplification of polymorphic DNA (RAPD) has 
also been applied for Campylobacter typing. In this technique, PCR of genomic DNA 
using a single 10 to 15 bp long primer, which binds to multiple sites in the genome, will 
generate different amplicon patterns in different strains (Acik and Cetinkaya, 2006; On 
et al., 2008b). Ribotyping detects polymorphism in the ribosomal-DNA loci. Genomic 
DNA is digested, then hybridised with rRNA-specific probes followed by visualisation 
of the labelled patterns. This technique is technically demanding, difficult to standardise 
(On et al., 2008b) and less discriminatory than pulsed-field gel electrophoresis using 
SmaI (Ge et al., 2006).   
Pulsed field gel electrophoresis (PFGE) detects polymorphism in the restriction patterns 
of enzymes, such as SmaI, KpnI and SalI that cut the Campylobacter chromosome 
infrequently (Cornelius et al., 2005; Gilpin et al., 2006; Malik-Kale et al., 2007). 
Although it is a technically demanding and expensive technique, it is widely regarded as 
among the most discriminatory typing methods for bacterial typing (On et al., 2008b). 
Comparison between large numbers of isolates have been facilitated by software such as 
BioNumerics (Applied Maths, Ghent, Belgium), which is electronically able to compare 
the electrophoresis patterns generated.  
Multi-locus sequence typing (MLST) compares DNA sequence differences in several 
(usually seven) Campylobacter house-keeping genes. For each gene; alleles are 
assigned an arbitrary number. The allele number for all the genes are then combined and 
given a unique sequence type number. MLST has shown C. jejuni to be genetically 
diverse yet weakly clonal (Dingle et al., 2002; Maiden et al., 1998; Manning et al., 
2003b).  
In this decade, the sequencing of genomes of Campylobacter species has opened up the 
post-genomic era, and DNA microarrays and down-scaling of detection processes to the 
Lab-on-chip scale have been found helpful in determining the differences between 
Campylobacter strains (Keramas et al., 2003; Keramas et al., 2004; Poly et al., 2004). 
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The disadvantage of microarrays is the high cost of the technique and the technically 
demanding nature of the methodology (Dorrell et al., 2001).    
   
1.5 The C. jejuni genome 
The progress in the whole-genome sequencing of Campylobacter and related bacteria 
presents an opportunity to deduce all biological aspects of these bacteria. The first full 
genome-sequence of C. jejuni was published in 2000 (Parkhill et al., 2000) which 
produced many interesting observations including a capacity for polysaccharide 
biosynthesis and the presence of hypervariable homopolymeric tract sequences. Since 
then the number of whole genome sequences has increased and currently at least 25 
completed and incomplete genome sequences have been obtained for 15 species 
belonging to the Campylobacteraceae (www.genomesonline.org). Based on the 
completed genome sequences of 6 C. jejuni strains NCTC11168 (Gundogdu et al., 
2007; Parkhill et al., 2000), RM1221 (Fouts et al., 2005), 81-176 (Hofreuter et al., 
2006), 269.97, 81116 (Pearson et al., 2007) and CG8486 (Poly et al., 2007b), the 
average size of the Campylobacter jejuni genome is 1.68 Mb, which encodes ~1756 
genes and has a G + C content of ~30.57%. Strain to strain variation in genetic content 
of C. jejuni has been observed; the genome of strain NCTC11168 encodes for 1,643 
genes while 2,037 genes are encoded by that of C. jejuni subsp. doylei 269.97. The 
genome of three human clinical isolates shared 1,474 core genes, with 35 genes unique 
to 81-176, 38 genes unique to CG8486, and 8 genes unique to NCTC11168; the number 
of pseudogenes also varied greatly from strain to strain e.g. no pseudogene was found in 
C. jejuni 81-176 while 251 pseudogenes were present in the C. jejuni subsp. doylei 
269.97 genome (Champion et al., 2008).  
The genome of all the four clinical isolates of C. jejuni that have been sequenced so far 
did not show the presence of orthologues of virulence factors that have been well 
characterised in other enteric pathogens (Champion et al., 2008). Unlike C. jejuni 81-
176 which possesses the pVir and pTet plasmids (Bacon et al., 2000; Batchelor et al., 
2004), the genome of strain NCTC11168, RM1221, 81116 and CG8486 do not contain 
plasmids. The size of plasmids in Campylobacter varies from 1.3 to 208 Kb (Aquino et 
al., 2002; Lee et al., 1994; Miller, 2008) and all plasmids are not associated with 
virulence (Schmidt-Ott et al., 2005), however, pVir may be important for pathogenesis 
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in some C. jejuni strains (Champion et al., 2008). Pathogenicity islands or insertion 
sequences were not found in the genome of strain NCTC11168 and CG8486, however, 
the genome of strain RM1221 is disrupted by four large integrated elements and a 
Campylobacter Mu-like phage (CMLP1) (Fouts et al., 2005). The sequence of 81-176 
chromosome also revealed a 6 Kb element with characteristics of an integrated plasmid 
(Champion et al., 2008).        
The genome sequence of Campylobacter jejuni NCTC11168 revealed the presence of 
repeat sequences or homopolymeric G/C tracts that were proposed to be responsible for 
gene slip in and out of frame or phase variation (Parkhill et al., 2000). The clusters of 
genes involved in biosynthesis or modification of surface structures e.g. 
lipooligosaccharide, capsule polysaccharide and flagella biosynthesis and O-linked 
glycosylation are among the most hypervariable regions in the Campylobacter genome 
(Miller, 2008). Pearson et al. reported the identification of at least 7 hypervariable 
plasticity regions (PR1 to PR7) in C. jejuni genome using whole genome microarrays. 
The authors found that 16.3% (269) of the genes present in the first genome sequenced 
C. jejuni NCTC11168 were either absent or highly variable in sequence among the 
examined C. jejuni strains. Most of the variable genes were clustered in groups 
designated plasticity regions which contained 136 (50%) of the variable gene pool 
(Pearson et al., 2003). 
 
1.6 Clinical and epidemiological aspects of Campylobacter infection 
1.6.1 Clinical aspects of disease in humans 
Campylobacter cause a diverse range of infections including diarrhoea, abortion, 
infertility, periodontal diseases or may live commensally without harming their host. C. 
jejuni, C. coli and infrequently C. upsaliensis, C. lari and C. fetus, are considered 
human pathogens (Humphrey et al., 2007). C. jejuni and C. coli mainly are major 
causes of human bacterial diarrhoea worldwide. Campylobacter jejuni infections vary 
from asymptomatic to severe gastroenteritis characterised by fever, abdominal cramps 
and inflammatory watery or blood-stained diarrhoea. C. jejuni gastroenteritis is usually 
self-limiting but bacteria may enter blood and cause septicaemia and meningitis 
especially in immunocompromised patients (Black et al., 1988). The first sign is often 
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fever, which may be followed by abdominal pains, myalgia and nausea. This is rapidly 
followed by an acute attack of diarrhoea lasting for 2 to 7 days. Stools are usually 
extremely watery and often contain blood and mucous (Blaser and Engberg, 2008). In 
developed countries, young adults are the most common group with disease and the 
diarrhoea is often associated with an inflammatory colitis and bloody faeces, whereas in 
developing countries enteritis usually occurs in infants and the diarrhoea is generally 
profuse and watery (Young and Mansfield, 2005). 
Some debilitating neuropathies including Guillain-Barré syndrome (GBS), Miller-
Fisher syndrome and septic arthritis have been seen in humans previously infected with 
C. jejuni (Young and Mansfield, 2005; Yuki et al., 1995). GBS is a rare complication 
but the most common form of acute neuromuscular paralysis. The symptoms generally 
develop 1-3 weeks after a C. jejuni infection and begin with motor and sensory deficits 
of the lower extremities, which can subsequently spread to the upper extremities and 
trunk  (Mishu and Blaser, 1993).  It is estimated that 1 in 1000 infections lead to GBS 
but the risk increases to 1:200 for a patient infected with a particular C. jejuni Penner 
type HS:19 (Nachamkin, 2002). It has been hypothesised that the patients who develop 
GBS after C. jejuni infection develop antibodies against the bacterial 
lipooligosaccharides. These antibodies cross-react with the peripheral nerve cell surface 
gangliosides, leading to an autoimmune response and causing acute neuromuscular 
paralysis (Penner and Aspinall, 1997; Willison and Yuki, 2002). The less common 
variant of GBS is Miller-Fisher syndrome (MFS) which is also associated with C. jejuni 
(Yuki et al., 1995). MFS is characterised by acute onset of unsteadiness of gait (ataxia), 
absence of reflexes and an inability to move the eyes (Ang et al., 2002). Other sequelae 
of Campylobacter infections are the development of septic arthritis which commonly 
affects the knee joints (Blaser and Engberg, 2008). 
 The infective dose of C. jejuni is often low and infection has been induced with doses 
as low as 500 bacteria in experimental human infection (Black et al., 1988; Robinson, 
1981). Thus campylobacters are much more infectious than enteropathogenic E. coli 
and Salmonella Typhi, for which the infective doses are 108 – 109 and 103, respectively 
(Blaser and Newman, 1982; Donnenberg et al., 1993). On the contrary, C. jejuni is not 
as infectious as other enteric pathogens such as Shigella and enterohaemorrhagic E. coli 
for which as few as 10 – 100 microorganisms can cause infection (DuPont et al., 1989; 
Ge et al., 2002). The typical period from transmission of microorganisms to appearance 
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of symptoms ranges from 1 to 7 days and the mean incubation period is 3 days (Blaser 
and Engberg, 2008).  
1.6.2 Habitat and sources of infection 
Campylobacters are widespread in nature and have been isolated from many water 
sources including rivers, wells, domestic water supplies contaminated with sewage 
effluent, as well as surface water from farms (Engberg et al., 1998; Moore et al., 2001). 
Campylobacter species have also been found in a wide range of animals including 
chickens, turkeys, ducks, geese, ostrich, sheep, cattle, deer, goats, pigs, cats, dogs, 
rodents, wild birds, shell fish, and even reptiles harbour them (On et al., 2008a). Whilst 
a diverse range of animals carries campylobacters, each Campylobacter species may 
favour colonisation of different hosts. C. jejuni is predominantly found in the guts of 
poultry, domestic and wild birds whilst C. coli is mainly found in pigs and birds 
(Humphrey et al., 2007). 
Human campylobacteriosis is primarily a food-borne disease. C. jejuni is usually a gut 
commensal in most of the food-producing animals and birds, and animal faecal 
contamination of the food is a well characterised route of transmission to humans. 
Infection is generally spread by consumption and handling of raw or under-cooked 
poultry meat and water or milk contaminated with bacteria. Natural hosts of 
Campylobacter species are the reservoir and primary sources of infection in humans as 
poultry meat accounts for up to 70% of C. jejuni infections (Deming et al., 1987). C. 
jejuni lives in the intestine of wild and domestic birds and animals and infection is not 
only transmitted by contact with/handling these birds or eating contaminated meat but 
the bacteria released through faeces into the environment contaminate water sources and 
transmit infection to new hosts consuming this water (Blaser et al., 1980). 
1.6.3 Disease burden  
The disease burden has been described in different ways. In the US, it has been 
estimated that food-borne Campylobacter infections number around 2.5 million each 
year (Mead et al., 1999). The World Health Organisation (WHO) estimates that ~1% of 
Western Europe will be infected with campylobacters each year (Humphrey et al., 
2007). This estimate is supported by findings that only 10% of Campylobacter cases are 
reported in England and Wales (Wheeler et al., 1999) . In England and Wales there 
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were 46,603 culture-confirmed cases of Campylobacter reported to health protection 
agency centre for infection in 2006 (Health Protection Agency, UK) which is 3.4 times 
higher than the combined cases of Salmonella, Shigella and Yersinia in the same year. 
The actual numbers of infections in the community are not known, the actual cases of 
Campylobacter infection in 2006 could be as high as 465,000 assuming Wheeler’s 
estimate was correct. The economic burden of Campylobacter infection is large, the 
average cost of a case of acute Campylobacter infection (excluding long-term sequelae) 
in England in 1995 was estimated to be £1315 (Humphrey et al., 2007). Therefore, 
Campylobacter infection costs the UK at least £61 million per annum and the true 
figure is probably 10-times higher even if we ignore inflation since 1995. Generally 
duration of illness is not longer than 10 days but restlessness and psychological 
disturbance also contribute to the disease burden. Patients should be excluded from 
working as food handlers until they have been symptom-free for 48 hours, however, 
some food businesses may ask infected employees to submit stool samples for testing in 
line with their own occupational health requirements which will keep them away from 
work for longer (Humphrey et al., 2007).   
 
1.7 Pathogenesis and host response to Campylobacter infection 
Campylobacter jejuni infection is generally transmitted to humans by consumption of 
undercooked poultry meat, contaminated water and unpasteurised milk (Allos and 
Blaser, 1995). The bacteria pass through an acidic environment of the stomach and 
colonise the small intestine in the early stage of infection, they later move to the large 
intestine and may cause local acute inflammatory changes in both the small and large 
intestine but the large intestine is the major target (Black et al., 1988). Bacterial 
adhesion and invasion of the intestinal epithelium is a well-established early event 
before initiation of inflammatory processes and diarrhoeal development (Ketley, 1997). 
C. jejuni colonises a range of animals commensally without causing a disease similar to 
that observed in humans, thus the lack of a convenient animal model that mimics the 
disease in humans has severely hampered investigations into the molecular mechanisms 
of C. jejuni infection. However, some host processes and bacterial determinants 
involved in the pathogenesis of the bacteria have been determined using studies 
including animal models and in vitro cell culture. The host response to C. jejuni 
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infection and the bacterial factors that contribute to its pathogenesis will be briefly 
discussed below.   
1.7.1 Host response to C. jejuni infection 
C. jejuni mainly colonise the human and chicken gut; it can also colonise the intestinal 
tract of other animals. The bacteria have to bypass the mechanical and immunological 
barriers of the gastrointestinal tract to establish an infection. The human stomach’s 
highly acidic environment provides the first line of defence against infection (Black et 
al., 1988), the mucous layer overlying the intestinal epithelium serves as another line of 
defence in the intestine. C. jejuni has developed many traits that contribute to its ability 
to pass through these barriers. These include the motility and corkscrew morphology of 
C. jejuni (Young et al., 2007) and the relatively short O-side chain of its 
lipooligosaccharide (LOS), which is proposed to reduce its non-specific binding to the 
mucin glycoproteins (McSweegan and Walker, 1986). The high concentrations of bile 
salt in the intestine can kill bacteria by disrupting bacterial cell membranes (Sung et al., 
1992), however, C. jejuni is resistant to bile salts present in the human intestine (Lin et 
al., 2003).  
In addition to the acidic pH of the stomach and the physical barrier of the intestinal 
epithelial layer, the human body has also acquired immune defences to defend itself 
from microbial insult. The human acquired immune defence can be divided into two 
categories: cell-mediated and humoral or antibody-mediated, which will be described 
briefly. 
1.7.1.1 Cell-mediated immunity 
C. jejuni infection in naïve immunocompetent adults clears before the adaptive humoral 
immune response is mounted (Blaser and Engberg, 2008); thus, the major immune 
response to clear C. jejuni from human body is cell-mediated immunity and presumably 
involves the dendritic cells (DCs) and macrophages (Rathinam et al., 2009; Young et 
al., 2007). The epithelial lining of the gut not only provides a physical barrier protecting 
the underlying mucosa from the external environment, but it also plays an important 
role in microbial sensing and mounting appropriate innate immune responses by the 
production of chemokines, cytokines and antimicrobial peptides (Eckmann, 2005; 
Kagnoff and Eckmann, 1997).  
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The NF-κB family of transcription factors are the central regulators in early host 
immune responses to infection. The production of NF-κB in intestinal epithelial cells is 
stimulated in response to C. jejuni infection (Chen et al., 2006; Mellits et al., 2002) 
which consequently initiates expression of several innate immune genes (Sansonetti, 
2006). In a previous study, NF-κB-deficient mice that were orally infected with C. 
jejuni 81-176 developed gastritis and duodenitis in contrast to wildtype mice suggesting 
the role of NF-κB in innate defence against C. jejuni (Fox et al., 2004).   
C. jejuni infection of human monocytes has shown the induction of proinflammatory 
cytokines IL-1α, IL-1β, IL-6, tumour necrosis factor alpha (TNF- α) and IL-8 (Hickey 
et al., 2005; Jones et al., 2003). Interleukin-8 (IL-8) is a proteolytic chemokine 
produced by myeloid and epithelial cells. It is a potent chemoattractant known to recruit 
lymphocyte and neutrophils to the site of local inflammation. Activation of extracellular 
signal-regulated kinase (ERK) and p38 mitogen activated protein (MAP) kinase 
pathways by C. jejuni infection is essential for IL-8 production (Watson and Galan, 
2005). IL-8 production triggered by enteric pathogens also requires signalling through 
NF-κB (Hobbie et al., 1997; Mellits et al., 2002; Philpott et al., 2000). C. jejuni 
adhesion/invasion (Hickey et al., 1999) and the presence of cytolethal distending toxin 
(Hickey et al., 2000; Zheng et al., 2008) are crucial mediators of IL-8 production in 
intestinal epithelial cells. The degree of IL-8 induction varies in in vitro models of 
infection and the response is dependent on both the bacterial strain and cell line used 
(MacCallum et al., 2006).  Recently a study showed a correlation between the ratio of 
pro-inflammatory and anti-inflammatory cytokine levels with histological changes in a 
mouse lung model of C. jejuni infection (Al-Banna et al., 2008) that suggests the 
important role of cytokines in C. jejuni in vivo infection.  
Defensins are a major family of antimicrobial, cysteine-containing cationic peptides 
produced by neutrophils and mammalian epithelia (Iovine, 2008). Like human α 
defensins, β defensins 1 (HBD1) are constitutively expressed in cells throughout the 
gastrointestinal tract (Lehrer et al., 1993), whereas expression of the inducible β 
defensins 2, 3 and 4 is activated by proinflammatory cytokines (Iovine, 2008). C. jejuni 
induced the expression of human β defensins 2 and 3 in human intestinal epithelial cell 
lines Caco-2 and HT-29 but did not affect expression of the β defensins 1 (Zilbauer et 
al., 2005). Defensins contribute to innate defence against Campylobacter in poultry as 
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well. The avian defensins called gallinacins may also contribute to the resistance of 
chickens to Campylobacter infection (van Dijk et al., 2007).  
C. jejuni pass through the mucous layer, adhere to and invade the intestinal epithelial 
lining (Ketley, 1997). Where invasion of bacteria in intestinal epithelial cells protects 
them from phagocytosis by neutrophils, monocytes/macrophages and dendrictic cell, it 
also exposes them to Toll-like receptors (TLRs). TLR5, which is expressed on the 
apical side of human intestinal epithelial cells, recognises flagellin of enteropathogens 
such as Salmonella leading to activation of NF-κB (Hayashi et al., 2001). TLR5-
dependent signalling is activated by conserved amino acid residues on positions 89 
through 96 in bacterial flagellin (Andersen-Nissen et al., 2005); however, C. jejuni and 
Helicobacter use alternative amino acids at these positions rendering them 
unrecognisable by TLR5 (Andersen-Nissen et al., 2005). TLR9, which recognises 
unmethylated CpG dinucleotides, is also not stimulated during C. jejuni infection 
(Dalpke et al., 2006), most probably due to the AT-rich genome of this organism. TLR4 
senses C. jejuni LOS and triggers an NF-κB-dependent cascade leading to the 
production of proinflammatory cytokines (Iovine, 2008). The role of TLR-2 and TLR-4 
in inducing an immune response against C. jejuni has recently been suggested using 
murine dendritic cells (Rathinam et al., 2009). The role of other TLRs in eliciting host 
responses during C. jejuni infection is yet unknown; however, the cytoplasmic 
pathogen-recognition receptor NOD1 plays an important role in immune stimulation by 
C. jejuni (Zilbauer et al., 2007). 
C. jejuni infection in humans is characterised by the influx of neutrophils and other 
phagocytic cells (van Spreeuwel et al., 1985b). The direct antimicrobial activities of 
these phagocytes are attributable to the production of antimicrobial peptides/proteins 
and reactive oxygen species (Iovine, 2008). The ability of phagocytes to ingest and kill 
Campylobacter is strain-dependent and varies with the host source of the phagocytes 
(Wassenaar et al., 1997; Wooldridge and Ketley, 1997). Generally phagocytosis of 
C. jejuni is enhanced by opsonins such as complement (Blaser et al., 1985). Extremely 
limited availability of iron inside host tissue is thought to represent a non-specific host 
defence system against pathogenic bacteria (Schaible and Kaufmann, 2004). The 
intestinal mucous layer contains the iron-sequestering protein lactoferrin which makes 
the majority of iron unavailable for bacteria (Ward and Conneely, 2004). C. jejuni have 
to cope with iron-restricted conditions for successful colonisation of the intestine and 
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they acquire iron using the iron chelator protein FeoB and iron released from dying host 
cells during the inflammatory process (Stintzi et al., 2008).   
1.7.1.2  Antibody-mediated immunity 
Epidemiological studies have provided the evidence of protective humoral immunity 
against Campylobacter-mediated diarrhoea. A survey in breast-fed Mexican infants 
showed a lower incidence of Campylobacter-associated diarrhoea in those infants 
whose mothers had Campylobacter-specific secretory IgA (sIgA) antibodies in breast 
milk (Ruiz-Palacios et al., 1990). In the developing world where Campylobacter 
exposure is frequent, campylobacteriosis is more common in early childhood and a 
Campylobacter-specific antibody-mediated immune response starts developing within 
the first 2 years of life which is followed by continued increase in IgA levels and it is 
accompanied by lower incidence of illness and milder symptoms of Campylobacter 
infection in adults (Tribble et al., 2008). On the other hand, in the industrialised world 
where hygienic conditions are much better than the developing regions, Campylobacter 
enteritis generally occurs in adult patients who manifest moderate to severe symptoms 
and dysentery consistent with naïve or a semi-immune status (Tribble et al., 2007). A 
secretory immunoglobulin A (sIgA) response at the intestinal mucosa is considered the 
primary specific defence against Campylobacter. In the case of Campylobacter, 
flagellin, outer-membrane proteins and LOS elicit sIgA and IgG responses (Black et al., 
1988; Cawthraw et al., 2002) and Campylobacter-specific secretory IgA and serum IgA 
antibodies levels correlate with protection against disease (Tribble et al., 2008).  
Immunoglobulin G which mainly provides protection in blood and tissue can be 
detected in serum a few days post-infection and their levels peak 2-3 weeks after 
infection (Cawthraw et al., 2002) which persisted after clearance but elevated levels of 
IgA were detected only from onset of symptoms until the clearance of C. jejuni (Kaldor 
et al., 1983).  
In chickens, both the innate and humoral responses are activated against C. jejuni; new 
born chicks carry Campylobacter-specific maternal antibodies for the first two weeks of 
their life.  Such antibodies which recognise LOS, outer membrane proteins and flagellin 
(Cawthraw et al., 1994), lead to complement-mediated killing of C. jejuni in a strain 
specific manner (Sahin et al., 2003). The chick produces flagellin-specific antibodies by 
the age of 3 weeks (Cawthraw et al., 1994) but unlike humans, no antibodies are 
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produced against cytolethal distending toxin (Abuoun et al., 2005) and a poor immune 
response is elicited against the C. jejuni capsule (Jeurissen et al., 1998). 
   
1.7.2 Bacterial virulence determinants 
The bacterial pathogens use their weapons, the bacterial determinants, to establish an 
infection and develop the pathological changes in their host. A reasonable 
understanding of clinical and epidemiological aspects of C. jejuni infection has been 
achieved. Though molecular basis of C. jejuni pathogenesis is not fully understood, 
many bacterial factors that contribute to the pathogenesis of this organism have been 
identified; following is the brief description of these determinants. 
1.7.2.1 Cytolethal distending toxin 
Cytolethal distending toxin (CDT) is produced by many Gram-negative bacteria, 
including E. coli, Haemophilus ducreyi, Shigella dysenteriae, and Helicobacter species 
(Cope et al., 1997; Okuda et al., 1995; Peres et al., 1997; Young et al., 2000b). CDT 
was first described in C. jejuni in 1987 (Johnson and Lior, 1988) and since then 
considerable progress has been made in determining its role in disease and 
pathogenesis. The toxin causes the arrest of the eukaryotic cell cycle at the G2/M 
transition, preventing them to enter mitosis, leading to cell death (Lara-Tejero and 
Galan, 2000; Whitehouse et al., 1998). The toxin was named after the morphological 
changes associated with its action: cytoplasmic distension. The active holotoxin is a 
tripartite complex of CdtA, CdtB and CdtC (Lara-Tejero and Galan, 2001). The CdtB is 
the toxic component and microinjection or transfection of this subunit alone into host 
cells leads to the effects that are observed with the holotoxin (Lara-Tejero and Galan, 
2000). The B subunit of CDT shares similarity with a family of DNase I-like proteins 
and is thought to act as a DNase. It localises to the nucleus of host cells and causes 
DNA damage by double-strand breaks (Hassane et al., 2003). The functions of CdtA 
and CdtC subunits are not clear but they might mediate binding to host cells. CdtA and 
CdtC have some similarity to the B chain of the ricin toxin, which is responsible for 
receptor-mediated endocytosis of ricin (Lara-Tejero and Galan, 2001). Moreover, CdtA 
and CdtC bind HeLa cells with specificity, probably using the same receptor (Lee et al., 
2003). 
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CDT is responsible for the secretion of interleukin (IL)-8, a hallmark of C. jejuni 
pathogenesis, but there are also CDT-independent mechanisms of IL-8 stimulation 
(Hickey et al., 1999; Hickey et al., 2000). CDT might have a role in asymptomatic, 
commensal infections, which would provide a way to either avoid host immune-
response mechanisms or redirect them towards tolerance. In vitro, C. jejuni CDT 
induces cell death by apoptosis in human monocytic cells (Hickey et al., 2005). In a 
study that used a mouse model of H. hepaticus colonisation it was suggested that CDT 
has a function in immune modulation and persistent colonisation (Ge et al., 2005; Pratt 
et al., 2006). In a murine model experiment, the persistent colonisation of NF-κB-
deficient, but not wildtype mice, with wildtype C. jejuni 81-176 and its CdtB mutant 
was associated with a significantly impaired humoral antibody response in NF-κB-
deficient mice which indicates that CDT might allow C. jejuni to escape immune 
surveillance in an NF-κB-dependent manner (Fox et al., 2004).  
1.7.2.2 Lipooligosaccharides  
 Like many Gram-negative pathogenic bacteria, C. jejuni has surface polysaccharides 
including lipooligosaccharides (LOS) and capsule. Lipopolysaccharides (LPS) and LOS 
are anchored to the outer membrane of bacteria by lipid A and are considered toxic with 
potent immuno-modulating and immuno-stimulating properties (Gilbert et al., 2008). 
High molecular weight LPS is composed of a polymer of repeating oligosaccharide 
units linked to the core oligosaccharide of 10 -15 sugar residues which are anchored to 
lipid A. In contrast to LPS, LOS has a low molecular weight and lacks repeating 
oligosaccharide chain and consists of an outer core of non-repeating oligosaccharides 
anchored to lipid A (Gilbert et al., 2008). The outer core of C. jejuni LOS is highly 
variable (Dorrell et al., 2001; Parker et al., 2008) and is capable of mimicking human 
gangliosides. This mimicry can induce the post-infection autoimmune neurological 
disorders Guillain-Barré syndrome and Miller-Fisher syndrome (Guerry and Szymanski, 
2008; Willison and Yuki, 2002; Yuki et al., 1995). C. jejuni is capable of the 
endogenous synthesis of sialic acid for incorporation into ganglioside-like LOS cores. 
Mutants that lacked LOS core sialylation showed reduced reactivity with GBS patient 
serum and failed to induce an anti-ganglioside antibody response in mice (Godschalk et 
al., 2007). LOS and its sialylation are important for the virulence of this organism. 
Strains expressing sialylated LOS were more invasive in cultured epithelial cells than 
strains expressing non-sialylated LOS (Louwen et al., 2008). Moreover, mutation in 
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sialyltransferase (Cst-II) reduced the invasiveness in the mutants (Louwen et al., 2008). 
In C. jejuni the inactivation of galE, a gene important for biosynthesis of LOS, resulted 
in organisms with a reduced potential to invade epithelial cells in vitro (Fry et al., 
2000). Mutants in cgtA, which encodes an N-acetylgalactosaminyltransferase in C. 
jejuni 81-176, exhibited increased bacterial attachment and invasion of human cells, and 
increased protection from complement mediated killing (Guerry et al., 2002). Deletion 
of the LOS biosynthesis locus in C. jejuni NCTC11168 showed attenuated growth, loss 
of invasion and natural transformation efficiency of the mutant (Marsden et al., 2009). 
LOS is also involved in natural transformation competence and antibiotic resistance in 
C. jejuni. LOS truncation resulted in increased sensitivity to antibiotics and an increased 
natural transformation efficiency in the mutant (Jeon et al., 2009; Marsden et al., 2009).  
1.7.2.3 Capsule 
Many bacteria contain cell surface structures called capsules which are generally 
polysaccharide in nature however the capsule of bacteria including Yersinia pestis 
(Karlyshev et al., 1992), Bacillus anthracis (Ezzell and Welkos, 1999), Francisella 
tularensis (Su et al., 2007) and the S-layer of C. fetus (Blaser et al., 1988) are made up 
of polypeptides. Unlike LPS and LOS, capsule polysaccharides are loosely attached to 
the bacterial cell surface via a phospholipid moiety and are susceptible to the action of 
phospholipases (Karlyshev et al., 2008). Until recently, many strains of C. jejuni were 
thought to produce both LOS and a high molecular weight LPS. Sequencing of the first 
C. jejuni genome showed the presence of capsule biosynthesis genes and subsequent 
mutagenesis of these genes demonstrated that these high molecular weight LPS were 
actually capsular polysaccharides (Karlyshev et al., 2000). Capsule is also the major 
serodeterminant of the Penner serotyping scheme (Karlyshev et al., 2000). Capsule 
polysaccharides (CPS) play an important role in resistance to desiccation, the 
bactericidal activity of serum, as well as phagocytic uptake and may also contribute to 
intraphagocytic survival of the organism (Guerry and Szymanski, 2008). CPS can 
exhibit structural variation and confer resistance to complement-mediated killing of the 
bacteria. Indeed, loss of the C. jejuni capsule through inactivation of kpsM in C. jejuni 
resulted in organisms which were more sensitive to complement and which displayed 
reduced virulence in the ferret model (Bacon et al., 2001). A study found that the 
capsule provides no greater protection  to C. jejuni against the potent antimicrobial 
action of human β-defensins 2 or 3 (Zilbauer et al., 2005), however, capsule may 
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provide protection against β-defensins 1 and lysozyme (Zilbauer et al., 2008). Capsule 
also confers other virulence traits to bacteria. Inactivation of kpsE in C. jejuni 81116 
resulted in reduced adhesion and invasion in cultured epithelial cells; however, the 
ability to colonise the chicken gut was not affected in the mutant (Bachtiar et al., 2007). 
Bacterial cell-surface polysaccharides including capsule are required for biofilm 
formation (Moran and Annuk, 2003), which contributes to virulence of bacteria and 
leads to increased resistance to antibacterial drugs (Jeon et al., 2009). In a recent report, 
the expression of C. jejuni capsule polysaccharides, bacterial invasion and serum 
resistance were reduced when bacterial cells were co-cultured with epithelial cells 
(Corcionivoschi et al., 2009) which shows the interesting link between bacterial capsule 
and virulence.  
1.7.2.4 Glycosylation system 
Glycosylation of proteins is necessary for extending protein life, protease resistance and 
biological activity (Nothaft et al., 2008). It had long been believed that post-
translational N-linked glycosylation of proteins is a eukaryotic phenomenon and that 
bacteria only express non-glycosylated proteins. In 1989, post-translational 
modification of flagellin in C. jejuni was discovered (Logan et al., 1989). Following this 
observation, other studies found that Campylobacter express two protein glycosylation 
systems: one modifies serine or threonine residues on flagellin  (O-linked glycosylation) 
and the other modifies asparagine residues on many proteins (N-linked glycosylation) 
(Szymanski et al., 1999; Szymanski et al., 2003; Szymanski and Wren, 2005).  
O-linked glycosylation in C. jejuni was first observed in flagellin and the gene cluster 
encoding for O-linked glycosylation mapped adjacent to the flagellin structural genes in 
one of the most hypervariable regions of the C. jejuni chromosome. The flagellin in C. 
jejuni 81-176 is glycosylated with pseudaminic acid (Guerry and Szymanski, 2008), 
whereas, the flagellin of C. coli VC167 is modified with legionaminic acid (Young et 
al., 2007). More recently, in addition to the pseudaminic acid and legionaminic acid, 
two unusual 2,3-di-O-methylglyceric acid modifications of a nonulosonate sugar were 
identified in C. jejuni 11168 (Logan et al., 2009). O-linked glycosylation of flagellin is 
necessary for the proper assembly of the flagellar filament (Goon et al., 2003), thus 
defects in O-linked glycosylation result in a loss of motility and autoagglutination, a 
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decrease in the adherence to and invasion of host cells and decreased virulence in ferrets 
(Guerry et al., 2006).  
Unlike other polysaccharide surface structures of C. jejuni, the pgl genes encoding for 
the N-linked glycosylation system are conserved in C. jejuni and C. coli (Dorrell et al., 
2001; Szymanski et al., 2003). The N-linked glycan which is assembled by the Pgl 
system in Campylobacter consists of a heptasaccharide, unlike the tetrasaccharide that is 
transferred by the eukaryotic glycosylation system (Young et al., 2007). The role of N-
linked glycosylation in the biology of C. jejuni is not clear. However, strains with an 
inactivated Pgl system show defects in natural competence (Larsen et al., 2004) as well 
as reduced adherence and invasion in INT-407 cells and colonisation in chicken and 
mouse models (Kakuda and DiRita, 2006; Karlyshev et al., 2004; Szymanski et al., 
2002). The pgl gene mutation affects the glycosylation of numerous proteins and the 
resulting pleiotropic effects also include reduced protein reactivity to both human 
immune and Penner typing antisera (Nothaft et al., 2008).  
1.7.2.5 Flagella 
In humans, campylobacters mainly colonise the mucus filled crypts of the intestine. To 
survive and replicate in this viscous environment, flagella and the spiral-curved shape of 
Campylobacter aid its movement giving it a corkscrew motion (Shigematsu et al., 
1998). A rapid and darting motility of Campylobacter is mediated by polar flagella 
which is also one of the most well-characterised virulence determinants. The flagellum 
consists of an unsheathed polymer of flagellin subunits encoded by flaA and flaB that 
share 95% sequence homology (Nuijten et al., 1990) and are independently transcribed. 
Transcription of flaA is regulated by σ28 (encoded by fliA) whereas flaB expression is 
regulated by σ54 (encoded by rpoN) and this regulation is controlled by two component 
system FlgRS (Carrillo et al., 2004; Hendrixson and DiRita, 2003; Hendrixson, 2006; 
Sommerlad and Hendrixson, 2007; Wösten et al., 2004).  Mutation of flaA results in the 
production of a truncated flagellar filament composed of FlaB and having a severe 
reduction in motility (Wassenaar et al., 1991). Mutants in flaB, in contrast, showed no 
significant change in motility and produced flagellar filament that appears structurally 
normal (Guerry et al., 1991; Nuijten et al., 1990; Wassenaar et al., 1991). Flagella of C. 
jejuni are not only essential for motility but the importance of flagella in virulence of C. 
jejuni was realised in early studies. Experimentally intact flagella are necessary for 
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optimal colonisation of birds, model animals and humans (Black et al., 1988; 
Nachamkin et al., 1993; Wassenaar et al., 1993). C. jejuni mutants in motility were 
reduced in adhesion and invasion in cultured eukaryotic cells (Grant et al., 1993; 
Wassenaar et al., 1991; Yao et al., 1994). There are several reports that in the absence 
of a type-III secretion system in C. jejuni, flagella can function to secrete Cia proteins 
that might modulate virulence (Konkel et al., 1999; Konkel et al., 2004; Rivera-Amill et 
al., 2001). One of the secreted proteins, CiaB, was found important for C. jejuni F38011 
invasion into INT-407 cells (Konkel et al., 1999).  Secretion of FlaC which shares 77% 
similarity to FlaA but has no role in motility is proposed to be secreted through flagella. 
Its secretion was not observed in mutants in flgE (encoding the flagellar hook) and flgC, 
flgI or flgK which encodes the basal-body (Poly et al., 2007a; Song et al., 2004). The 
flaC gene is involved in virulence as mutation of flaC in C. jejuni TGH9011 resulted in 
a 86% reduction in invasion in HEp-2 cells (Poly et al., 2007a), however a flaC mutant 
of C. jejuni stain 81-176 showed 58% less invasion in INT-407 cells compared to the 
wildtype (Goon et al., 2006). Though not well-established in C. jejuni, 
autoagglutination is often associated with virulence of other pathogens (Chiang et al., 
1995; Frick et al., 2000; Sherlock et al., 2005). Flagella of C. jejuni have been shown to 
mediate autoagglutination (Golden and Acheson, 2002) and glycosylation of flagellins 
is also important for autoagglutination in this organism (Guerry et al., 2006). The 
functional aspects of Campylobacter flagella have recently been reviewed elsewhere 
(Guerry, 2007). 
1.7.2.6  Chemotaxis 
Bacteria respond to changes in their environmental conditions and change their 
temporal position to avoid unfavourable conditions and move towards favourable 
niches. Chemotaxis, where the bacterial cell moves in response to a chemical signal, is 
regulated by alternating between the clockwise and counter-clockwise rotation of the 
flagellum (Korolik and Ketley, 2008; Young et al., 2007). C. jejuni  displays 
chemotactic motility towards amino acids that are found in high levels in the chick 
gastrointestinal tract and towards components of mucous (Hugdahl et al., 1988; Tu et 
al., 2008). Chemotactic motility has an important role in the commensal lifestyle and is 
essential for colonisation and pathogenicity of C. jejuni. Non-chemotactic mutants 
failed to colonise in a suckling mouse model (Takata et al., 1992). Mutants in methyl-
accepting chemotaxis receptors (Cj0019c or Cj0262c) showed decreased chicken 
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colonisation ability (Hendrixson and DiRita, 2004). Strains that lack CheY, a response 
regulator that controls flagellar rotation, showed decreased virulence in a ferret disease 
model (Yao et al., 1997), reduced chicken colonisation (Hendrixson and DiRita, 2004) 
but appeared to be hyperinvasive (Golden and Acheson, 2002). Bioinformatics based 
genetic analysis showed that C. jejuni transduces an energy taxis (aerotaxis) signal 
using two proteins, CetA and CetB, in place of the single Aer protein used by E. coli 
and other species (Hendrixson et al., 2001; Young et al., 2007). C. jejuni mutants of 
chemoreceptor CetB (Cj1189) were deficient in their ability to invade cultured human 
intestinal epithelial cells (Golden and Acheson, 2002). In a recent report invasion of 
cells via the subcellular route (subvasion) was increased in C. jejuni in which 
expression of CheW, a scaffolding protein, was decreased (van Alphen et al., 2008). 
This all clearly demonstrates that there are some interesting connections between the C. 
jejuni chemotactic response and host cell interactions. 
 
1.7.3 Animal models of disease 
C. jejuni causes gastroenteritis in humans but the infection is asymptomatic in chickens 
and most other animals. The basis of the different outcomes in different hosts are not 
well understood (Zilbauer et al., 2008). This is partly due to lack of a good small animal 
model that reproduces human disease. Different animal models including chickens 
(Biswas et al., 2007; Hendrixson and DiRita, 2004; Jones et al., 2004), hamsters 
(Humphrey et al., 1985), ferrets (Bell and Manning, 1990), dogs (Olson and Sandstedt, 
1987), primates (Russell et al., 1989; Russell et al., 1993), rabbits (Burr et al., 1988; 
Caldwell et al., 1983; Walker et al., 1988), mice (Baqar et al., 2008; Watson et al., 
2007; Ziprin et al., 2001), guinea pigs (SultanDosa et al., 1983) and swine (Boosinger 
and Powe, 1988; Harvey et al., 2001; Mansfield and Gauthier, 2004) have all been used 
to study different aspects of Campylobacter infection. These models have been useful in 
understanding mechanisms of Campylobacter-induced disease and in determining 
different bacterial factors that contribute to disease by using bacterial strains in which 
different potentially virulence-related genes were mutated (Abuoun et al., 2005; Baqar 
et al., 2008; Fox et al., 2004; Hendrixson and DiRita, 2004; MacKichan et al., 2004), 
but limitations exist with these models. Monkeys and ferrets infected with pathogenic 
C. jejuni isolates can exhibit symptoms of disease that are seen in humans, including 
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inflammation of the gut and diarrhoea (Fox et al., 1987), but high cost and lack of 
knockout technology to study the host factors that are involved in disease reduced the 
attractiveness of these models. However, knock-out mice models have recently been 
used to study Campylobacter disease mechanisms and host immune responses (Fox et 
al., 2004; Mansfield et al., 2007; Watson et al., 2007) and may prove useful in 
understanding the host factors that contribute to C. jejuni infection. Chicken is a good 
model for studying the host colonisation and is potentially a good target for designing 
strategies to reduce Campylobacter infection in humans. Animal models of disease have 
their own limitations including high cost, inconsistency in results, ethical and legal 
processes involved in these studies as well as lack of disease and post-infection 
symptoms that mimic human disease. In addition to natural and experimental models of 
animal infection, much of the data on pathogenic mechanisms used by C. jejuni has 
come from in vitro studies using cultured human and animal cells. 
 
1.7.4 Interaction of Campylobacter jejuni with host cells  
Bacterial diseases of the gastrointestinal tract typically result from multifactorial 
processes of interactions between the offending bacteria and the host. Humans have 
developed a variety of innate mechanisms including mucous layer, epithelial barrier and 
gastric acidity to protect themselves from pathogenic organisms but at the same time 
bacteria have also evolved pathogenic attributes to circumvent these innate host 
defences. The understanding of interactions of C. jejuni with host cells is very important 
for understanding the mechanisms of pathogenesis. A brief description of interactions of 
C. jejuni with the host is given below. 
1.7.4.1 Colonisation 
Campylobacter is transmitted to the host through contaminated food and after passage 
through the stomach these organisms colonise the intestinal mucosa of most vertebrate 
hosts (Newell and Fearnley, 2003). In chickens, this colonisation is commensal, with C. 
jejuni found at highest levels in the mucosal crypts of caeca and to a lesser extent in the 
small intestine (Beery et al., 1988). However, in humans C. jejuni mainly colonises the 
colon and to a lesser extent the small intestine, and colonisation can lead to acute 
enteritis (Black et al., 1988). The surface of the intestinal tract is covered with a 
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viscous, mucin-rich mucous layer that provides lubrication and protection to underlying 
epithelial cells against chemical, enzymatic and microbial insult (Tu et al., 2008). 
Mucins are major chemoattractants for C. jejuni (Hugdahl et al., 1988) and the 
bacterium exhibits higher adherence and invasion in Caco-2 cells in the presence of 
mucous (Szymanski et al., 1995). Most pathogenic bacteria including C. jejuni that 
colonise the gastrointestinal tract subvert the mucous barrier by producing mucolytic 
enzymes and effective motility (Wassenaar et al., 1993). The flagella and flagellar 
motility is very important in host gut colonisation by C. jejuni (Black et al., 1988; 
Nachamkin et al., 1993; Wassenaar et al., 1993). Exposure of C. jejuni to mucin up-
regulates the expression of flaA but not flaB and genes encoding mucin-degrading 
enzymes including Cj1344c and Cj0843c (Tu et al., 2008). Additionally, mutants in 
genes that encode the flagellin and flagellar biosynthesis regulators FlgR, σ54 and σ28 all 
display defects in host colonisation (Fernando et al., 2007; Hendrixson and DiRita, 
2004; Hendrixson, 2006; Nachamkin et al., 1993; Wassenaar et al., 1993; Wösten et al., 
2004). Two component regulatory systems of C. jejuni are important for chicken gut 
colonisation; the DccRS regulated genes whose function is yet unknown are important 
for growth and/or chicken gut colonisation (MacKichan et al., 2004), and the RacRS 
regulatory system of C. jejuni is required for the organism’s survival at avian body 
(higher) temperature and colonisation in the chicken gut (Bras et al., 1999). Another 
two-component regulator that regulates the ability of enteric bacteria to resist the 
antimicrobial effects of bile is also important for their colonisation of the host intestinal 
tract. A mutant in CprS part of the two-component regulatory system, CprRS which 
regulates the Campylobacter planktonic growth showed a reduction in chicken 
colonisation (Svensson et al., 2009).  Inactivation of the Campylobacter bile resistance 
regulator, CbrR encoded by Cj0643, resulted in the reduction in deoxycholate resistance 
and chicken colonisation in C. jejuni strain F38011 (Raphael et al., 2005).   
Glycosylation systems, chemotaxis and the ability to degrade reactive oxygen species 
are also important for host gut colonisation in C. jejuni. The mutants with inactivated O-
linked and N-linked glycosylation system were severely affected in their ability to 
colonise chickens (Howard et al., 2009; Kakuda and DiRita, 2006; Karlyshev et al., 
2004). Signature tagged-mutagenesis of C. jejuni in a chicken model of infection 
resulted in the identification of two adjacent genes, one was a methyl-accepting 
chemotaxis protein (MCP) and the other was a putative cytochrome peroxidase 
Chapter 1. Introduction 
 26 
(Hendrixson and DiRita, 2004). A C. jejuni 81-176 mutant of luxS encoding for an 
autoinducer-2 biosynthesis enzyme showed reduced chicken gut colonisation potential 
and chemotaxis toward organic acids (Quinones et al., 2009) suggesting the importance 
of chemotaxis in host gut colonisation. Recently two genes, docA and Cj0382, encoding 
for a putative cytochrome C peroxidase showed a modest decrease in chick colonisation 
ability of C. jejuni 81-176 (Bingham-Ramos and Hendrixson, 2008).  Other bacterial 
determinants involved in chicken gut colonisation include znuA (Cj0143c) encoding for 
a periplasmic component of a putative Zinc ABC transport system (Davis et al., 2009), 
γ-glutamyl transpeptidase (Barnes et al., 2007), an autotransporter protein, CapA 
(Ashgar et al., 2007), CmeR, a transcriptional repressor modulating the expression of 
the multidrug efflux pump CmeABC in Campylobacter jejuni (Guo et al., 2008), kpsM 
encoding for capsule polysaccharide export protein (Jones et al., 2004) which is in 
contrast to another report that found that capsular polysaccharide is not important for 
chicken gut colonisation (Bachtiar et al., 2007), Campylobacter outer membrane 
protein, CadF (Ziprin et al., 1999) and Campylobacter secreted protein, CiaB (Ziprin et 
al., 2001).  
Human intestine colonisation by C. jejuni is usually accompanied by inflammatory 
disease whereas the chicken gut colonisation is asymptomatic. This difference in the 
outcome of gut colonisation may be due to differences in body temperature and/or 
immune responses of both the hosts. Recently a study suggested that the expression of 
Cj0414 and Cj0415 encoding for a putative gluconate dehydrogenase in C. jejuni 81-
176 was higher at chicken body temperature (42oC) than at human body temperature 
(37oC). The mutant in Cj0415 had defective chicken colonisation but not in mice whose 
body temperature is 37oC and the authors suggested that the ability of C. jejuni to use 
gluconate as an electron donor via GADH activity is an important metabolic 
characteristic that is required for full colonization of avian but not mammalian hosts 
(Pajaniappan et al., 2008). A recent study in which the immune response of chicken 
against C. jejuni colonisation was investigated, found that Campylobacter infection 
significantly reduced expression of seven antimicrobial peptide (AMP) genes (Meade et 
al., 2009). These antimicrobial peptides play an important role in clearing the bacteria 
from host intestinal surfaces (Zilbauer et al., 2008) and the reduced expression of the 
antimicrobial peptides in chickens infected with Campylobacter may be involved in 
prolonged chicken colonisation of bacteria (Meade et al., 2009).     
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1.7.4.2 Adhesion and invasion 
Bacterial disease of the enteric tract generally results from a set of complex interactions 
between the causative bacterial organism and the host. Many bacterial pathogens 
including Yersinia enterocolitica, Salmonella, Shigella species and C. jejuni develop 
specific interactions e.g. adherence and/or invasion with host mucosa to initiate disease 
(Hu and Kopecko, 2008). Campylobacter invasion into the epithelial mucosa appears to 
be an essential process leading to the disease outcome i.e. gastroenteritis (Ketley, 1997). 
The results of analysis of intestinal biopsy samples of patients infected with C. jejuni 
(van Spreeuwel et al., 1985b), as well as experiments with infected primates (Russell et 
al., 1989; Russell et al., 1993) and other experimentally infected model animals 
(Babakhani and Joens, 1993; Newell and Pearson, 1984; Yao et al., 1997), together with 
in vitro experiments that used human epithelial cells (De Melo et al., 1989; Ketley, 
1997; Konkel and Joens, 1989; Oelschlaeger et al., 1993), have clearly demonstrated 
that C. jejuni can adhere to and invade the cells of the intestinal tract. Invasion studies 
with intestinal epithelial cells as well as other cell lines revealed that the relative ability 
of different C. jejuni isolates to invade cultured cells is strain dependent (Everest et al., 
1992; Konkel and Joens, 1989; Newell et al., 1985) and a statistically significant 
correlation was observed between the ability of C. jejuni to invade cultured cells and 
clinical symptoms of infection (Everest et al., 1992). A previous study found that 
C. jejuni recovered from patients with diarrhoea and fever adhered to cultured human 
cells with higher efficiency than those isolated from asymptomatic individuals 
(Fauchere et al., 1986). Everest et al. reported that 86% of isolates of C. jejuni from 
patients suffering from colitis were able to invade and translocate across Caco-2 
polarised cells compared to 48% of strains isolated from individuals with non-
inflammatory disease (Everest et al., 1992). Immunofluorescent and electron 
microscopy examination of HeLa cells infected with C. jejuni showed that the strains 
isolated from the environment were much less invasive than clinical isolates (Newell et 
al., 1985). Fearnley et al. identified a higher ratio of hyperinvasive strains among 
clinical isolates of C. jejuni than those obtained from poultry or environmental sources 
(Fearnley et al., 2008). These observations emphasize the importance of bacterial 
invasiveness as a virulence factor for Campylobacter pathogenesis as different 
Campylobacter isolates vary in their virulence properties and that those having a higher 
ability to invade intestinal epithelial cells are more virulent.   
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1.7.4.2.1 Cytoskeleton required for invasion 
Invasive bacteria are those that are capable of inducing their own uptake into non-
phagocytic cells. The mechanisms underlying bacterial entry, host cytoskeleton 
requirements and dissemination reveal common strategies as well as unique tactics used 
by individual species to establish infection. Some enteropathogens including Yersinia 
enterocolitica and Listeria monocytogenes express surface ligands that bind host cell 
receptors often involved in cell-cell adherence. Binding of the bacterial ligand to the cell 
receptor leads to the formation of a vacuole that engulfs bacteria through a zippering 
process in which relatively modest cytoskeleton rearrangements and membrane 
extensions occur in response to engagement of the receptor (Cossart and Sansonetti, 
2004). Other pathogens such as Shigella and Salmonella species use a trigger 
mechanism of entry in which components of a bacterial type-III secretion system make 
a bridge between the bacterium and host cell transmembrane receptor which then 
mediates the entry process. The pathogens bypass the adhesion step and interact directly 
with the host cell machinery, inject effector molecules through a dedicated secretory 
system that causes massive cytoskeletal changes triggering the formation of a 
macropinocytic pocket and bacterial cell internalisation (Cossart and Sansonetti, 2004). 
Microfilaments are the major cytoskeleton exploited in both the pathways described 
above for the entry of enteric pathogens into host cells. In contrast to the processes 
described above, some microorganisms including C. jejuni enter host cells via a 
microtubule and/or a microfilament dependent pathway (Hu and Kopecko, 2008).  
C. jejuni strains have been reported to exhibit different host cytoskeletal requirements 
for invasion, which are dependent upon the bacterial strain and host cell utilised. Only a 
few C. jejuni strains have been studied in detail for the molecular mechanism of host 
cell invasion but results suggest that Campylobacter may utilise either microfilament 
dependent (De Melo et al., 1989; Konkel and Joens, 1989) or microtubule dependent 
(Hu and Kopecko, 1999) or both microtubule and microfilament dependent (Biswas, 
2003; Monteville et al., 2003) pathways for entry into host cells. During INT-407 cell 
invasion, finger like epithelial cell membrane protrusions were formed in response to 
signal transduction from C. jejuni strain 81-176 bound to cells. The formation of these 
membrane protrusions is a result of actin filament depolymerisation and polymerisation 
of microtubule bundles (Hu and Kopecko, 2008). Once internalised C. jejuni remains 
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within a membrane-bound endosome and the endosome containing C. jejuni moves 
along microtubules to the perinuclear region of the cell (Hu et al., 2008).   
1.7.4.2.2 Translocation 
The occurrence of extra-intestinal C. jejuni infections and isolation of the bacteria from 
human blood implies that the bacteria pass through the normally impermeable intestinal 
epithelial barrier to reach the lamina propria. Translocation of bacteria in in vitro 
systems has been reported for C. jejuni (Everest et al., 1992; Konkel et al., 1992). The 
pathways used by bacteria to traverse the intestinal barrier are transcellular where 
bacteria pass through the epithelial cell cytoplasm or paracellular where bacteria pass 
through the tight junctions of cell layers (Hu and Kopecko, 2008; Konkel et al., 1992). 
Campylobacter species have been observed to use the paracellular route to translocate 
across polarised epithelial cell monolayers (Everest et al., 1992; Grant et al., 1993; 
Konkel et al., 1992). Once internalised, C. jejuni does not escape from the endosome 
and these bacteria undergo limited intracellular replication during the first 8 to 10 hours 
post infection (Hu and Kopecko, 2008). The endosome carrying the internalised bacteria 
moves towards and fuses with the basolateral membrane to release the bacteria by 
exocytosis (Hu and Kopecko, 2008). C. jejuni infection does not disrupt tight junction 
integrity at early times after infection (Hu and Kopecko, 2008); however, infection of 
polarised Caco-2 cells with high multiplicities of infection (i.e. 10,000) was found to 
cause loss of transmembrane electrical resistance 24 hours after infection (MacCallum 
et al., 2005). The loss of transmembrane electrical resistance was accompanied by 
rearrangement of tight junction proteins (MacCallum et al., 2005) and similar 
observations were also made during infection of polarised T84 cells with C. jejuni 
(Chen et al., 2006). Recently a paracellular pathway of C. jejuni mucosal translocation 
termed subvasion has been described (van Alphen et al., 2008). During infection of 
non-polarised epithelial cells, C. jejuni were observed to pass between cells and proceed 
basally before internalisation (van Alphen et al., 2008). 
1.7.4.2.3 Bacterial determinants involved in host cell adhesion and invasion 
Microorganisms generally require surface molecules such as pili and adhesins for their 
adherence to molecules on the host cell surface (i.e. receptors) to successfully bind and 
colonise their host (Young et al., 2007). In some instances, such binding is also required 
for host cell invasion, where the organisms are protected from the immune responses. 
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Moreover, pathogenic bacteria typically utilise host cell molecules to promote their own 
pathogenic ability; for example Salmonella species and Shigella species secrete effector 
molecules through type-III secretion machinery into eukaryotic host cells. These 
bacterial adherence factors and secreted effector proteins initiate host signal 
transduction events that lead to internalisation of the pathogen (Hu and Kopecko, 2008). 
The genome sequences of many strains reveal that C. jejuni does not contain an 
orthologue of any obvious pilus or classical adhesins, invasins or pathogenicity islands 
(Fouts et al., 2005; Parkhill et al., 2000). The virulence-associated factors of the 
genetically related Helicobacter pylori are absent in C. jejuni, with the only revealed 
orthologues being housekeeping genes (Hu and Kopecko, 2008).  
In the absence of identifiable adherence organelles and a type-III secretion system, 
several proteins have been reported that contribute to C. jejuni adherence to and 
invasion of eukaryotic cells. The reported adhesins of C. jejuni include flagella, outer 
membrane proteins and surface polysaccharides (Fauchere et al., 1986; Jin et al., 2001; 
Karlyshev et al., 2004; McSweegan and Walker, 1986). The role of flagella in 
colonisation of host gut, cultured epithelial cell adherence and internalisation of C. 
jejuni into host epithelial cells has been suggested by many studies (Grant et al., 1993; 
Konkel et al., 1992a; Wassenaar et al., 1991; Yao et al., 1994). Mutation in genes 
encoding for flagella biosynthesis alternate sigma factors fliA (Sigma 28) and rpoN 
(sigma 54) resulted in reduced motility and invasion in cultured HeLa cells (Fernando et 
al., 2007). C. jejuni mutants with paralysed flagella showed 30- to 40-fold reduced 
adhesion and invasion in INT-407 cells in vitro when compared to the wildtype strain 
(Yao et al., 1994).  
Other than flagellar motility, chemotaxis also plays a very important role in C. jejuni 
adhesion to host cells (Hendrixson and DiRita, 2004). Insertional inactivation of cheY, a 
gene thought to have a role in chemotaxis, results in a more adherent and invasive 
phenotype compared to the wildtype strain (Golden and Acheson, 2002; Yao et al., 
1997). Duplication of the cheY gene resulted in attenuation of virulence in the ferret 
model, however colonisation in the mouse model was not affected (Yao et al., 1997); 
these observations suggest cheY to be a repressor of adhesion and invasion. C. jejuni 
mutants of the chemoreceptor CetB (Cj1189) were deficient in their ability to invade 
human epithelial cells in vitro (Golden and Acheson, 2002). In a recent report invasion 
of cells via the subcellular route (subvasion) was increased in C. jejuni in which 
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expression of CheW, a chemotaxis-associated protein, was decreased (van Alphen et al., 
2008). It suggests an interesting link between the C. jejuni chemotactic response and 
host cell invasion. 
The CadF (Campylobacter adhesion to fibronectin), a C. jejuni outer membrane protein 
mediates the binding of the pathogen to the host extracellular matrix component, 
fibronectin (Konkel et al., 1997). Anti-CadF antibody reduced the binding of C. jejuni 
to immobilised fibronectin by more than 50%. CadF is required for maximal binding 
and invasion of cultured eukaryotic cells by C. jejuni (Monteville et al., 2003). The 
major outer membrane protein of C. jejuni is also thought to bind to INT-407 cells 
(Schroder and Moser, 1997). JlpA is another surface exposed adhesin of C. jejuni; it is 
lipoprotein in nature and is important for C. jejuni binding to HEp-2 cells (Jin et al., 
2001). JlpA binds to the host cell’s heat shock protein Hsp90α that consequently 
activates NF-κB and p38 mitogen-activated protein (MAP) kinase, both of which 
contribute to proinflammatory responses (Jin et al., 2003). This indicates how some of 
the adhesins contribute to the inflammation that is observed during C. jejuni 
pathogenesis. Another lipoprotein, CapA, is a Campylobacter autotransporter protein 
which was implicated as a possible adhesin. A CapA-deficient mutant showed 
decreased attachment to Caco-2 cells and reduced colonisation in a chick model (Ashgar 
et al., 2007). 
Some putative adhesins of C. jejuni are located in the periplasm. PEB1 is a 28-kDa 
Campylobacter periplasmic protein and it belongs to other related proteins, PEB2-4 (Pei 
et al., 1991). PEB1 is conserved in C. jejuni and C. coli strains (Pei and Blaser, 1993; 
Pei et al., 1998). PEB1 and PEB3 are antigenically similar; PEB3 shows partial 
homology with class 1 pili of Neisseria meningitidis and heat-labile enterotoxin B-unit 
of E. coli, both of which are involved in adhesion to human mucosal epithelia (Pei et 
al., 1991). PEB1 is crucial for C. jejuni binding to HeLa cells and shares homology with 
the periplasmic-binding proteins involved in nutrient uptake i.e. ATP-binding cassette 
(ABC) transporters (Leon-Kempis Mdel et al., 2006; Pei and Blaser, 1993). Although 
PEB1 has not been localised to the inner or outer membrane, some has been observed in 
culture supernatants (Leon-Kempis Mdel et al., 2006). The glycoprotein Cj1496c is 
another periplasmic protein of C. jejuni, which has homology to a magnesium 
transporter and is also required for maximal adherence and invasion in cultured INT-
407 cells (Kakuda and DiRita, 2006). 
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C. jejuni invasion is dependent both on host cell signal transduction and bacterial 
nascent protein synthesis (Konkel et al., 1999; Wooldridge and Ketley, 1997). C. jejuni 
secrete a set of proteins called Cia (Campylobacter invasion antigen) proteins when 
grown in the presence of human intestinal epithelial cells; CiaB is one of Cia proteins 
and has been characterised in detail (Konkel et al., 1999). CiaB is predicted to be 73.1 
kDa in size and shows no similarity to other known proteins. Mutation of the ciaB gene 
in C. jejuni strain F38011 resulted in the loss of secretion of this protein and a 50-fold 
reduction in invasion of the mutant into INT-407 cells compared to wildtype strain 
(Konkel et al., 1999); however, mutation of this gene in C. jejuni strain 81-176 had no 
significant effect on the invasion of INT-407 cells (Goon et al., 2006).  
The surface polysaccharide molecules including the LOS and capsule of C. jejuni also 
play important roles in the interaction of the bacteria with hosts. The high-molecular 
weight glycan capsule and LOS of C. jejuni are also required for bacterial attachment 
and invasion in host cells in vitro and full virulence in the ferret animal model (Bacon et 
al., 2001; Kanipes et al., 2004; Karlyshev et al., 2000). Purified LOS can bind to INT-
407 cells which can be inhibited by periodate oxidation of LOS; moreover, epithelial 
cell binding of purified LOS subsequently inhibits adhesion of whole C. jejuni cells 
(McSweegan and Walker, 1986). Inactivation of galE, a gene involved in LOS 
biosynthesis, also caused a reduction in C. jejuni adhesion to and invasion in INT-407 
cells, however, the ability of chicken colonisation of the mutant was not affected (Fry et 
al., 2000). Mutation in the LOS locus of C. jejuni results in the loss of invasiveness in 
cultured intestinal epithelial cells (Kanipes et al., 2004). A large deletion of the whole 
LOS biosynthesis locus showed that LOS was not essential for the viability of C. jejuni 
but it abolished invasion of the mutant in Caco-2 cells (Marsden et al., 2009).  
Sialylation of LOS is also important for C. jejuni invasion in cultured epithelial cells; 
inactivation of LOS sialyltransferase encoded by Cst-II in three GBS-associated C. 
jejuni strains reduced their ability to invade cultured epithelial cells (Louwen et al., 
2008). 
The N-linked general protein glycosylation pathway (pgl) of C. jejuni is also important 
for host cell adherence and invasion. The inactivation of pglH in C. jejuni resulted in a 
significant reduction in the adherence and invasion in Caco-2 cells in vitro (Karlyshev 
et al., 2004). C. jejuni pgl mutants are reduced in their ability to adhere to and invade 
cultured Caco-2 cells (Hu and Kopecko, 2008). Inactivation of the glycosylation 
Chapter 1. Introduction 
 33 
associated genes pglB and pglE encoding for an oligosaccharide transferase and a 
putative aminotransferase in C. jejuni, respectively, resulted in reduction in adhesion 
and invasion of the mutants in INT-407 cells in vitro (Szymanski et al., 2002). Mutation 
of Cj1121c encoding for an aminotransferase which is involved in protein glycosylation 
in C. jejuni impaired the motility of the mutant and reduced its ability to invade 
intestinal epithelial cells in vitro (Vijayakumar et al., 2006). A C. jejuni glycoprotein 
encoded by Cj1496c is important for invasion in intestinal epithelial cell line INT-407, 
however, glycosylation of the protein is not important for virulence (Kakuda and 
DiRita, 2006). A previous report showed a monoclonal antibody that bound to the 
flagella and the surface of a less passaged (invasive) strain only bound to the flagella of 
the same strain that had lost its invasiveness by repeated passage. Western blots of 
lysates of the invasive and repeatedly passaged strains identified antigens of 38-42 kDa, 
possibly glycoproteins, which were only expressed by the invasive strain (Konkel et al., 
1990). These results suggest that glycosylation pathway is important for pathogen-host 
cell interactions and glycoproteins of C. jejuni may act as adhesins and promote 
invasion in epithelial cells. 
Other C. jejuni factors involved in adherence to and/or invasion in cultured host cells 
include Cj1461 encoding for a methyltransferase (Kim et al., 2008), luxS encoding for 
an autoinducer-2 biosynthesis enzyme (Quinones et al., 2009), a putative 
posttranslational regulator CsrA of C. jejuni 81-176 (Fields and Thompson, 2008), clpP 
and lon encoding for ATP-dependent proteases (Cohn et al., 2007), Cj0125c encoding 
the transcription regulator DskA-like protein in C. jejuni (Yun et al., 2008) and SpoT, a 
stringent response regulator of C. jejuni (Gaynor et al., 2005). Characterisation of some 
the proteins found on a C. jejuni plasmid, pVir, has suggested their role in virulence of 
C. jejuni strain 81-176. All the four plasmid-encoded proteins (comB1, comB2, comB3 
and virB11) have some homology to components of type-IV secretion systems and 
similarity to Helicobacter pylori proteins (Bacon et al., 2000). These proteins have been 
shown to be important in INT-407 cell adhesion and invasion, as well as contributing to 
virulence in the ferret model (Bacon et al., 2000).  
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1.7.5 Project background and aims of study 
Clinical observations and experimental evidence indicate that the ability of C. jejuni to 
invade the host intestinal epithelium is an important determinant of its ability to cause 
focal necrosis of the colonic mucosa (van Spreeuwel et al., 1985a). However, the 
molecular mechanisms involved in C. jejuni invasion of host epithelial cells remain 
largely uncharacterised. Moreover, the ability of C. jejuni to invade cultured epithelial 
cells varies from strain to strain and the strains isolated from individuals suffering from 
inflammatory disease have shown a higher ability of host cell invasion compared to 
those isolated from asymptomatic individuals. This suggests that invasiveness is an 
important marker of virulence in C. jejuni. Many studies have been undertaken to 
investigate the bacterial factors that contribute to invasiveness exhibited by C. jejuni. 
However, the molecular basis underlying the variation in invasiveness in C. jejuni 
strains is not yet fully understood.  
In a previous study, the variation in invasiveness of C. jejuni was investigated and a 
number of strains were found to be hyperinvasive in vitro (Fearnley et al., 2008).  One 
of these strains, 01/51, a clinical isolate, was studied further by using transposon 
insertion mutagenesis. A random transposon mutant library (ca. 1000) was generated in 
this strain and a number (n=96) of these mutants were screened for invasion using the 
human intestinal epithelial cell line INT-407 in a pilot study (Manning et al., 2003a). A 
considerable number of the mutants were yet to be screened to find the mutants with 
reduced invasion compared to wildtype strain and hence identify the genes involved in 
invasion.  
The overall aim of this investigation was to identify the molecular basis of hyper-
invasiveness in Campylobacter jejuni. A number of approaches were adopted to achieve 
this aim: 
1. To establish a Campylobacter jejuni invasion assay using human colonic 
epithelial (Caco-2) cells and to confirm the invasion phenotype of selected 
C. jejuni strains from a previous study.  
2. To screen a random transposon mutant library constructed in hyper-invasive 
strain C. jejuni 01/51 (as determined in a previous study using INT-407 
cells) for genes involved in host cell invasion. 
3. To confirm the host cell invasion-associated role of the identified genes 
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using further mutagenesis and complementation tools. 
4. To characterise the phenotypic properties of selected identified genes using 
defined and complemented mutants in a variety of assays including chick 
colonisation, motility, growth and stress survival assays. 
5. To determine the functional aspects of the selected gene(s) to determine the 
molecular basis of the invasion-related role. 
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2 MATERIALS AND METHODS 
 
2.1 Chemicals, bacterial strains, plasmids and primers 
All the chemicals were purchased from Sigma-Aldrich (Poole, UK) unless specified. 
All bacterial strains were previously isolated and identified and were obtained from the 
Veterinary Laboratories Agency, Weybridge, UK. Bacterial genetic modifications made 
in this study will be mentioned. 
2.1.1 Bacterial strains used in this study 
All the bacterial strains used in this study were kindly provided by Prof. DG Newell, 
Veterinary Laboratories Agency (VLA), Weybridge, UK. Details of these strains are 
given in Table 2.1. 
Table 2.1 Bacterial strains and mutants used in this study.  
Source Strain Isolated 
from  
Invasion 
 potential 
Comment/reference                                        
C. jejuni 
01/04 
Blood Hyperinvasive (Fearnley et al., 2008) 
 
 
C. jejuni 
01/10 
Blood Hyperinvasive (Fearnley et al., 2008) 
 
 
C. jejuni 
NCTC11168 
Faeces Highly 
invasive 
This strain of C. jejuni was first isolated 
from the feaces of a human patient 
suffering from diarrhoea by Martin 
Skirrow in 1977 (Gaynor et al., 2004). 
The NCTC11168 is a laboratory adapted 
strain that was the first fully sequenced 
genome C. jejuni (Parkhill et al., 2000). 
C. jejuni 
81116 
Faeces Low invasive Isolated from patient with diarrhoea 
during a water-borne outbreak in a 
boarding school (Palmer et al., 1983). 
The whole genome sequence of this 
strain has been published (Pearson et al., 
2007). 
 
C. jejuni 
01/51 
Faeces Hyperinvasive (Fearnley et al., 2008) 
 
 
C. jejuni 
01/32 
Faeces Hyperinvasive (Fearnley et al., 2008) 
 
 
C. jejuni 
01/35 
Faeces Hyperinvasive (Fearnley et al., 2008) 
 
 
Human 
 
 
 
 
 
  
C. jejuni Faeces Hyperinvasive (Fearnley et al., 2008) 
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01/41  
 
C. jejuni 
01/46 
Faeces Low invasive (Fearnley et al., 2008) 
 
 
C. jejuni 
01/50 
Faeces Hyperinvasive (Fearnley et al., 2008) 
 
 
Environment C. jejuni 
EX114 
Puddle Hyperinvasive This strain was isolated from a puddle 
near a poultry farm (Fearnley et al., 
2008). 
 
 C. jejuni 
01/51∆cipA 
  The C. jejuni 01/51 mutant in cipA (this 
study). 
 C. jejuni 
01/51 
∆Cj0690c 
  The C. jejuni 01/51 mutant in Cj0690c 
(this study). 
 C. jejuni 
01/51 
∆Cj1136 
  The C. jejuni 01/51 mutant in Cj1136 
(this study). 
 C. jejuni 
01/51 
∆Cj1245c 
  The C. jejuni 01/51 mutant in Cj1245c 
(this study). 
 C. jejuni 
01/51 
∆Cj1305c 
  The C. jejuni 01/51 mutant in Cj1305c 
(this study). 
 C. jejuni 
01/51 
∆Cj1539c 
  The C. jejuni 01/51 mutant in Cj1539c 
(this study). 
 C. jejuni 
01/51 
∆cipA+cipA 
  The C. jejuni 01/51 mutant in cipA 
complemented with cipA along with 
presumptive promoter (this study). 
 C. jejuni 
01/51 
∆Cj0690c+
Cj0690c 
  The C. jejuni 01/51 transposon mutant in 
Cj0690c complemented with Cj0690c 
along with presumptive promoter (this 
study). 
 C. jejuni 
01/51 
∆Cj1136+ 
Cj1136 
  The C. jejuni 01/51 transposon mutant in 
Cj1136 complemented with Cj1136 
along with presumptive promoter (this 
study). 
 C. jejuni 
01/51 
∆Cj1539c+ 
Cj1539c 
  The C. jejuni 01/51 transposon mutant in 
Cj1539c complemented with Cj1539c 
along with presumptive promoter (this 
study). 
Chicken C. jejuni 
RM1221 
Carcass Not known This strain is a genome sequenced 
C. jejuni strain (Fouts et al., 2005). 
Invitrogen, 
UK 
E. coli 
TOP10 
Commercial Not known F- mcrA ∆(mrr-hsdRMS-mcrBC) 
Φ80lacZ∆M15 ∆lacX74recA1 araD139 
∆l(ara-leu)7697 galU galK rpsL (StrR) 
endA1 nupG 
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2.1.2 Plasmids used in this study 
Table 2.2 Plasmids used in this study. 
Plasmid name  Plasmid description Antibiotic resistance 
cassette 
Original source 
pGEM®-T Easy PCR products cloning vector Ampicillin  Promega, UK 
pUOA18 Campylobacter shuttle vector Chloramphenicol (Wang and Taylor, 
1990) 
pMA24 Source of kanamycin cassette Kanamycin 
Ampicillin 
(Abuoun, 2007) 
pGEM:685 pGEM®-T Easy with cloned 
cipA gene 
Ampicillin This study 
pGEM:685::kan cipA mutation construct in 
pGEM®-T Easy vector 
Ampicillin 
Kanamycin 
This study 
pGEM:690 pGEM®-T Easy with cloned 
Cj0690c gene 
Ampicillin This study 
pGEM:690::kan Cj0690c mutation construct in 
pGEM®-T Easy vector 
Ampicillin 
Kanamycin 
This study 
pGEM:1136 pGEM®-T Easy with cloned 
Cj1136 gene 
Ampicillin This study 
pGEM:1136::kan Cj1136 mutation construct in 
pGEM®-T Easy vector 
Ampicillin 
Kanamycin 
This study 
pGEM:1245 pGEM®-T Easy with cloned 
Cj1245c gene 
Ampicillin This study 
pGEM:1245::kan Cj1245c mutation construct in 
pGEM®-T Easy vector 
Ampicillin 
Kanamycin 
This study 
pGEM:1305 pGEM®-T Easy with cloned 
Cj1305c gene 
Ampicillin This study 
pGEM:1305::kan Cj1305c mutation construct in 
pGEM®-T Easy vector 
Ampicillin 
Kanamycin 
This study 
pGEM:1539 pGEM®-T Easy with cloned 
Cj1539c gene 
Ampicillin This study 
pGEM:1539::kan Cj1539c mutation construct in 
pGEM®-T Easy vector 
Ampicillin 
Kanamycin 
This study 
pAJ20 Part of Cj0652, Cj0653c and 
intergenic region cloned in 
PGEM®-T Easy 
Ampicillin This study 
pAJ21 pAJ20 with additional BamHI 
site introduced in intergenic 
region. 
Ampicillin This study 
pAJ22 C. jejunji complementation 
suicide vector with Cmr 
cassette cloned in pAJ21. 
Ampicillin 
Chloramphenicol  
This study 
pAJ23 C. jejunji complementation 
suicide vector with kanr 
cassette cloned in pAJ21. 
Ampicillin 
Kanamycin  
This study 
pAJ22-1136 pAJ22 with cloned Cj1136 
along with its promoter 
Ampicillin 
Chloramphenicol  
This study 
pAJ22-cipA pAJ22 with cloned cipA 
(Cj0685c) and its promoter 
Ampicillin 
Chloramphenicol 
This study 
pAJ22-1245 pAJ22 with cloned Cj1245c 
along with its promoter 
Ampicillin 
Chloramphenicol  
This study 
pAJ22-690 pAJ22 with cloned Cj0690c 
along with its promoter 
Ampicillin 
Chloramphenicol  
This study 
pAJ23-690 pAJ23 with cloned Cj0690c 
along with its promoter 
Ampicillin 
Kanamycin 
This study 
pAJ22-1539 pAJ22 with cloned Cj1539c 
along with its promoter 
Ampicillin 
Chloramphenicol  
This study 
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2.1.3 Primers used for amplification and sequencing 
All the primers were purchased from Sigma-Aldrich (UK) and are shown in Table 2. 2.  
Table 2. 3 Oligonucleotides used in this study. 
Oligo Tm* (ºC) Sequence 5’ to 3’ Comments 
Transeq 62.8 CCCGGGAATCATTTGAAG Transposon sequencing primer. 
KCN-F 75.4 ggaggatccGATAAACCCAGCGAACC Kanr PCR primer, BamHI site near 
5’ end. 
Kan-Fex 72.5 gcaggatccGACATCTAAATCTAGGTAC
TAAAACAATTC 
Kanr PCR reverse primer, BamHI 
site near 5’ end. 
KNHD-F 72.3 caaaaaagcttgATAAACCCAGCGAACC Kanr PCR primer, HindIII site near 
5’ end. 
KNHD-R 69.8 caaaaaagcttgACATCTAAATCTAGGTAC
TAAAACAATTC 
Kanr PCR primer, HindIII site near 
5’ end. 
KanBgl-R 73 cacaagatctGACATCTAAATCTAGGTAC
TAAAACAATTC 
Kanr PCR reverse primer, BglII site 
near 5’ end. 
aj1-FOR 60.6 GCTTGATAGTGTTACTGAACAACTG PCR primer for Cj1245c binds at 69 
bp downstream to start codon. 
aj1-REV 59.0 CTACTTACATCACTTAAAACTTCGC PCR primer for Cj1245c binds at 
1151 bp downstream to start codon. 
1136-F 62.8 GCTCGAAATCAATCATCAAATTT Cj1136 PCR primer binds at 66 bp 
upstream to start codon. 
1136-R 63.0 CAACTCTTTGGGAAGAAATTCAA Cj1136 PCR primer binds at 90 bp 
downstream to termination codon. 
1136-INF 60.2 caaaaggatccGCACTATCACTCCAAGAG
ACTATG 
Cj1136 inverse PCR primer binds at 
566 bp downstream to start codon, 
BamHI site near 5’ end. 
1136-INR 60.5 caaaaggatccCCATCATCATAAATACAA
GCATG 
Cj1136 inverse PCR primer binds at 
509 bp downstream to start codon, 
BamHI site near 5’ end. 
685-F 62.5 CATCGATAAATTCAGCACAATATAC
AG 
Cj0685c PCR primer binds at 400 bp 
upstream to start codon. 
685-R 63.4 CACCCATATCATTACATAGGTCGTT  Cj0685c PCR primer binds at 1141 
bp downstream to start codon. 
690-F 61.4 GAAGCTTTTGCGTATTTTTATAGTGT  Cj0690c PCR primer binds at 586 bp 
downstream to start codon. 
690-R 64.0 CCATCTCCACTGCCTTTGTT Cj0690c PCR primer binds at 2483 
bp downstream to start codon. 
1305-F 62.5 GATCATGGTTGTGGTATACCTGAT Cj1305c PCR primer binds at 188 bp 
upstream to start codon. 
1305-R 62.4 CAAATTTGTCACCCACATCTTT 
 
Cj1305c PCR primer binds at 1198 
bp downstream to start codon. 
1539-F 62.8 GGTATTGCCACTTTCTTTTTCATAA Cj1539c PCR primer binds at 188 bp 
upstream to start codon. 
1539-R 64.5 GTAGATTTTCCACTTCCATTCGC Cj1539c PCR primer binds at 126 bp 
downstream to stop codon. 
1539-INF 59.5 caaggatccGCAGTTTATCTTAGCGCTTC
CTAT 
Cj1539c inverse PCR primer binds 
at 351 bp downstream to start codon, 
BamHI site near 5’ end. 
1539-INR 60.2 caaggatccGTAAAAAGCAATCCAAATT
CTCCC 
Cj1539c inverse PCR primer binds 
at 329 bp downstream to start codon, 
BamHI site near 5’ end. 
CML-F 60 caaggatccGTCGGTATCGTATGGAGCG CAT gene PCR primer, BamHI site 
near 5’ end.  
CML-R 60 cacaagatctCCTAAAGGGTTTTTATCAG
TGCG 
CAT gene PCR primer, BglII site 
near 5’ end. 
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C1136-F 60 caaggatccCGCAAAGTAATTTTACAAG
GTTCA 
Cj1136 PCR primer binds at 458bp 
upstream to start codon, BamHI site 
near 5’ end.  
C1136-R 60 caaggatcctCAACTCTTTGGGAAGAAAT
TCAA 
Cj1136 PCR primer binds at 90 bp 
downstream to stop codon, BamHI 
site near 5’ end. 
C1245-F 61 caaggatcctCGCGTAGGGCTTTGGACT Cj1245c PCR primer binds at 476 bp 
upstream to start codon, BamHI site 
near 5’ end. 
C1245-R 59                                        caaggatccGCTTCATTTGCGCTCACA 
 
Cj1245c PCR primer binds at 135 bp 
downstream to stop codon, BamHI 
site near 5’ end. 
C690-F 62 caaggatccCACAAGCAGTAACCATAAC
AGCG 
Cj0690c PCR primer binds at 428 bp 
upstream to start codon, BamHI site 
near 5’ end. 
C690-R 60 caaggatccGTGCTTGTTATTCCTACAGA
TGAAGA 
Cj0690c PCR primer binds at 99 bp 
downstream to stop codon, BamHI 
site near 5’ end. 
C1539-F 60 caaggatccCAGGAACACCGCCAAGAT Cj1539c PCR primer binds at 507 bp 
upstream to start codon, BamHI site 
near 5’ end. 
C1539-R 59 caaggatccCCATTCGCTCCCATTAAGAT Cj1539c PCR primer binds at 110 bp 
downstream to stop codon, BamHI 
site near 5’ end. 
C685-F 58 caaggatccGCCGTGATTTACACCGATA
C 
Cj0685c PCR primer binds at 506 bp 
upstream to start codon, BamHI site 
near 5’ end. 
C685-R 57 caaggatccGAAGTGAAAATCATAAAGC
TTTAGTG 
Cj0685c PCR primer binds at 186 bp 
downstream to stop codon, BamHI 
site near 5’ end. 
652-F 60 GAACTTACGATAGATATAGAGC Cj0652 PCR primer binds at 697 bp downstream to start codon 
653-F 62 TTATGATGAAATCATCATGGAGC Cj0653c PCR primer binds at 737 bp downstream to start codon. 
IN652-R 54 caaggatccCAAGATTTTTAAACCAATT
GC 
Inverse PCR primer binds 42 bp 
downstream to stop codon of 
Cj0652. 
IN653-R 50 caaggatccAATTATAAGTTTAATACAA
GG 
Inverse PCR primer binds 72 bp 
downstream to stop codon of 
Cj0652. 
652Seq-F 59 GGCAACTGTAGCTAAAATTTATCAA
A 
Sequencing primer binds at 1752 
downstream to start codon i.e. 54 bp 
upstream to stop codon of Cj0652. 
653Seq-F 59 CCTAAGCTAGGTGATTATCCAAAAG    Sequencing primer binds at  86 bp 
upstream to stop codon of Cj0653c. 
CML-Frev 60 CGCTCCATACGATACCGAC Reverse complement of CML-F 
designed to sequence insert in 
pGEM643CML. 
napAL2 74 CTT TAG AAG GGC TTT TAG CTC 
GTG C 
C. jejuni subspeciation primer binds 
the napA upstream region. 
napAR4 74 ATT TCC CTG CAA GAT AAA ATC 
TGT AGC 
C. jejuni subspeciation primer binds 
the napA downstream region. 
*Tm denotes the melting temperature of the oligonucleotide. Tm given in the table were calculated on the 
basis of Campylobacter-specific sequences and do not consider the additional endonuclease restriction 
sites along with extra nucleotides at 5’ ends of the primers, where added, and these additional restrictions 
sites and extra nucleotides are shown in lower case.  
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2.1.4 General buffers 
All buffers were prepared using distilled water (dH2O) unless specified. 
0.1 M Phosphate buffered saline (pH 7.2)  
Phosphate buffered saline (PBS) was purchased from (Sigma, UK). The composition of 
PBS was 23.4 mM disodium hydrogen phosphate, 6.6 mM potassium dihydrogen 
orthophosphate and 70.0 M sodium chloride. PBS was sterile and ready to use. 
 
50x Tris-acetate-EDTA buffer 
50x Tris-acetate-EDTA (TAE) buffer was purchased National diagnostics, England. 
The composition of TAE buffer was 2.0 M Tris-acetate and 100 mM sodium EDTA. 
For use x1 TAE buffer was prepared by diluting 20 ml of the concentrated buffer in 980 
ml distilled water. 
2.2 Culture media 
All culture media were obtained from Oxoid (Basingstoke, UK) unless specified and 
prepared using distilled water. Culture media sterilisation was carried out by 
autoclaving at 121oC, 15 psi for 15 min. All the culture media used were adjusted to pH 
7.4. Sheep blood was added to the media after it had cooled to 52oC. Media plates were 
stored at 4oC. 
5% (v/v) blood agar plates 
Columbia agar base*     39 g 
(* Contains peptone 23 g, starch 1.0 g, sodium chloride 5.0 g and agar 10 g per litre) 
Defibrinated sheep blood (TCS Biosciences, UK) 50 ml 
Distilled water                  1 L 
 
Mueller-Hinton agar/ Mueller-Hinton broth biphasic media 
10 ml of Mueller-Hinton (MH) agar dispensed onto 250 cm3 tissue culture flasks left in 
standing position for 30 minutes to solidify, then overlaid with 20 ml of MH broth. 
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Mueller-Hinton Agar 
MH agar powder*   38 g 
(*Contains beef, dehydrated infusion from 300 gm, casein hydrolysate 17.5 gm, starch 
1.5 gm and agar 17.0 gm per litre) 
Distilled water   1 L 
 
Mueller-Hinton broth 
MH broth powder*   21 g 
Distilled water   1 L 
 
2.3 Bacterial culture methods 
All strains were stored at -80oC in 1% (w/v) proteose peptone water containing 10% 
(v/v) glycerol until required. Strains were routinely grown from frozen on 5% (v/v) 
blood agar (BA) plates for 48 hours at 37oC in the compact anaerobic work station (Don 
Whitley scientific, UK) attached to a gas cylinder supplying 10 % CO2, 5% O2 and 85% 
(v/v) N2 or in a gas jar where a CampyGen® pack (Oxoid, UK) sachet was added to 
generate microaerobic conditions. Other culture media including MH agar and MH 
broth were also used to grow C. jejuni and are mentioned, where used. 
2.4 Bacterial growth curve by viable count method 
Strains were grown overnight on BA plates and the cells were harvested for preparing 
the inoculum. One hundred microlitres of bacterial suspension in 0.1 M phosphate 
buffered saline pH 7.2 was inoculated into pre-warmed MH broth and incubated 
overnight in microaerobic conditions on a shaker. Then each of nine pre-warmed (37oC) 
MH/MH biphasic broth flasks was inoculated to an OD (550 nm) of 0.05 with the 
overnight growth and left to grow at 37oC under microaerobic conditions. A viable 
count of the bacterial culture was taken, in triplicate, after 0, 3, 6, 9, 12, 20, 24 and 30 
hours of growth. The number of viable bacteria was determined by serially diluting the 
bacterial culture with PBS and plating by spreading out 20 µl of each dilution onto pre-
dried blood agar plates. The plates were incubated for 48 hours at 37oC under 
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microaerobic conditions and the colonies counted. The bacterial growth curve 
experiment was done in duplicate. 
2.5 Estimating the number of bacteria by measuring DNA content 
In a standard gentamicin protection assay, an estimated number of bacterial cells were 
added to the cell cultures. There are a number of methods available to measure bacterial 
numbers in a solution and measuring the bacterial DNA content is one way, however, 
this method does not take into account the number of live and dead bacteria. The actual 
viable count was determined retrospectively by serial dilution of the bacterial inocula in 
PBS and plating onto blood agar plates.  
An estimate of the number of bacteria per ml was made by lysing 50 µl of the bacterial 
suspension in 950 µl of 1 M sodium hydroxide. The optical density (OD) of the released 
nucleic acid was measured at λ260 nm. A calibration curve (Figure 2.1) was prepared 
using different dilutions of C. jejuni 01/51 cell suspension in phosphate buffered saline 
whereby OD (260 nm) was plotted against actual bacterial numbers, which were 
measured by the viable cell count method. When the values of this experiment were 
applied (y = 2E+10x - 4E+08) using the straight line equation, (y=mx+c, where the y is 
Y-axis value (cfu/ml in this case), x is the X-axis value (OD260nm), m is gradient of 
straight line and c is the Y-intercept), an OD (260 nm) of one was equal to 1.96 x 1010 
bacterial cells per millilitre and this equation was used for calculating the approximate 
cell count (cfu/ml) of C. jejuni strain 01/51. Because calibration curve was plotted with 
bacterial cell suspensions having DNA content   with optical density (260nm) between 
0.06 and 0.45; for the gentamicin protection assay bacterial cell suspension having 
DNA content with optical density (260 nm) between 0.1 and 0.4 was used to keep 
within known linear range and cell suspension density was adjusted accordingly by 
diluting or concentrating the suspension if was found outside this range.  
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Figure 2.1 A calibration curve of C. jejuni 01/51 cell number determined by measuring the DNA 
content. 
C. jejuni cell number was estimated by measuring its DNA content after lysing the cells in 1 M sodium 
hydroxide. A calibration curve using different dilutions of a known cell number of C. jejuni 01/51 was 
prepared. The calibration curve was drawn by plotting optical density (260 nm) of DNA content of 
different dilutions of bacterial cell suspension prepared in sterile phosphate buffered saline against actual 
bacterial cell numbers, which were measured by the viable count method. This calibration curve was used 
to calculate the cell number of C. jejuni in a cell suspension by measuring the DNA content.  
 
2.6 Culture of mammalian cell lines 
All the cell culture media and supplements were purchased from Sigma, United 
Kingdom unless specified. INT-407 cells (Human Caucasian embryonic intestinal 
epithelial, ECACC# 85051004) and Caco-2 cells (Human colonic carcinoma epithelial, 
ECACC# 86010202) were obtained from the European Collection of Cell Cultures 
(Porton Down, Salisbury, UK). Frozen ampoules were thawed quickly and added to 10 
ml of pre-warmed complete cell culture media consisting of Eagle’s minimal essential 
medium with glutamine supplemented with 10% foetal calf serum and 1% non-essential 
amino acids. Gentamicin (200 µg/ml) was added to the media in the first two passages. 
The cells were pelleted by centrifugation at 1200 rpm for 5 min using CENTAUR2 
centrifuge (MSE, UK). The supernatant was removed and the cells resuspended in 25 
ml of complete media and added to a sterile 250 cm3 polypropylene tissue culture flask. 
The cells were incubated for 48 hours at 37oC in 5% (v/v) CO2 until a confluent 
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monolayer was present. Confluent monolayers were trypsinised with trypsin-EDTA 
solution (Sigma) and split in the ratio of 1:3 to 1:6 and the growth continued. 
 
2.7 The gentamicin protection invasion assay 
A twenty four well tissue culture plate was seeded with INT-407 or Caco-2 cells at a 
concentration of 1 x 105 cells per well in complete cell culture media without antibiotics 
and incubated at 37oC with 5% (v/v) CO2 for forty eight hours to establish confluent 
monolayers (3 x 105 cells per well).  
Bacteria were harvested from blood agar plates after 48 hours incubation in a 
microaerobic atmosphere. A few colonies were resuspended in PBS and the bacterial 
count was estimated by measuring the DNA (2.5). Bacterial counts in the final inoculum 
were confirmed retrospectively by viable cell count method. The bacterial suspension 
was diluted in pre-warmed complete cell culture media to a multiplicity of infection 
(MOI) of 100; MOI is the ratio of bacterial cell number in the initial inoculum to the 
eukaryotic cell number in the well. Cell culture media covering the monolayers was 
replaced with 1 ml of bacterial suspension. Infected monolayers were incubated for 
three hours at 37oC in 5% (v/v) CO2 to allow the bacteria to invade the cells. The 
monolayers were washed three times with PBS. To remove any external bacteria that 
had not invaded, 1 ml of complete cell culture media supplemented with 250 µg 
gentamicin ml-1 was added to each well and incubated for a further two hours. 
Following incubation the monolayers were washed three times with PBS as before and 
lysed with 1 ml of 1% (v/v) Triton-X100 in PBS. After 10 minutes the lysate was mixed 
well by pipetting up and down and the total number of viable bacteria per well was 
determined by serially diluting the cell lysate with PBS and spread plating out 20 µl of 
the undiluted and dilutions of lysate onto pre-dried blood agar plates. Plates were 
incubated at 37oC in microaerobic conditions and the colonies were counted after 48 
hours. Each colony was assumed to represent one bacterium that had become 
internalised.  
The invasion efficiency of each isolate was calculated using the formula below, where 
the number of bacteria internalised per well was expressed as a percentage of the 
bacterial cell number added to the well at the start of the experiment. Assays were done 
in triplicate. A non-invading flagellar double mutant C. jejuni 81116 flaA-/flaB-  
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(Wassenaar et al., 1994) was used as negative control and was processed in the same 
way as the test strains in the assay. The standard error of the mean (SEM) was 
calculated for the invasion efficiencies of each isolate tested in triplicate wells. Error 
bars were used to represent the SEM of invasion efficiencies. 
 
Invasion efficiency:  Total number (c.f.u.) of internalised bacteria x 100 
   Total number (c.f.u.) of bacteria in inoculum      
. 
2.8 Adhesion assay 
Adhesion assays were done to check the ability of bacterial strains and mutants to 
adhere to INT-407 or Caco-2 cells. Adhesion and invasion assays were done at the same 
time using the same batch of cultured eukaryotic cells and the same bacterial cell 
suspensions to minimise the assay to assay variation.  Adhesion assays were done in 
triplicate for each strain. 
INT-407 or Caco-2 cells were grown as described above (2.6). The bacterial suspension 
was diluted in pre-warmed complete cell culture medium to a multiplicity of infection 
(MOI) of 100. Cell culture media covering the monolayers was replaced with 1ml 
bacterial suspension. Infected monolayers were incubated for three hours at 37oC in 5% 
(v/v) CO2. Following incubation the monolayers were washed three times with PBS and 
lysed with 1 ml of 1% (v/v) Triton-X100 in PBS. The lysate was mixed well by 
pipetting up and down and the total number of viable bacteria per well was determined 
by serially diluting the cell lysate with PBS and spreading out 20 µl onto pre-dried 
blood agar plates. Plates were incubated at 37oC in microaerobic conditions and the 
colonies counted. Each colony was assumed to represent one bacterium that had become 
internalised. A second cell infection plate was processed for the invasion assay at this 
point. 
The adhesion efficiency of each isolate was calculated using the formula below, where 
the number of bacteria adhered per well was expressed as a percentage of the bacterial 
cell number added to the well at the start of the experiment. A non-adhering flagellar 
double mutant C. jejuni 81116 flaA-/flaB-  was used as negative control and was 
processed in the same way as the test strains in the assay. The standard error of the 
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mean (SEM) was calculated for the adhesion efficiencies of each isolate tested in 
triplicate wells. Error bars were used to represent the SEM of adhesion efficiencies. 
 
Adhesion efficiency:  Total bacterial numbers counted - Total number of internalised bacteria x 100 
   Total number (c.f.u.) of bacteria in inoculum      
 
2.9 General molecular biology techniques used in gene 
manipulation 
2.9.1 Separation of DNA fragments by agarose gel electrophoresis 
Analysis of DNA fragments was done in 1% (w/v) agarose in 1 X TAE buffer.  A DNA 
molecular marker of established DNA band sizes was run alongside the DNA samples. 
The 1 kbp DNA ladder (Promega, Southampton, UK) was the DNA molecular marker 
used and 250 ng of marker was loaded on the gel. 2 µl of 6 x DNA loading buffer 
(Promega) was added to the sample (10 µl) before loading the agarose gel. The agarose 
gel was placed in a Mini-Sub® Cell GT tank (Bio-Rad Laboratories Ltd., Hertford, UK) 
and submerged in 1 x TAE buffer and electrophoresed at 100 V. The gel was incubated 
in an ethidium bromide solution (1 mg/ml) for 30 min and the DNA bands were 
visualised under ultra-violet light using InGenius® gel documentation system (Syngene, 
UK). 
2.9.2 Estimation of DNA concentration 
DNA concentration was measured by using a UV spectrometer at 260 nm. DNA 
concentration was calculated using the formula: OD x 50 x dilution factor = DNA 
concentration in µg/ml.  
The NanoDrop® ND-1000 UV-Vis spectrophotometer (NanoDrop Technologies, USA) 
was also used at the University of Nottingham to quantify the DNA concentration prior 
to sequencing. A one microlitre sample was used to record the absorbance at OD (260 
nm)
 
and a reading of 1.0 at this wavelength was equivalent to 50 µg/ml of double 
stranded DNA. The purity of the DNA preparation was determined by measuring the 
optical density at λ260 nm and 280 nm and the ratio of 1.8 defined a pure preparation.  
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2.9.3 Restriction digests of DNA 
Genomic, plasmid and other DNA fragments were digested using restriction 
endonucleases obtained from Promega, Southampton, UK. Digestions were carried out 
according to the manufacturer’s instructions with the appropriate reaction buffer. 
Generally, 1-2 µg DNA was incubated in the presence of 10-20 units of restriction 
enzyme for 1-4 hours at 37ºC in 20-100 µl reaction volumes. 
2.9.4 Dephosphorylation of DNA at the 5’ end 
To avoid self-ligation, the restriction digest plasmid DNA was dephosphorylated at 5’ 
ends. Thermostable alkaline phosphatase (TSAP) was obtained from Promega, 
Southampton, UK. Immediately following restriction digestion, 2 units of TSAP was 
added directly to the restriction digest which was then incubated at 37ºC for 15-30 min. 
The dephosphorylated DNA was then either purified using the GenElute® PCR clean-up 
kit (Sigma, Dorset, UK) or the restriction endonuclease and TSAP were inactivated by 
incubating at 74ºC for 15 min depending upon the endonuclease used.  
2.9.5 Ethanol precipitation of DNA 
DNA was precipitated by the addition of 0.1 x vol 3M sodium acetate (pH 4.6) and 2 x 
vol absolute ethanol. The mixture was incubated at -20ºC for 30 min and then 
centrifuged at 15,115 rcf at 4ºC for 15 min. The pellet was washed with ice-cold 70% 
(v/v) ethanol (500 µl), air dried at room temperature for 5-10 min and resuspended in 
10-20 µl of water. 
2.9.6 Extraction of DNA from agarose gels 
Digested DNA was run on a 1% (w/v) agarose gel and the DNA band of interest was 
excised using a sterile scalpel blade and subjected to the QIAEX II DNA extraction 
procedure (QIAGEN, Crawley, UK). Briefly, the gel slice was solublised and the DNA 
adsorbed to silica particles. The bound DNA was washed a number of times and then 
eluted with water. 
2.9.7 Ligation of DNA 
T4 DNA ligase 1 U/µl was obtained from Promega, Southampton, UK and was supplied 
with a 10x ligase buffer (300mM Tris-HCl (pH 7.8), 100mM MgCl2, 100mM DTT and 
Chapter 2. Materials and methods 
 50 
10mM ATP). Reactions were carried out according to manufacturer’s instructions; 
generally 120 ng of insert and 20 ng of vector was used in a reaction volume of 10 µl 
and incubated overnight at 4ºC. The ligation mixture was used as such in the 
transformation of chemically competent cells or was ethanol precipitated for use in 
electro-transformation reactions. 
2.9.8 Cloning into pGEM®-T Easy vector 
The pGEM®-T Easy vector (Promega, Southampton, UK) (Figure 2.2) was used for 
general cloning and to generate a suicide vector due to its ease of use to directly clone 
PCR products by TA cloning and its inability to replicate inside Campylobacter species. 
It allows blue/white selection of colonies and carries the ampicillin resistance gene. 
BamHI, BglII, BclI and HindIII are amongst many other endonucleases that do not cut 
inside the vector and their restriction sites in the gene of interest can be exploited to 
generate insertional mutations by inserting an antibiotic cassette. 
 
Figure 2.2 Circular map of pGEM®-T Easy vector  (Promega, UK). 
Cloning of PCR products was carried out using the pGEM®-T Easy vector according to 
the manufacturer’s instructions. Briefly, it involved incubating the pGEM®-T Easy 
vector (50 ng) with the PCR product to be cloned (50 ng) in the presence of T4 DNA 
ligase (supplied with the kit) for one hour at room temperature or 4ºC overnight. The 
ligation mixture (2-5 µl) was used to transform One Shot® chemically-competent 
TOP10 E. coli cells (Invitrogen, Paisley, UK) and selection was made on LB agar 
containing 100 µg ampicillin ml-1 and 30 mg X-gal (5-bromo-4-chloro-3-indolyl-b-D-
galactopyranoside) ml-1. After overnight incubation at 37ºC, white or light blue colonies 
were picked and subcultured onto LB agar containing ampicillin. 
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2.10 Preparation of competent cells and transformation 
2.10.1 Preparation of electrocompetent E. coli 
Electroporation with high voltage is the most efficient method for transforming E. coli 
with large plasmid DNA (Dower et al., 1988) and plasmids generated in the plasmid 
rescue technique 5.2.1) were likely to have large molecular weights so electroporation 
was done to transform electrocompetent E. coli S-17λpir in this study. Electrocompetent 
E. coli cells were prepared following the method of Ausubel (Ausubel et al., 1994). 
Briefly, E. coli S-17λpir was grown in LB broth overnight at 37ºC with moderate 
shaking. 500 ml pre-warmed LB broth was inoculated with 2.5 ml of the culture and 
incubated at 37ºC with shaking at 300 rpm to an OD (600 nm) of ~0.5 to 0.6. Cells were 
chilled in ice-cold water for 10 to 15 min and centrifuged for 20 min at 4000 rcf at 2ºC. 
The supernatant was poured off and cells were washed 3x by resuspending in 160 ml 
ice-cold water followed by centrifugation. Finally an opaque dense (~109 CFU/ml) 
suspension of the pelleted cells was prepared in ice-cold water and aliquots (50 µl) were 
used immediately or they were resuspended in 10% ice-cold glycerol and aliquots (50 
µl) were frozen down rapidly in an absolute ethanol bath on dry-ice and stored at -80 
ºC.  
2.10.2 Electroporation of E. coli cells 
Electrocompetent E. coli S-17λpir cells (fresh or thawed on ice) were mixed with 5 µl 
of DNA (0.5 µg) by gentle tapping and then incubated on ice for 10 min. The bacteria 
were transferred to a pre-chilled 2 mm cuvette (Bio-Rad laboratories, Hertford, UK) and 
pulsed at the preset programme for E. coli transformation (2.5 kV, 25 µF, 400 ohms) 
using the Bio-Rad Gene Pulser Xcell™. Immediately following the pulse the contents 
of the cuvette were flushed with 500 µl pre-warmed SOC medium (0.5% yeast extract, 
2% tryptone, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2 , 20 mM MgSO4, 20 mM 
glucose) and transferred to a sterile Eppendorf tube and incubated for 60 min with 
moderate shaking at 37ºC. The cells were plated out onto LB agar plates supplemented 
with the appropriate antibiotic. The plates were incubated at 37ºC overnight to select for 
transformants.  
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2.10.3 Preparation of electrocompetent C. jejuni cells 
Campylobacter strains were cultured on blood agar plates for 17 hours at 37 ºC in a 
microaerobic atmosphere. The culture plates were then placed at 4ºC for 20 min to 
allow the agar to become firm. Campylobacter cells were harvested from the plates and 
resuspended in ice-cold sucrose solution (272 mM sucrose in 5% (v/v) glycerol). Cells 
were washed in sucrose solution three times by centrifugation at 4000 rcf for 15 min at 
4ºC. Finally the pelleted cells were resuspended in sucrose solution to give an opaque 
density. Electrocompetent Campylobacter cell (50 µl) aliquots were immediately frozen 
as described above and stored at -80ºC. 
2.10.4 Electroporation of C. jejuni cells 
Two 50 µl aliquots of the electrocompetent Campylobacter cells were thawed on ice, 
one was mixed with 5 µl of DNA (0.5 µg) and other with 5 µl of sterile water to act as a 
negative control. They were incubated on ice for 10 min and then were transferred to 2 
mm cuvettes (Bio-Rad laboratories, Hertford, UK) and pulsed at 2.48 kV, 25 µF, 600 
ohms using Bio-Rad Gene Pulser Xcell™. The contents of the each cuvette wase 
flushed with 500 µl pre-warmed BHI broth (37ºC) and plated onto two pre-dried BA 
plates. Cells were recovered for 5 hours at 37ºC in a microaerobic atmosphere. The 
bacteria were harvested from the recovery plates using 1 ml pre-warmed PBS and plated 
onto pre-dried BA plates containing the appropriate antibiotic and incubated for 72 
hours at 37ºC. Plates were examined for the presence of colonies for up to 72 hours. 
Colonies were sub-cultured onto the appropriate antibiotic-containing media. 
2.10.5 Heat shock transformation of E. coli cells 
Ten microlitres of plasmid DNA (10 ng) or ligation reaction mixture was added to 50 µl 
of thawed One Shot® chemically-competent TOP10 E. coli cells (Invitrogen, Paisley, 
UK) and incubated on ice for 30 minutes. The cells were heat shocked for 30 seconds at 
42ºC, before being recovered for one hour at 37ºC with shaking (200 rpm) in 250 µl of 
SOC medium. After recovery the cells (20, 50 and 100 µl) were plated out onto LB agar 
plates supplemented with the appropriate antibiotic(s). The plates were incubated at 
37ºC overnight to select for transformants.  
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2.11 DNA extraction procedures 
2.11.1 Genomic DNA preparation from Campylobacter 
Genomic DNA from the Campylobacter cultures was extracted using the 
GenElute®Bacterial Genomic DNA kit (Sigma, Dorset, UK) according to the 
manufacturer’s instructions. Briefly, Campylobacter strains were grown on BA plates 
for 48 hours under microaerobic conditions at 37ºC. The growth from half of the plate 
was resuspended in lysis solution T (360 µl); RNase A solution (40 µl) was added, 
mixed and incubated for 2 min at room temperature. Then Proteinase K solution (40 µl) 
was mixed in and incubated for 30 min at 55ºC before adding lysis solution C (400 µl), 
followed by vortex mixing and incubation for 10 min at 55ºC. After preparing the DNA 
binding columns (provided with the kit) the cell lysate was loaded and centrifuged and 
the DNA was allowed to bind to the columns. The columns were washed twice with 
wash solution and finally DNA was eluted with 200 µl elution buffer and stored at -
20oC for further use.  
2.11.2 Mini DNA plasmid preparations from E. coli 
Following transformation (Section 2.10), an E. coli colony was picked and a small 
culture (5 ml) was grown in Luria-Bertani broth supplemented with appropriate 
antibiotic for 18-20 hours in a shaker at 37ºC. The culture was used to extract plasmid 
DNA from the E. coli  cells using QIAprep spin miniprep kit (QIAGEN, Crawley, UK) 
as described by the manufacturer. Biefly, E. coli cell pellete was resuspended in 250 µl 
of buffer P1 followed by alkaline lysis with an equal volume of buffer P2. Then lysate 
was neutralised and cell proteins and genomic DNA were precipitated by mixing with 
350 µl of buffer N3. After centrifugation for 10 minutes at ~17900 x g, the supernatant 
was moved into a silica column provided with the kit. After washing the column with 
buffers PB and PE, the plasmid DNA was eluted in 50-100 µl of water or 10 mM Tris-
HCl (pH 8.0) and stored at -20oC for further use.  
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2.12 Polymerase chain reaction (PCR) 
2.12.1 Standard PCR 
PCR reactions were generally carried out in 50 µl volumes. GoTaq® Flexi DNA 
polymerase (1.5 unit) (Promega, Southampton, UK), MgCl2 (2.5 mM), dNTPs (0.2 
mM), forward and reverse primers (0.5 µM each) and DNA template (0.1 µg) were used 
in the PCR reaction mixture. DNA was denatured by incubating at 94ºC for 4 min; 
followed by 30 cycles of 94ºC for 45 sec, 50-65ºC for 45 sec (depending on the Tm of 
primers) and 72ºC for 1-5 min (depending on expected PCR product size i.e. 1 min/1 
kb). After all the cycles were completed a final incubation at 72ºC for 10 min was 
performed and the PCR products visualised by gel electrophoresis (Section 2.9.1). 
2.12.2 Proof reading PCR 
Where high fidelity was required Pfu DNA polymerase (Promega, Southampton, UK) 
was used for DNA polymerisation. The PCR reaction mixture was prepared as 
mentioned above and kept on ice to avoid exonuclease activity of Pfu DNA polymerase 
and the extension time in the reaction was 2 min for every 1 kbp to be amplified.  
2.12.3 Colony PCR 
A loopful of freshly grown bacteria was suspended in 300 µl of water. The bacterial cell 
suspension was boiled for 10 minutes and centrifuged at 15,500 rcf for 5 min and one 
microlitre of the supernatant was used as template in a standard PCR (Section2.12.1). 
2.12.4 Purification of PCR products 
PCR amplification products were purified from other components in the reactions, such 
as excess primers, nucleotides, DNA polymerase and salts. The GenElute®PCR clean-
up kit (Sigma, Poole, UK) was used for this purpose. Purification was done according to 
manufacturer’s instructions. Briefly, PCR reaction products were mixed with loading 
buffer and a silica membrane column was loaded with mixture. After centrifugation, the 
column was washed with wash buffer and finally the PCR products were eluted with 
50-200 µl of elution buffer. 
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2.13 Generation of transposon mutant library 
The mariner-based Himar transposon was used to generate a transposon random 
insertion mutant library in a hyperinvasive clinical isolate C. jejuni strain 01/51. The 
transposon library was generated in the Professor Duncan Maskell’s laboratory at the 
Cambridge University following the protocol described previously (Grant et al., 2005).  
Briefly, the plasmid pEnterprise2 (Hendrixson et al., 2001) which contains a mariner-
based transposon (derived from Himar1) on a pUC19 backbone, was used to construct 
the transposons. Transposition reactions were performed as previously detailed 
(Hendrixson et al., 2001), using total bacterial DNA (2 µg) and 250 ng Himar1 
transposase purified as described by Lampe et al. (Lampe et al., 1996) from E. coli 
harboring pET29b+C9, an expression vector containing the C9 hyperactive Himar1 
transposase (Lampe et al., 1999). The transposed DNA was introduced into C. jejuni by 
natural transformation using a plate biphasic method. Transposon mutants were 
recovered on selective agar after growth under standard conditions for 60 to 72 h. 
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3 OPTIMISATION OF THE GENTAMICIN 
PROTECTION ASSAY 
 
3.1 Introduction 
Campylobacter jejuni generally infects humans by colonising the mucous layer of the 
intestine followed by adherence and invasion of epithelial cells (Ketley, 1997). Clinical 
observations and experimental evidence indicate that the ability of C. jejuni to invade 
the host intestinal epithelium is an important determinant of its ability to cause focal 
necrosis of the colonic mucosa (Black et al., 1988; Russell et al., 1989). Studying the 
mechanisms of Campylobacter pathogenesis is complicated by the lack of simple 
animal models that mimic the disease in humans. In vitro cell culture methods provide a 
useful alternative to investigate the interaction between Campylobacter and the host 
epithelium that occur during infection. The invasiveness of Campylobacter in cultured 
epithelial cell lines has, in some cases, been correlated with the disease outcome (Bacon 
et al., 2000; Fauchere et al., 1986; Newell and Pearson, 1984) supporting the view that 
cell culture models are useful indicators of pathogenicity. Different cell lines of human 
intestinal origin including Caco-2 (Hanel et al., 2004), INT 407 (Hu and Kopecko, 
1999), HT29 and T84 (MacCallum et al., 2006; Van Deun et al., 2007), and non-
intestinal origin including HeLa, HEp-2 (de Melo and Pechere, 1990; Prasad et al., 
1996) and Vero (Johnson and Lior, 1986) have been used to study the pathogenesis of 
C. jejuni but INT 407 and Caco-2 cells have recently been most extensively used to 
study the adhesion and invasion in this organism. The gentamicin protection assay 
(Elsinghorst, 1994) has become a standard method to measure cultured eukaryotic cell 
penetration by bacteria. There are many different parameters in this assay that 
independently affect optimal invasion and, consequently, methods described in the 
literature often differ and the assay has been review well in Friis’ paper  (Friis et al., 
2005). The aim of this part of the study was to check and standardise some of the 
important factors in the gentamicin protection assay and to find the parameters that give 
optimal invasion in C. jejuni.  
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3.2 Results and discussion 
3.2.1 Growth curve of Campylobacter jejuni 01/51 
Hu and Kopecko reported that Campylobacter jejuni inoculum taken from exponential 
phase of growth show maximum invasion in cultured INT-407 cells (Hu and Kopecko, 
1999). A growth curve of C. jejuni 01/51 was done to find the growth phases over time 
periods so that inoculum for gentamicin protection assay could be taken from 
exponential phase of bacterial growth. C. jejuni grown in Mueller-Hinton agar/Mueller-
Hinton broth (MHA/MHB) biphasic medium has been used in gentamicin protection 
assay in many previous studies (Gaynor et al., 2004; Hu and Kopecko, 1999; Kakuda 
and DiRita, 2006; Monteville et al., 2003). So, initially C. jejuni 01/51 was grown in 
MHA/MHB biphasic medium and samples were taken at different time intervals to 
measure the bacterial cell number by the serial dilution method. The bacterial growth 
curve (Figure 3.1) showed progressive growth up to 25 hours followed by a decline in 
growth with visible aggregation of the bacterial cells. It has previously been reported 
that C. jejuni 81-176 autoagglutinates at higher densities (Misawa and Blaser, 2000) and 
this visible aggregation might be the result of autoagglutination of the C. jejuni cells. 
There were no cultureable bacterial cells in the samples taken at 48 hours of growth (not 
shown), which was an unusual finding. Generally, the bacterial growth curve consists of 
initial lag phase where bacteria adjust themselves to the new environment followed by 
exponential growth phase, then a comparatively long stationary phase and finally a 
decline phase. In this experiment the stationary phase was not obvious. This experiment 
was also repeated separately using brain heart infusion agar/brain heart infusion broth 
(BHIA/BHIB) biphasic medium, standard brain heart infusion broth and standard 
Mueller-Hinton broth where the growth curves (not shown) were similar to that 
observed in MHA/MHB biphasic medium. The lack of stationary phase observed in the 
growth curve of C. jejuni 01/51 correlates with an other report stating that C. jejuni 
lacks a 'classic' stationary phase (Kelly et al., 2001). One of the possible reasons for 
lack of the stationary phase in C. jejuni growth is the lack of stationary phase sigma 
factor rpoS in the genome sequence of C. jejuni NCTC11168 (Parkhill et al., 2000), 
which modulates stress and stationary phase responses in many Gram-negative bacteria 
(Ishihama, 2000; Venturi, 2003). It has been reported that C. jejuni changes its 
morphology during different phases of growth being spiral in early exponential phase 
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and changes its shape to coccoid as the culture ages or is exposed to stress (Thomas et 
al., 1999). The conversion to coccoid morphology is accompanied by a rapid loss of 
culturability (Boucher et al., 1994). This loss of in vitro culturability of C. jejuni might 
be responsible for the lack of stationary phase and rapid decline in viable plate counts. 
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Figure 3.1 A growth curve of C. jejuni 01/51 in MHA/MHB biphasic media. 
Growth of C. jejuni 01/51 was checked in Mueller-Hinton agar/Mueller-Hinton broth (MHA/MHB) 
biphasic medium. For the growth curve pre-warmed MHA/MHB was inoculated to an OD (550 nm) of 
0.05from an overnight culture of C. jejuni 01/51 in MH broth. The bacterial culture was incubated at 37oC 
on an orbital shaker at 200 rpm and samples were taken at different time intervals for up to 48 hours and 
the viable cell count was done. The assay was done in duplicate and the error bars show the standard 
deviation. 
 
3.2.2 Pre-assay bacterial optimal growth conditions 
The effect of the bacterial growth conditions prior to the invasion assays, including 
culture media and incubation period was studied to select the optimal conditions for 
bacterial invasion in the gentamicin protection assay. Bacteria were grown in the 
Mueller-Hinton agar/Mueller-Hinton broth (MHA/MHB) biphasic medium for 22 hours 
and on blood agar plates for 24 hours and 48 hours before the invasion assay. The 
growth curve of C. jejuni 01/51 grown in MHA/MHB biphasic media (Figure 3.1) 
showed that the bacteria were in exponential phase for up to 25 hours after inoculation 
and later entered into the decline phase and there was no growth observed after 48 hours 
of incubation thus 48 hours growth in MHA/MHB biphasic medium was not included in 
this experiment.  
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Gentamicin protection assay using C. jejuni 01/51 grown on blood agar and MHA/MHB 
biphasic media for different time periods showed that bacteria grown on blood agar 
plates for 48 hours gave the maximum invasion efficiency in cultured Caco-2 cells 
(Figure 3.2) moreover, there was a little growth on blood agar plates after 24 hours as 
compared to 48 hours incubation and it was easy to pick the colonies from a 48 hours 
growth plate, thus 48 hours growth on blood agar plates was used in further assays. 
Blood agar grown C. jejuni has also been used in gentamicin protection assays by others 
(Malik-Kale et al., 2008; Monteville et al., 2003; Pei et al., 1998). It has previously 
been reported that a group of Campylobcater secreted antigens (cia proteins) are 
required for the maximal host cell invasion by C. jejuni and secretion of these proteins 
was enhanced by addition of serum in the growth media (Konkel et al., 1999). It was 
thought that by growing C. jejuni on blood agar the expression of such proteins will also 
be enhanced and the a change in invasion efficiency shown by C. jejuni will remain at 
their maximum level and will not be affected by a change in the expression levels of cia 
protein.  
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Figure 3.2 The efficiency of invasion of C. jejuni 01/51 grown on different media from 22 to 48 
hours prior to assay.  
To determine the bacterial growth conditions that give maximum invasion efficiency in the gentamicin 
protection assay, C. jejuni 01/51 growth on blood agar for 24 hour and 48 hour as well as Mueller-Hinton 
biphasic medium for 22 hours was used. Maximum invasion efficiency was shown by C. jejuni 01/51 
grown on blood agar for 48 hour and it was used in further gentamicin protection assays. The efficiency 
of invasion was the number of bacteria internalised expressed as a percentage of total bacterial cell 
number added to the Caco-2 cell monolayer at the start of the assay.  
 
3.2.3 Optimal multiplicity of infection (MOI) for invasion assay 
Evidence exists from previous assays that variation in the inocula could affect the 
invasion levels measured (Hu and Kopecko, 1999). A dose response curve was 
produced to find out the optimal number of bacteria per Caco-2 cell that give the best 
invasion efficiency in the assay. Thus the total number of bacteria internalised per well 
was measured against a range of MOI from 25 to 1000.  
The results showed that the number of internalised bacteria increases with increasing 
MOI up to 200 after that there is no significant increase (Figure 3.3). Fearnley et al. 
reported a progressive increase in internalised C. jejuni cell number in INT-407 cells up 
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to the multiplicity of infection of 200 followed by a plateau (Fearnley et al., 2008); 
similar findings were reported in a previous study where INT-407 cells were used to 
assess the C. jejuni invasion (Hu and Kopecko, 1999). Invasion efficiency of each MOI 
was also calculated and the averaged invasion efficiency was maximum (0.34) at the 
minimal MOI used i.e. 25 and invasion efficiency in Caco-2 cells was steadily 
decreased with increasing MOI of C. jejuni 01/51 (Appendix 1). The inverse 
relationship of invasion efficiency with MOI of C. jejuni 81-176 in cultured INT-407 
cells i.e. decrease in invasion efficiency with increasing MOI was also reported by Hu 
and Kopecko (Hu and Kopecko, 1999) and suggests that this organism is a highly 
efficient solitary invader; i.e. a single C. jejuni can induce its own uptake into host cells. 
This contrasts sharply with S. typhi invasion, invasion efficiency is suboptimal at lower 
and higher MOIs, but reaches a broad optimum at an MOI 40 (Huang et al., 1998). The 
MOI of 100 was selected for further invasion assays so that an experimental variation in 
adjusting the MOI could not have a major effect on the invasion efficiency; as the MOI 
above 200 is not part of straight line and thus was expected to give lower invasion 
efficiency than the actual. 
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Figure 3.3 The number of internalised C. jejuni 01/51 cells against different MOIs in the Caco-2 cell 
invasion assay. 
Multiplicity of infection (MOI) of C. jeuni 01/51 that gives maximum invasion level in Caco-2 cell based 
gentamicin protection assay was determined.  A range of MOIs from 25 to 1000 was used in the assay 
and there was an increase in the number of internalised bacteria with increasing MOI but maximum level 
of invasion was observed at MOI 200 after which was not a big increase in the number of internalised 
bacteria with increasing MOI. The MOI 200 was selected as maximum MOI for further gentamicin 
protection assays.    
1. 4 
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Briefly, C. jejuni 01/51 grown on blood agar for 48 hour and MOI 200 were found to 
give optimal level of invasion in Caco-2 cells and were thus used in gentamicin 
protection assays in future. C. jejuni with known invasion potential in INT-407 cells 
were tested in Caco-2 cell gentamicin protection assay to check if the invasiveness in 
INT-407 cells could be conferred in Caco-2 cells.  
 
3.3 Confirmation of the invasion phenotype of selected C. jejuni 
strains from a previous study 
 Now that optimal conditions for Caco-2 cell based gentamicin protection assay were 
determined and the assay was used to test and validate the invasion potential of C. jejuni 
strains with known invasion capability in INT-407 cells. Most of the Campylobacter 
strains used in this study at Nottingham Trent University were previously isolated and 
their ability to invade human intestinal cells was studied using INT-407 at the 
Veterinary Laboratories Agency, Weybridge, UK. In the previous studies C. jejuni 
strains were up to x10, x10-25 and more than x25 invasive in INT-407 cells compared 
to C. jejuni 81116 were classified as low, high and hyperinvasive, respectively. In those 
previous studies C. jejuni strains 01/04, 01/10, 01/35, 01/41, 01/51 and EX114 were 
found to be hyperinvasive and C. jejuni strains 01/32, 01/46, 01/50 and 81116 were low 
invaders of INT-407 cells (Fearnley et al., 2008). In order to corroborate these results 
and to see whether this phenotype would exist in an alternative cell line, these strains 
were re-tested for invasion in Caco-2 cells. Gentamicin protection assays using Caco-2 
cells were performed to see how these bacterial strains invade Caco-2 cells. Results 
showed that four (01/04, 01/41, 01/51 and EX114) out of six strains that were 
hyperinvasive in a previous study using INT-407 cells were still hyper or highly 
invasive in this assay with Caco-2 cells (Figure 3.4). C. jejuni 01/51 was hyperinvasive 
in both the studies so was still best strain to use. The strains (01/10 and 01/35) were 
hyperinvasive in INT-407 cells but not in Caco-2 cells which could be due to inherent 
differences in different cell lines. The same Campylobacter strain can vary in invasion 
efficiency for different host cell lines and this dependence appears to be host cell line-
specific (Konkel et al., 1992a; Oelschlaeger et al., 1993). In addition, the reduced 
invasion phenotype of a number of transposon mutants of C. jejuni 01/51 that had 
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shown reduced invasion in a previous study with INT-407 cells (Dr. Georgina Manning, 
personal communication) was also tested using Caco-2 cells. Generally, the level of 
invasion in Caco-2 cells was similar to that previously observed in INT-407 cells as all 
the mutants showed very low level of invasion in Caco-2 cell but mutant 1E8 which was 
non-invasive in INT-407 cells showed 64% invasion in Caco-2 cells as compared to 
wildtype strain 01/51 (Table 3.1). Broadly, the reduced invasion phenotype observed in 
INT-407 cell was persistent in Caco-2 cells. 
 
 
Figure 3.4  The invasion efficiency of different C. jejuni strains into Caco-2 monolayers. 
C. jejuni strains whose invasiveness in INT-407 cells was previously known were checked for invasion in 
Caco-2 cells. The X1 band indicates the invasion efficiency of C. jejuni 81116 used as a reference low 
invasive strain in this assay. Bands X10 and X25 indicates the invasion efficiency of test strains as 10 fold 
and 25 fold, respectively, higher than the reference strain. Non-invasive C. jejuni 81116 ∆flaA/flaB strain 
was used as a negative control in the assay. The strains that show invasion above x10 were high and 
above x25 compared to C. jejuni 81116 were hyperinvasive (Fearnley et al., 2008).  
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Table 3.1 The invasion efficiency of mutants of C. jejuni 01/51 into INT-407 and Caco-2 
monolayers. 
Mutants Invasion 
(INT-407)  
Invasion 
(Caco-2)  
Comments 
1C1 19 5 Transposon mutant of Cj0490: ald, aldehyde 
dehydrogenase C-terminus 
1D7 10 3 Transposon mutant of Cj0486: putative sugar 
transporter 
1E8 0 64 Transposon mutant: gene not yet determined 
1G5 4 3 Transposon mutant: gene not yet determined 
1H10 0 1.6 Transposon mutant of dtpT gene in 01/51: di-tripeptide 
transporter protein not present in NCTC11168 
∆Cj0497 0.8 10 Targeted mutant of Cj0497: putative lipoprotein 
∆flaA/flaB 0 0 C. jejuni 81116 double mutant of flaA and flaB.  
Mutants of C. jejuni 01/51 whose invasion potential in INT-407 cells was previously known were tested 
for their invasiveness in Caco-2 cells using optimised gentamicin protection assay. Invasiveness is 
presented as a percentage of the invasiveness of the wild-type 01/51. The figure given is the mean of three 
replicates from within a single assay. Non-invasive C. jejuni 81116 ∆flaA/flaB strain was used as a 
negative control in the assay. 
 
3.4 Summary and conclusions 
Cultured eukaryotic cell invasion assays have become standard technique for the study 
of bacterial internalisation. The gentamicin protection assay was optimised and C. jejuni 
01/51 grown on blood agar for 48 hours gave maximal invasion at MOI 100 in Caco-2 
cells. When selected C. jejuni strains and transposon mutants of C. jejuni 01/51 with 
previously known invasion capability into INT-407 cells were tested for invasion into 
Caco-2 cells using optimised gentamicin protection assay, invasion in Caco-2 cells was 
found generally similar to INT-407 cells though two C. jejuni strains out of eleven and 
one C. jejuni 01/51 mutant out of six showed major differences in invasiveness in Caco-
2 than INT-407 cells. Generally bacterial invasion phenotype in INT-407 was 
transferable into Caco-2 which is a widely accepted human intestinal epithelial cell-line 
and on the basis of these findings INT-407 cells were selected to screen a transposon 
mutant library generated in a hyperinvasive clinical isolate C. jejuni 01/51 for invasion.  
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4 SCREENING OF THE TRANSPOSON MUTANT 
LIBRARY 
 
4.1 Introduction  
Campylobacter jejuni strains vary in invasiveness in eukaryotic cells. A number of 
hyperinvasive clinical strains of C. jejuni have recently been identified. These isolates 
were found to invade the human epithelial cell lines INT-407 and Caco-2 to high levels 
compared with a low-invasive control strain C. jejuni NCTC81116  (Fearnley et al., 
2008). Despite the fact that many C. jejuni genome sequences have been completed, the 
molecular mechanisms by which Campylobacter jejuni invade the intestinal epithelial 
cells and cause disease in human are not yet well understood. The analysis of the C. 
jejuni genome sequences produced many interesting observations, including an 
unappreciated capacity for polysaccharide biosynthesis and the presence of 
hypervariable homopolymeric tract sequences, but there was apparent lack of genes 
encoding virulence determinants similar to those expressed in other more extensively 
characterised enteric pathogens such as Escherichia coli and Salmonella enterica 
serovars (Fouts et al., 2005; Parkhill et al., 2000; Pearson et al., 2007). This paucity of 
information is also due to a lack of genetic tools; in particular the lack of a transposon 
mutagenesis method for the efficient generation of random mutants of Campylobacter 
spp. Previous attempts to generate mutants have relied on shuttle mutagenesis and 
homologous recombination (Bleumink-Pluym et al., 1999; Labigne et al., 1992; Yao et 
al., 1994). However, more recently a highly permissive mariner-based transposon 
known as Himar1 has been utilized for efficient random transposon mutagenesis in C. 
jejuni (Golden et al., 2000; Grant et al., 2005; Hendrixson et al., 2001); the transposon 
mutant libraries were screened for mutants with reduced motility (Hendrixson et al., 
2001), motility and autoagglutination (Golden and Acheson, 2002), and chicken 
colonisation (Grant et al., 2005). Therefore, an in vitro mariner-based transposon 
mutagenesis was used to produce a random insertional mutant library in a hyperinvasive 
clinical isolate of C. jejuni, strain 01/51. The chloramphenicol acetyltransferase (cat) 
gene was used as selection marker for the generation of transposon mutant library. The 
library consisting of 867 mutants was previously generated in collaboration with Prof. 
Duncan Maskell, Cambridge University, United Kingdom and the randomness of 
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transposon insertion was also confirmed by Southern blotting and sequencing of a 
selection of mutants. In this study, this transposon mutant library was screened in assays 
of invasion to find those mutants having reduced invasion levels in human intestinal 
epithelial cells as compared to parent strain C. jejuni 01/51. 
 
4.2 Methods 
4.2.1 Screening of the transposon mutant library 
The invasion assay used was an adaptation of the gentamicin protection assay, using the 
human intestinal epithelial cell line, INT-407 (Elsinghorst, 1994; Fearnley et al., 2008).  
For screening of the transposon mutants the semi-quantitative 96-well plate assay was 
adapted from that of Golden and Acheson (Golden and Acheson, 2002).  Briefly, the 
frozen transposon mutant library was thawed on ice and 10 µl transferred to Columbia 
agar (100 µl) supplemented with sheep blood (5%) and chloramphenicol (10 µg/ml) in a 
96-well plate. The plates were incubated at 37oC in microaerobic conditions for 48 
hours. At the same time INT-407 cells were resuspended in complete cell culture media 
(Modified Eagle’s Medium, MEM, supplemented with 1% non-essential amino acids 
and 10% calf serum (Sigma)) at a density of 1 X 105 cells per ml. Two hundred 
microlitres of cell suspension was added to each well in the 96-well plates and 
incubated for 48 hours at 37oC in 5% (v/v) CO2. On the day of the assay, the cell culture 
media covering the INT-407 cell monolayers was replaced with 200 µl fresh pre-
warmed complete cell culture media. Complete cell culture media (100 µl) was added to 
each well of the plate containing bacterial growth and left for 5-10 min for colonies to 
soften. Bacterial cells were resuspended by pipetting and 20 µl of the suspension was 
added to each well of the INT-407 monolayers. Infected plates were incubated for 3 
hours at 37oC in 5% (v/v) CO2. After incubation monolayers were washed 3X with PBS 
and were covered with 200 µl complete cell culture media with 250 µg gentamicin ml-1. 
Following a 2 hour incubation, monolayers were washed 3X with PBS and cells were 
lysed with 100 µl 1% (v/v) Triton-X100. The number of viable bacteria per well was 
determined by serial dilution with PBS and spotting 3 µl onto large pre-dried BA plates. 
Plates were incubated at 37oC in microaerobic conditions and the colonies counted. 
Campylobacter jejuni 01/51 and Campylobacter jejuni 81116 flaA-/flaB- were also used 
as reference parent strain and negative control, respectively, in the assays. The invasion 
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screening assay was repeated three times independently. The mutant invasion results 
were compared with those of the parent strain 01/51. 
4.2.2 Motility  
Like many other enteric pathogens, motility in C. jejuni is important for invasion into 
cultured epithelial cells and those strains with reduced motility are reduced in invasion. 
The C. jejuni 01/51 and those transposon mutants that showed reduction in invasion 
than parent strain 01/51 were tested for their motility so that those mutants with low 
motility could be excluded from further studies. Motility of the bacterial strains was 
tested by measuring growth on 0.4% MH agar plates. C. jejuni 01/51 and its selected 
transposon mutants were initially grown on blood agar plates and harvested cells were 
suspended in sterile phosphate buffered saline to an OD (550 nm) of 1.0. Approximately 
1 µl of this suspension was stabbed into the centre of the MH agar plate. The low 
density of the agar allowed the bacteria to move within the agar forming a halo of 
growth around the point of inoculation. Following inoculation the bacteria were 
incubated microaerobically at 37ºC for 48 hours. The diameter of the ring of growth 
formed by the mutants was measured and compared with that formed by the C. jejuni 
01/51. The flagellar double mutant C. jejuni 81116 flaA-/flaB- was used as negative 
control. The assay was carried out in triplicate and mean of values was plotted. 
 
4.3 Results and discussion 
4.3.1 Results of screening of the transposon mutant library 
A transposon mutant library previously generated in Campylobacter jejuni 01/51 was 
screened for invasion potential using INT-407 cells to find the mutants with a reduced 
invasion phenotype. INT-407 cells were used because they are easy to grow and 
C. jejuni invade them at higher levels than Caco-2 cells (Hu et al., 2008) thus it gives a 
better resolution for screening the transposon mutant library. Moreover, INT-407 cells 
were used to screen 96 mutants out of this library in a previous study at the Veterinary 
Laboratories Agency, Weybridge, UK so these cells were used for comparative studies 
at Nottingham Trent University. The reduced invasion phenotype of previously 
identified transposon mutants using INT-407 cells was generally transferable to Caco-2 
(Table 3.1) which also supported the selection of INT-407 cells for transposon mutant 
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library screening. The invasion screening assay was repeated three times. Mutants that 
showed up to six colonies in undiluted lysate spots (3 µl) compared to too many to 
count by the parent strain 01/51 were selected for further testing of their motility. It is 
known that reduced motility in C. jejuni results in reduced invasion into in vitro 
cultured cells (Wassenaar et al., 1991) and thus motility was determined to rule out 
those mutants with reduced motility. In this study, 768 transposon mutants were 
screened for their capability to invade INT-407 cells and 174 mutants consistently 
showed reduced invasion in screening assays and were therefore selected for further 
characterisation (appendix 2). Figure 4.1 shows the invasion screening results for one 
96-well plate of mutants and those mutants indicated by shaded boxes were selected for 
motility tests.  
 
Figure 4.1 The combined results recorded for each well of one of the 96-well plates included in the 
invasion screen.  
 1 2 3 4 5 6 7 8 9 10 11 12 
A + ++ +++ +++ + +++ +++ +++ ++ +++ + NG 
B 3 +++ +++ + X ++ + +++ +++ X +++ NG 
C +++ + 2 ++ +++ +++ + ++ +++ + NG NG 
D +++ ++ +++ +++ +++ +++ +++ +++ +++ ++ X NG 
E ++ +++ +++ +++ ++ +++ ++ ++ X + + X 
F ++ +++ ++ +++ +++ +++ +++ ++ +++ X +++ X 
G ++ ++ ++ +++ +++ +++ +++ ++ +++ +++ ++ +++ 
H +++ +++ +++ + +++ +++ +++ ++ + X +++ X 
 C. jejuni 01/51: +++ C. jejuni 81116 ∆flaA/flaB: X 
The transposon mutant library was screened for invasion in INT-407 cells. Mutants that showed up to six 
colonies in the undiluted lysate were selected (shaded) for motility testing. Key: NG: no growth in the 
inoculum; X: no colonies seen in test lysate; 1,2 or 3: exact number of colonies counted; +: 4 to 6 
colonies counted; ++: 7 to 9 colonies counted; +++: more than 9 colonies per spot. 
 
4.3.2 Motility  
Motility has been implicated in intestinal colonisation and virulence in many enteric 
pathogens including Yersinia enterocolitica (McNally et al., 2007; Young et al., 2000a), 
Salmonella Typhimurium (Schmitt et al., 1994)  and C. jejuni  also depends on flagellar 
motility for its pathogenicity (Wassenaar et al., 1991). One study showed both flaA and 
flaB mutants adhere to cultured intestinal epithelial cells but they were deficient in their 
ability to invade Caco-2 cells (Grant et al., 1993). Therefore motility was tested in the 
transposon mutants (Section 4.2.2) with a low invasion capability in the screening 
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assays and only those mutants that were highly motile were included in further studies 
to confirm the reduced invasion phenotype in standard gentamicin protection assays.  
The motility was tested in the 174 transposon mutants that showed reduced invasion by 
growing the bacteria on semisolid Mueller-Hinton broth supplemented with 0.4% agar 
and measuring the diameter of growth after 48 hours of incubation in microaerobic 
conditions. A non-motile mutant C. jejuni 81116 flaA-/flaB- (Wassenaar et al., 1991) 
was used as negative control in the motility assay. There was a range in motility shown 
by the mutants as compared to wildtype strain C. jejuni 01/51, most of the mutants 
showed motility at approximately the same level as wildtype strain but five of them 
were non-motile (Appendix 3). The motility and invasion data for a selection of mutant 
is given in (Table 4.1). Previously, during the generation of random transposon 
mutagenesis library of C. jejuni strain 480, mutants with 0 – 70% motility of the 
wildtype strain, were characterised; the ability to invade cultured INT-407 cells in these 
mutants was reduced (Golden et al., 2000; Golden and Acheson, 2002). So an arbitrary 
level of motility (75%) was selected and forty mutants that showed motility above 75% 
as compared to wildtype strain 01/51 and up to three colonies in the screening assays 
were selected for confirmation of the reduced invasion phenotype by standard 
gentamicin protection assays using INT-407 and Caco-2 cells. 
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Table 4.1 An example of the combined results of the invasion and motility screen. 
Mutant Invasion Diameter of growth 
(cm) 
% motile* 
3A8 X 0.6 14.6 
3A10 2 4.3 87.8 
3B10 3 5.2 106.1 
3C1 X 3.5 71.4 
3C2 + 3 61.2 
3C5 + 4.4 89.8 
C. jejuni 01/51 +++ 4.9 100 
C. jejuni 81116 
∆flaA/flaB 
X 0.5 10.2 
*%motile: percentage of motility shown by the mutants as compared to that shown by C. jejuni 01/51. Selected 
mutants were tested for motility and the table shows the results of 6 out of 174 mutants. The mutants that 
showed up to three colonies in the invasion screening assay and more than 75% motility as compared to 
wildtype strain were selected (shaded) for confirmation of the reduced invasion phenotype in INT-407 
and Caco-2 cells. C. jejuni 81116∆flaA/flaB was used as negative control in the assays. Key: X: no 
colonies; 1, 2 or 3: exact number of colonies counted; +: 4 to 6 colonies; ++: 7 to 9 colonies; +++: more 
than 9 colonies counted in 3 µl spot of the undiluted lysate in invasion screening assay.  
 
4.3.3 Confirmation of phenotype using a standard gentamicin protection 
assay 
The reduced invasion phenotype in the selected transposon mutants was confirmed by a 
standard gentamicin protection assay. The standard 24-well plate gentamicin protection 
invasion assay using INT-407 cells was performed as described earlier in Section 2.7 
and the forty transposon mutants that showed very low or no invasion in INT-407 cells 
in the semi-quantitative invasion screening assays but good motility were tested for 
their invasion potential in the standard invasion assays. For ease of handling the forty 
mutants were divided into three groups and their invasion potential was tested in three 
independent gentamicin protection assays. Wildtype strain C. jejuni 01/51 and some of 
the non-motile mutants identified in this study were used as reference and negative 
controls, respectively, in the assays. Most of the mutants showed reduced invasion in 
INT-407 cells as determined in the previous screens. Interestingly five of the mutants 
showed invasion levels higher than the wildtype strain 01/51 including 5E12 and 5F12 
that showed more than 40% higher invasion than the wildtype strain (Appendix 4). The 
Chapter 4. Screening of the transposon mutant library 
 
73 
five motility mutants (3G4, 3H9, 9B2, 6G1 and 6G3) identified in this study were used 
as negative controls in the standard invasion assays and all of them showed very little 
invasion in INT-407 cells that was in agreement with previous reports (Grant et al., 
1993; Malik-Kale et al., 2007; McNally et al., 2007; Wassenaar et al., 1991).  
The invasion efficiency of the wildtype strain was variable in the standard invasion 
assays and to make the comparison uniform the mean values of invasion efficiencies of 
the mutants from triplicate wells were compared with those of the wildtype strain in the 
same assay and the percentage of mutant invasion was calculated considering the 
wildtype mean invasion efficiency as 100% (Appendix 4). Therefore the invasion 
potential of each mutant was presented as a percentage of the invasion efficiency of the 
wildtype strain. To further shortlist the transposon insertion mutants with very low 
invasion potential, a stringent cut off value of 80% reduction in invasiveness into INT-
407 cells was used i.e. those mutants with up to 20% of invasion of the parent strain 
01/51. Mutants showing a reduction in invasiveness of more than an 80% compared to 
wildtype were selected for reconfirming their reduced invasion phenotype.  Fifteen out 
of forty mutants tested showed more than an 80% reduction in invasion i.e. having up to 
20% invasion of that shown by wildtype strain 01/51 in the standard invasion assays 
and were selected for further characterisation (Figure 4.2). These selected fifteen 
transposon mutants were tested to reconfirm their reduced invasion potential into INT-
407 as well as Caco-2 cells.  
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The selected fifteen transposon mutants were reconfirmed for their reduced invasiveness 
in INT-407 and Caco-2 cells and all the mutants, apart from two, maintained the 
reduced invasion phenotype in both the INT-407 (Figure 4.3) and Caco-2 cells (Figure 
4.4). Mutant 6A9 showed nearly a 50% reduction in invasion efficiency compared to 
wildtype strain in both cell lines in this assay and  mutant 9D2 showed a higher invasion 
in Caco-2 cells than INT-407 cells which might be due to its differential interaction 
with Caco-2 cells. It has previously been reported that the same Campylobacter jejuni 
strain can vary in invasion efficiency for different host cell lines and this dependence 
appears to be host cell line-specific (Konkel et al., 1992a; Oelschlaeger et al., 1993) 
however in this study the selected mutants in general do behave similarly in both cell 
lines. 
 
Figure 4.3 Invasion of C. jejuni 01/51 transposon mutants in INT-407 cells.  
The fifteen selected mutants that showed more than an 80% reduction in invasion compared to the 
wildtype strain 01/51 were retested for their invasion potential in INT-407 cells. All of them maintained 
the reduced invasion phenotype apart from mutant 6A9 which showed about a 50% reduction in invasion. 
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Figure 4.4 Invasion of C. jejuni 01/51 transposon mutants in Caco-2 cells. 
The fifteen selected mutants that showed greater than an 80% reduction in invasion in INT-407 cells were 
also checked for their invasion potential in another human intestinal epithelial cell-line Caco-2. Most of 
the mutants showed invasion potential in Caco-2 cells similar to that in INT-407 cells (Figure 4.3) except 
mutant 9D2 which showed slightly higher invasion in Caco-2 cells than INT-407 cells. 
 
4.4 Summary and conclusions 
Transposon mutagenesis was applied to a hyperinvasive Campylobacter jejuni 01/51 
and a library consisting of 867 mutants was generated previously. In this study, 768 
transposon mutants were screened to find those mutants in which transposon insertion 
resulted in reduced invasiveness. One hundred and seventy four mutants showed very 
low invasion in INT-407 cell-based semi-quantitative screening assays and they were 
subsequently tested for motility. It is believed that reduction in motility results in 
reduced invasion of culture eukaryotic cells in many enteric pathogens so the mutants in 
which reduced invasion was due to reduced motility were excluded from further studies. 
Forty mutants that showed very low invasiveness but maintained good motility were 
checked for invasion in INT-407 cells using standard quantitative gentamicin protection 
assays. Most of the mutants showed reduced invasion in INT-407 cells however five 
mutants showed increased invasion. Fifteen out of the forty mutants with greater than an 
80% reduction in invasion into INT-407 cells were re-confirmed using this cell line and 
were also tested in a second cell line Caco-2. All of the fifteen mutants maintained very 
low levels of invasiveness in INT-407 cells except one mutant (6A9) that showed just 
0.00 
0.05 
0.10 
0.15 
0.20 
0.25 
0.30 
01/51
10A4
6A7
6A9
3A10
9D
2
 
10D
10
 
10D
12
 
10E9
 
10E11
10H
1
 
10H3
 
3H
7
 
3H8
 
10H
12
 
Mutants 
In
v
a
s
io
n
 
e
ffi
c
ie
n
c
y 
10H
2
 
Chapter 4. Screening of the transposon mutant library 
 
77 
below fifty percent reduced invasion in both INT-407 and Caco-2 cells. These fifteen 
mutants with reduced invasion were selected for further study to determine the location 
of transposon insertion.  
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5 LOCALISATION OF TRANSPOSONS, 
BIOINFORMATICS ANALYSIS AND SUBSPECIATION 
 
5.1 Introduction  
Epithelial cell invasion is considered to be an essential step in Campylobacter infection 
(Hu and Kopecko, 2005; Konkel et al., 2000). Invasion studies with intestinal epithelial 
cells as well as other cell lines revealed that the relative ability of different C. jejuni 
isolates to invade cultured cells is strain dependent (Everest et al., 1992; Konkel and 
Joens, 1989; Newell et al., 1985) and a statistically significant correlation was observed 
between C. jejuni's ability to invade cultured cells and clinical symptoms of infection 
(Everest et al., 1992). Fearnley et al. identified a higher ratio of hyperinvasive strains 
among clinical isolates than those from poultry or environmental sources (Fearnley et 
al., 2008). These observations suggest that different Campylobacter isolates vary in 
their virulence properties and that those having a higher ability to invade intestinal 
epithelial cells are more virulent. Some bacterial cell components that affect the 
adhesion and invasion in C. jejuni have previously been reported i.e. flagella (Grant et 
al., 1993; Wassenaar et al., 1991; Yao et al., 1994), capsule (Bacon et al., 2001) and 
lipooligosaccharide (Guerry et al., 2002); moreover, C. jejuni also express different 
proteins to promote their own attachment followed by uptake by non-phagocytic cells 
such as intestinal epithelial cells, these proteins include PEB1, Cad-F, Iam, JlpA 
(Carvalho et al., 2001; Jin et al., 2001; Jin et al., 2003; Konkel et al., 1997; Pei and 
Blaser, 1993; Pei et al., 1998). Despite the identification of these factors, the 
mechanism of invasion and the molecular basis of this observed variation in 
invasiveness in C. jejuni is not fully understood. A transposon mutant library generated 
in a hyperinvasive clinical isolate C. jejuni 01/51 was studied to determine those genes 
that promote invasiveness in strain 01/51. The use of a hyperinvasive strain in this study 
will provide more insight into the molecular mechanisms underlying this phenotype in 
C. jejuni. So the transposon mutant library was screened to find those mutants with a 
reduced invasion phenotype and invasion-related genes interrupted by transposon 
insertion were identified.  
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5.2 Methods 
5.2.1 Localisation of transposon insertion sites 
Those genes disrupted by transposon insertion in the C. jejuni 01/51 mutants were 
identified by the plasmid rescue technique (Grant et al., 2005). Mutants were selected 
that showed very low invasion of Caco-2 and INT-407 cells in standard gentamicin 
protection invasion assays but good motility. Briefly, genomic DNA was isolated from 
the mutants using the GenElute® Bacterial Genomic DNA kit (Sigma, Dorset, UK) and 
digested with BglII (Promega, Southampton, UK) or SspI (Sigma, Dorset, UK). 
Digested DNA fragments were self-ligated using T4 DNA ligase (Promega, 
Southampton, UK) and E. coli S17λpir was transformed with these self-ligated DNA 
fragments by electroporation. Transformants were selected on LB agar containing 
chloramphenicol (10 µg/ml). The resulting plasmids were likely to be large and low 
copy number so the plasmid DNA was extracted from 10 ml overnight culture and 
plasmid DNA was eluted in pre-warmed (70ºC) elution buffer using the QIAprep spin 
miniprep kit (QIAGEN, Crawley, UK). Plasmids were sent for DNA sequencing at the 
University of Nottingham using the transposon specific Transeq primer (Table 2.3) on 
the BigDye cycle sequencing system (ABI Prism; PE Biosystems). The sites of 
transposon insertion into the C. jejuni 01/51 mutant genome were determined by 
subjecting the obtained DNA sequences to Basic Local Alignment Search Tool (BLAST) 
searches in the database of published Campylobacter genome sequences using web-
based local alignment search tools on http://xbase.bham.ac.uk/campydb/blast.pl and 
http://blast.ncbi.nlm.nih.gov/Blast.cgi.  
 
5.2.2 Bioinformatics analysis 
Bioinformatics analysis was carried out to further characterise the genes identified in the 
selected transposon mutants with a reduced invasion phenotype. The analysis including 
finding the restriction sites in a DNA sequence, nucleotide-nucleotide and protein-
protein sequence alignment and generation of DNA reverse complementary strands 
were done using the CCL sequence viewer software downloaded from 
http://www.clcbio.com/index.php. Pfam domains, the functional regions in the 
translational products of the gene of interest were searched online at 
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http://pfam.sanger.ac.uk/search/ and transmembrane helices that give an idea about the 
position of a protein in the cell were also checked online at 
http://www.cbs.dtu.dk/services/TMHMM/. 
 
5.2.3 Subspeciation of C. jejuni 
The subspecies of C. jejuni 01/51 was determined both biochemically using a nitrate 
reduction test and by PCR. C. jejuni subspecies jejuni reduces nitrate to nitrite while 
subspecies doylei cannot reduce nitrate (Steele and Owen, 1988) which is due to a 
deletion of 2.8 kbp in the napA gene that encodes for large subunit of nitrate reductase 
(Miller et al., 2007). 
5.2.3.1 Nitrate reduction test  
C. jejuni 01/51 (test strain), C. jejuni subspecies jejuni NCTC11168 (reference strain), 
Citrobacter koseri (positive control) and Acinetobacter baumannii (negative control) 
were grown overnight in Bacto® nitrate broth (Difco) at 37oC; C. jejuni was incubated 
in microaerobic conditions while C. koseri and A. baumannii were grown in aerobic 
conditions. Five millilitres of these broth cultures was transferred into test tubes and 100 
µl of sulfanilic acid and an equal amount of α-naphthylamine were added to each tube. 
Development of red colour indicated nitrate reduction; if no colour change was 
observed, a little amount of zinc powder was added to tubes to confirm whether nitrate 
was reduced to ammonia or N2. Development of red colour on addition of zinc powder 
indicated negative result.  
5.2.3.2 Determination of C. jejuni subspecies by PCR 
The subspecies of C. jejuni 01/51 was also determined using the PCR method described 
elsewhere (Miller et al., 2007). PCR using napAL2 and napAR4 primers (Table 2.3) 
was performed following the standard PCR protocol described in Section 2.12. napAL2 
and napAR4 are napA flanking primers that generate a 4 kbp PCR product from a 
subspecies jejuni DNA template while the amplicon resulting from  subspecies doylei is 
1.2 kbp. Genomic DNA extracted from C. jejuni 01/51 (test strain) and C. jejuni 
subspecies jejuni NCTC11168 (reference strain) was used as template and the PCR 
amplification time was kept at 4 minutes. A PCR reaction mixture containing all those 
components present in PCR for 01/51 except DNA template was used as the PCR 
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negative control. PCR products were run on an agarose gel (0.8%) and PCR product 
size was compared with a 1 kbp DNA marker (Promega, UK). 
 
5.3 Results and discussion 
5.3.1 Localisation of the transposon insertion 
A transposon mutagenesis library generated in a hyperinvasive clinical isolate C. jejuni 
01/51 was screened and fifteen mutants that showed very low levels of invasion into 
INT-407 and Caco-2 cells were selected to identify the genes that play a role in 
promoting invasion of the organism in cultured human intestinal epithelial cells. 
Location of transposon insertion that caused reduction in invasiveness in the selected 
mutants was determined in only those mutants that were more than 75% motile as 
compared to the parent strain 01/51 to focus the effort on identifying those genes with a 
role in invasion rather than motility. 
The transposon insertion point was identified by the plasmid rescue technique (Grant et 
al., 2005). Resulting plasmids carried the transposon along with the transposon insertion 
site flanking Campylobacter jejuni 01/51 genomic DNA. Plasmids were sequenced 
using Transeq (Table 2.3), a transposon derived primer and DNA sequences were 
searched for matching sequences at http://xbase.bham.ac.uk/campydb/. The transposon 
insertion point was identified in 12 out of 15 selected mutants; the transposon insertion 
site could not be determined in three mutants even after several attempts. The fact that 
no insertion site was determined for these mutants (10A4, 10E11 and 10H2) was either 
due to a failure in the plasmid rescue process or nucleotide sequencing. Initially the 
selected transposon mutants’ genomic DNA was digested using BglII for plasmid rescue 
and DNA sequencing was successful in seven mutants (3A10, 3H7, 3H8, 10D10, 10E9, 
10H1, and 10H12). It was possible that those plasmids resulting from BglII digestion 
where sequencing failed might have been very big in size and a good signal may not 
have been generated in the sequencing reactions. Plasmid rescue was attempted at least 
two times more from those mutants in which transposon localisation was initially failed 
using BglII digestion.  So, later genomic DNA was digested with SspI an enzyme that 
also does not cut inside the transposon sequence, and using this enzyme genes mutated 
by transposon insertion in another five mutants (6A7, 6A9, 9D2, 10D12 and 10H3) 
Chapter 5. Localisation of transposons, bioinformatics analysis and subspeciation 
 
83 
were identified. Thus those 12 genes into which transposon insertion had caused a 
reduction in invasion of the C. jejuni 01/51 mutants into INT-407 and Caco-2 cells were 
identified (Table 5.1).  
 
Table 5.1 The genes mutated by transposon insertion in 15 selected transposon mutants.  
Mutant Transposon location Mutant Transposon location 
3A10 Cj0685c: Invasion protein cipA 10D12 No database match found (date of last 
search March 2009) 
3H7 Cj1020c: Putative cytochrome C 10E9 Cj1136: Putative galactosyltransferase 
3H8 Cj0499: Putative HIT family protein 10E11 Not determined yet 
6A7 Cj1539c: Putative anion-uptake ABC-transport system permease protein 10H1 Cj1245c: Putative membrane protein 
6A9 Cj0690c: Putative 
restriction/modification enzyme 10H2 Not determined yet 
9D2 
JJD26997_1801: Capsular 
polysaccharide biosynthesis protein of 
C. jejuni subsp. doylei 269.97 
10H3 Cj1503c: putA; Putative proline dehydrogenase 
10A4  Not determined yet 10H12 Cj1305c: Hypothetical protein 
10D10 Cj1555c: Hypothetical protein   
The genes in selected transposon mutants of a hyperinvasive clinical isolate C. jejuni 01/51 where 
transposon insertion had reduced invasiveness into INT-407 and Caco-2 cells were identified by the 
plasmid rescue technique. All the identified genes except those in mutant 9D2 and 10D12 are also present 
in the first genome sequenced C. jejuni strain NCTC11168. The gene mutated in mutant 9D2 showed 
homology to JJD26997_1801, a gene encoding capsule polysaccharide biosynthesis protein in C. jejuni 
subspecies doylei 269.97 whereas the gene mutated in 10D12 did not show match to any of the genes in 
the available sequenced genome databases.  Genes shaded (n=6) were selected for generating targeted 
mutations and further characterisation. 
 
All but two of the transposon insertions were found to be in genes which are also 
present in NCTC11168, the original genome-sequenced strain (Parkhill et al., 2000). Of 
the remaining two insertions one in mutant 9D2 showed a match with the gene 
annotated as a capsule polysaccharide biosynthesis protein (JJD26997_1801) in C. 
jejuni subspecies doylei strain 269.97.  Interestingly in the second mutant (10D12) the 
sequence obtained had no database match at the time of searching, which may indicate 
that this region is unique to strain 01/51.  None of the transposons had inserted into 
orthologues of any of the known invasion-related genes found in other bacteria, such as 
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in Salmonella or Yersinia. This is not too surprising, as from the numerous genome 
sequences that are now available it is apparent that C. jejuni does not contain any such 
invasion-related genes, however this does not preclude there being novel invasion-
related genes present in strain 01/51. 
DNA sequence obtained from transposon mutant 3A10 showed a match with the cipA 
gene of Campylobacter species. cipA is a 1353 bp (450 amino acids) long gene present 
in genome-sequenced Campylobacter jejuni strains NCTC11168, 81-176 and RM1221 
but is absent from C. jejuni strains 81116 and 269.97. It contains a variable poly-G tract 
near its 3’ end, and shows some similarity with Cj1421c (28.0%) and Cj1422c (25.3%) 
both of which contain variable poly-G tracts. Originally it was annotated as a putative 
sugar transferase based on family clustering (BLASTP) with other C. jejuni predicted 
sugar transferases e.g. Cj1434c and Cj1438c. The cipA amino acid sequence has no 
transmembrane helices. A previous study reported that a mutation in the cipA gene of C. 
jejuni TGH9011 resulted in the reduced invasion of HEp-2 cells but there was no 
change in invasion of INT-407 and Caco-2 cells (Lynett, 1999). This gene has now been 
patented as encoding an invasion protein of Campylobacter species, which can be 
accessed at http://www.freepatentsonline.com/6087105.html. This gene was identified 
in our study to be involved in invasion of eukaryotic cells and was selected for further 
characterisation by targeted mutagenesis and complementation to study its role in the 
virulence of C. jejuni 01/51. 
A putative cytochrome C family protein (Cj1020c) was mutated in mutant 3H7. 
Cj1020c is a 453 bp (144 amino acids) long gene, also present in the genome-sequenced 
C. jejuni strains NCTC11168, RM1221, 81-176 and 269.97. The cytochrome C (CytC) 
domain was identified by Pfam search and one probable transmembrane helix was 
identified by TMHMM2.0 in the amino acid sequence of the translation product of this 
gene. This gene might be involved in energy production and electron transport but has 
not yet been characterised in C. jejuni. 
DNA sequence obtained from the mutant 3H8-derived plasmid showed a match with a 
gene (Cj0499) encoding for a putative histidine triad (HIT) family protein. Cj0499 is a 
486 bp (161 amino acids) long gene and its predicted amino acid sequence has no 
transmembrane helix. In addition to HIT, Pfam identified a molybdopterin 
oxidoreductase, Fe4S4 domain which is found in a number of dehydrogenases. This 
gene has not yet been characterised in C. jejuni.   
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Mutant 6A7 contained the transposon insertion at nucleotide 160 in Cj1539c, a putative 
anion-uptake ABC-transport system permease protein. Cj1539c is a 720 bp (239 amino 
acids) long gene present in genome-sequenced C. jejuni strains NCTC11168, 81-176, 
RM1221 and 269.97. Its translation product is similar to many involved in anion uptake 
including the sulphate transport system permease protein of E. coli (23.6%), the ABC-
transport permease protein of C. coli RM2228 (91%), C. upsaliensis RM3195 (85%), 
Wolinella succinogenes DSM1741 (57%) and Desulfovibrio vulgaris (48%). Pfam 
identified an inner membrane component domain of bacterial binding-protein-dependent 
transport in predicted amino acid sequence of Cj1539c and five probable 
transmembrane helices were also predicted by TMHMM2.0. It is established that ABC 
transport system components are involved in virulence in Mycobacterium species 
(Collins et al., 2003; Peirs et al., 2005), Streptococcus pneumoniae (Dintilhac et al., 
1997), Yersinia pestis (Bearden and Perry, 1999) and many other micro-organisms. The 
exact role of this gene in Campylobacter jejuni pathogenesis is not known and the gene 
was selected for targeted mutagenesis and complementation to further characterise and 
confirm its role in C. jejuni pathogenesis.  
A gene encoding for a putative restriction/modification enzyme (Cj0690c) was 
inactivated in the transposon mutant 6A9. Cj0690c is a 3753 bp (1250 amino acids) 
long gene of Campylobacter jejuni NCTC11168. The actual function of this gene is not 
known yet but in addition to a type I restriction enzyme domain, this gene also contains 
the signature of the N-6 adenine-specific DNA methylase (Prosite motif PC00092), 
indicating that it might have a regulatory role in the expression of virulence-associated 
genes, similar to other Dam methylases (Balbontin et al., 2006; Falker et al., 2005; Low 
et al., 2001). Indeed another gene (Cj1461, a predicted methyl transferase gene) 
containing this same signature was recently reported to have a role in the regulation of 
virulence in C. jejuni.  In that study a mutation in the Cj1461 gene resulted in reduced 
invasion and motility, but increased adhesion (Kim et al., 2008).  Cj0690c was also 
interrupted by transposon insertion in C. jejuni 81-176 in a separate study, however the 
mutant was only tested for chicken colonisation where it did not show significant 
reduction compared to the wildtype strain (Grant et al., 2005). A good correlation with 
chicken colonisation and invasion in INT-407 cells has been reported previously (Hanel 
et al., 2004), however, a galE deletion mutant of C. jejuni 81116 showed reduction in 
adherence and invasion of INT-407 cells but it was still able to colonise chickens to the 
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same level as the wildtype strain (Fry et al., 2000). This gene was selected for further 
characterisation to study its role in virulence of C. jejuni 01/51. 
  Two of the mutants (10D10 and 10H12) had transposon insertions in genes encoding 
putative or hypothetical proteins (Cj1555c and Cj1305c respectively), the function of 
which is not yet known. Cj1555c is 636 bp (211 amino acids) long. TMHMM2.0 did 
not find any transmembrane helix in the amino acid sequence of this hypothetical 
protein but DapB, a Dihydrodipicolinate reductase N terminus domain, which binds 
NADPH in the biosynthesis of lysine, was identified by Pfam. Cj1305c is 1218 bp (405 
amino acids) in size and it shows similarity with Cj1306c (78.1%), Cj0617 (38.9%), 
Cj0618 (37.1%), Cj1310c (63.7%), Cj1342c (38.9%) and hypothetical proteins of other 
bacteria including Aeromonas hydrophila (27%). It is a member of the 617 family of c.j. 
proteins (Szymanski and Wren, 2005). This 617 family of proteins contains 
homopolymeric tracts and are part of C. jejuni O-linked glycosylation locus (Cj1293 – 
Cj1342); no orthologues of this family are found in other bacterial species (Szymanski 
and Wren, 2005). Mutation of the Cj1305c homologue in C. jejuni 81-176 resulted in 
fully motile bacteria with no effect on flagellin glycosylation (Guerry et al., 2006). 
Cj1305c was selected for further characterisation. 
Cj1136, a putative galactosyltransferase was interrupted by transposon insertion in 
mutant 10E9; Cj1136 is 1173 bp (390 amino acids) in size. A glycosyltransferase family 
domain was identified in the amino acid sequence and it has homology (29%) to a 
glycosyltransferase of Streptococcus pneumoniae, however, it has not yet been 
characterised in Campylobacter species. This gene is part of the Campylobacter jejuni 
lipooligosaccharides (LOS) biosynthesis locus (Cj1131c - Cj1152c). The LOS is an 
important virulence factor in Gram-negative bacteria and has been reported to play a 
role in Campylobacter jejuni adhesion and invasion into human intestinal epithelial cells 
(Fry et al., 2000; Kanipes et al., 2008). Previous PCR based analysis of C. jejuni strains 
with differential Caco-2 cell invasion potential showed two genes, cgtB and wlaN, 
encoding putative β-1,3-galactosyltransferases, were detected in most of the strongly 
invasive strains and rarely in non-invasive strains (Hanel et al., 2007; Muller et al., 
2006; Muller et al., 2007). However, Muller el al. found no correlation between the 
presence or absence of other galactosyltransferases including  Cj1136  and invasion 
capability (Muller et al., 2007). Cj1136 was selected for further characterisation. 
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DNA sequence obtained from transposon mutant 10H1 showed a match with a putative 
membrane protein (Cj1245c) of Campylobacter jejuni. Cj1245c is 1197 bp (398 amino 
acids) in size and conserved in all the genome-sequenced C. jejuni strains. TMHMM2.0 
predicted two transmembrane helices in the amino acid sequence of the translation 
product of Cj1245c and no significant domain was identified by Pfam. Membrane 
proteins have been reported to be involved in the virulence of many bacterial pathogens; 
outer membrane proteins Rck of Salmonella Typhimurium and Ail of Yersinia 
enterocolitica were shown to have role in invasion/adhesion and serum resistance of the 
pathogens (Heffernan et al., 1994; Pierson and Falkow, 1993), MOMP (major outer 
membrane protein), JlpA, PEB1 and CadF (Campylobacter adhesion to fibronectin) of 
C. jejuni were involved with adhesion and invasion of the organism in cultured 
eukaryotic cells (Jin et al., 2001; Monteville et al., 2003; Moser et al., 1997; Pei et al., 
1998). Though Cj1245c did not show homology to any of the characterised virulence-
associated membrane proteins it would be interesting to study the role of this gene in the 
virulence of C. jejuni 01/51 and thus this mutant was selected for further 
characterisation. 
In mutant 10H3 the transposon was inserted in putA (Cj1503c), a putative proline 
dehydrogenase/delta-1-pyrroline-5-carboxylate dehydrogenase, which catalyses the 
oxidation of proline into glutamate. Cj1503c is 3489 bp (1162 amino acids) in size. 
TMHMM2.0 found no transmembrane helix in the amino acid sequence however Pfam 
identified domains matching to entry “PF00171 aldedh, Aldehyde dehydrogenase, 
PS00017 ATP/GTP-binding site motif A (P-loop), PS00687 Aldehyde dehydrogenases 
glutamic acid active site, and PS00070 Aldehyde dehydrogenases cysteine active site 
and domain PF01619 Proline dehydrogenase”. This gene might be involved in amino 
acid metabolism but functional characterisation has not been carried out in C. jejuni. 
The lack of well-defined virulence mechanisms in C. jejuni and the involvement of 
metabolism associated genes with virulence phenotypes suggest that:  C. jejuni is an 
opportunistic pathogen and does not possess specific virulence factors as in other 
bacteria, and that disease results as a consequence of the need of the organism to grow 
and survive within the human host.   
Briefly, to identify the genes that enhance invasiveness, the transposon insertion site 
was determined in twelve out of fifteen selected mutants of C. jejuni 01/51 with reduced 
invasion in INT-407 and Caco-2 cells. All of the identified genes except two were 
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present in the first genome-sequenced strain C. jejuni NCTC11168; among the two 
genes that were absent from NCTC11168, the gene mutated in 9D2 showed homology 
to JJD26997_1801, a capsule polysaccharide biosynthesis protein of C. jejuni 
subspecies doylei 269.97 while sequence obtained from mutant 10D12 did not show a 
match that could be a sequence specific to 01/51. None of the genes identified in this 
study showed homology to invasion-related genes reported in other bacteria and most of 
the genes identified in this study have yet not been characterised apart from cipA 
(mutant 3A10) which had previously been reported to be involved in invasion of C. 
jejuni TGH9011 (Lynett, 1999). Six of the genes mutated by transposon insertion in C. 
jejuni 01/51 were selected on the basis of their potential relevance to virulence and ease 
of genetic manipulation for further characterisation through targeted mutation and 
complementation to confirm their role in invasion in cultured eukaryotic cells. 
 
5.3.2 Subspeciation of C. jejuni 01/51 
C. jejuni has been subdivided into two subspecies: subspecies jejuni and subspecies 
doylei. Most of the isolated strains are subspecies jejuni, and subspecies doylei has 
infrequently been isolated. Subspecies doylei has primarily been isolated from human 
clinical samples and in addition to gastroenteritis (Kasper and Dickgiesser, 1985; 
Lastovica and Skirrow, 2000), it has been found associated often with bacteraemia in 
children (Musmanno et al., 1998). In a recent study subspecies doylei showed 
divergence from subspecies jejuni in many hypervariability regions including the 
capsule biosynthesis locus (Parker et al., 2007). Previously microarray and PCR based 
analysis has shown that in C. jejuni 01/51 many of the capsule genes are missing or the 
nucleotide sequence of capsule biosynthesis locus is different from the first genome 
sequenced strain C. jejuni NCTC11168 (Manning, personal communication). In the 
current study, the gene mutated in transposon mutant 9D2 showed a match with 
JJD26997_1801, a capsule biosynthesis protein of C. jejuni subspecies doylei 269.97. 
Moreover, the frequency of the observed hyperinvasive phenotype was previously 
reported to be higher amongst clinical isolates than those from poultry (Fearnley et al., 
2008). There is also evidence that subspecies doylei was isolated more often from blood 
cultures (24%) than from stool cultures (9.7%) (Lastovica, 1996); furthermore, 
subspecies doylei was isolated from 85.2% of Campylobacter/Helicobacter-related 
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bacteraemia cases (Morey, 1996). In light of these tenable links between its capsule 
biosynthesis gene, invasion and a clinical source of isolation, the subspecies of C. jejuni 
01/51 was determined both biochemically and by PCR and it was confirmed to be C. 
jejuni subsp. jejuni. The nitrate reduction test showed that C. jejuni 01/51 has a 
functional nitrate reductase enzyme (Figure 5.1) which is found in C. jejuni subsp jejuni 
but not C. jejuni subsp doylei (Steele and Owen, 1988). C. jejuni subsp jejuni 
NCTC11168 was used as a reference strain and it showed nitrate reductase activity as 
expected. In the absence of a known C. jejuni subsp doylei strain, Citrobacter koseri 
and Acinetobacter baumannii were used as positive and negative control respectively 
and they validated the test (Figure 5.1).  
Recently, a PCR method for subspeciation of C. jejuni was described elsewhere (Miller 
et al., 2007). In this method, primers napAL2 and napAR4 were designed based on the 
conserved sequences of the nitrate reductase (nap) locus of the genome-sequenced C. 
jejuni strains NCTC11168, RM1221 and C. coli RM2228. The napAL2 and napAR4 
primers bind in the flanking regions of napA and generate a 4 kbp product in C. jejuni 
subspecies jejuni but a 1.2 kbp DNA fragment is amplified in subspecies doylei. The 
subspecies of C. jejuni 01/51 was also confirmed as jejuni by PCR using napAL2 and 
napAR4 primers and both C. jejuni 01/51 and C. jejuni subspecies jejuni NCTC11168 
generated a 4 kbp product (Figure 5.2). No PCR product was obtained in PCR mixture 
without DNA template that validated the PCR reaction and confirmed that products 
were not due to primer dimerisation or contamination. Unfortunately, C. jejuni 
subspecies doylei was not available to be used as a reference strain in the assays.  
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Figure 5.1 Nitrate reduction test confirmed that C. jejuni 01/51 is C. jejuni subspecies  jejuni. 
Subspecies of C. jejuni 01/51 (tube 2) was determined biochemically using the nitrate reduction test. 
Development of a red colour on addition of sulfanilic acid and α-naphthylamine to an overnight broth 
culture indicated a positive result. Nitrate was reduced to nitrite by C. jejuni 01/51 which confirmed that 
the subspecies of 01/51 is jejuni. Citrobacter koseri (tube 1) and Acinetobacter baumannii (tube 4) were 
used as positive and negative controls, respectively, for the nitrate reduction test while C. jejuni 
NCTC11168 (tube 3) was used as reference subspecies jejuni. As expected, nitrate activity was also 
shown by Citrobacter koseri and C. jejuni NCTC11168 while nitrate reduction was negative in 
Acinetobacter baumannii.  
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Figure 5.2 PCR confirmed the jejuni subspecies of C. jejuni 01/51. 
The subspecies of C. jejuni 01/51 was determined by using a subspeciation PCR described by Miller et al. 
PCR using napAL2 and napAR4 primers generated a 4 kbp product for C. jejuni 01/51 (lane 2) and from 
reference strain C. jejuni subsp. jejuni NCTC11168 (lane 3). PCR confirmed that 01/51 is C. jejuni 
subspecies jejuni. PCR reaction control without template (lane 4) did not show a product as was expected. 
Lane 1: 1.0 kbp DNA markers (Promega, UK); lane 2: PCR product generated by 01/51 template, lane 3: 
PCR product generated by 11168 DNA template, and lane 4: PCR control with no template. 
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5.4 Summary and conclusions 
A transposon mutant library generated in C. jejuni 01/51 was studied and identification 
of the genes mutated by transposon insertion that resulted in the reduction in 
invasiveness but not motility was attempted in fifteen selected mutants. The site of 
transposon insertion was determined in twelve of the mutants and many previously 
uncharacterised genes with a potential role in host cell invasion have been identified in 
this study. Six of the genes were selected for further characterisation through targeted 
mutagenesis as well as complementation studies which it was hoped would provide 
greater insight into the molecular basis of the observed variation in virulence in C. 
jejuni. Moreover, despite this hyperinvasive strain possessing a capsular biosynthetic 
gene with similarity to one found in C. jejuni  subspecies doylei the subspecies of C. 
jejuni 01/51 was confirmed to be subspecies jejuni both biochemically and by PCR.   
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6 MUTAGENESIS AND COMPLEMENTATION OF THE 
GENES 
 
6.1 Targeted mutagenesis: an introduction 
The reduced invasion phenotype of the six transposon insertion mutants that were 
confirmed as poor invaders of both INT-407 and Caco-2 cell lines and were motile, was 
reconfirmed by generating targeted mutations. This was done to reconfirm that the 
reduced invasion phenotype in the mutants was not due to a polar effect of transposon 
insertion on the transcription of downstream gene(s). Targeted mutations were 
generated in the selected genes and the kanamycin resistance cassette (kanr) was 
inserted in a suitable restriction site in the gene i.e. a restriction site that was not present 
in the cloning vector, pGEM®-T Easy in this case. The kanr cassette was amplified 
from pMA24 (Abuoun, 2007); this cassette can be expressed in E. coli and C. jejuni and 
has no transcription termination sequences and thus was unlikely to have any polar 
effects. If a suitable restriction site was not present in the gene for insertion of kanr 
cassette then it was introduced by inverse PCR (Wren et al., 1994) of the gene with 
primers carrying the restriction sequences near their 5’ends. Though all the invasion 
associated genes identified by transposon mutagenesis were interesting, six genes (cipA, 
Cj0690c, Cj1136, Cj1245c, Cj1305c and Cj1539c) were selected initially for generating 
targeted mutations. The following points were considered when selecting the genes; a) a 
previous study has shown that the gene might play a role in either virulence or chicken 
colonisation; b) the gene product has transmembrane helices; and c) the gene should be 
more than 0.7 kbp in size for ease of genetic manipulation. The genome sequence of the 
C. jejuni strain 01/51 is not yet known thus the genome sequence of C. jejuni strain 
NCTC11168 (Parkhill et al., 2000) was used as the template for PCR primer designing 
and for bioinformatics analysis. The mutants generated by targeted mutations were 
tested for their adhesion and invasion into Caco-2 cells to confirm the reduced invasion 
phenotype. Mutations in these genes were also complemented with their wildtype 
alleles to satisfy Koch’s molecular postulates (Falkow, 1988) with an attempt to restore 
the invasion phenotype and verify the virulence-associated role of the genes. 
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6.1.1 Mutagenesis of Campylobacter invasion protein, cipA (Cj0685c) 
6.1.1.1  Introduction  
DNA sequence obtained from transposon mutant 3A10 showed a match with the cipA 
(Cj0685c) gene in Campylobacter species. cipA (1353 bp) contains a variable poly-G 
tract near its 3’ end and originally it was annotated as a putative sugar transferase. A 
previous study showed that a cipA deletion mutant of C. jejuni TGH9011 had reduced 
invasion in Hep-2 cells but there was no change in invasion of INT-407 and Caco-2 
cells (Lynett, 1999). This gene was identified in our study to be involved in invasion of 
eukaryotic cells, and interestingly the cipA mutation in C. jejuni 01/51 resulted in 
reduced invasion of both INT-407 and Caco-2 cells. The invasion-related role of cipA 
was reconfirmed by generating a targeted mutation in this gene. 
6.1.1.2  Cloning and generation of the mutant 
To study the role of cipA in the invasion potential of C. jejuni, a suicide vector was 
generated to mutate the gene in the strain 01/51. Standard E. coli vectors including 
pGEM®-T Easy have been frequently used as suicide vectors in Campylobacter 
because they are unable to replicate in it. Normally a double crossover event takes place 
leading to the elimination of vector sequence and replacement of the wildtype gene with 
disrupted gene. The cipA gene has a HindIII site at 108 bp in the CDS that was selected 
for insertion of a kanr cassette and inactivate the gene. Initially, a 1.5 kbp DNA 
fragment from 0.4 kbp upstream of the cipA gene to 1141 bp inside the cipA CDS was 
amplified by PCR (Section 2.12.1) using primers 685-F and 685-R (Table 2.3). The 
PCR product with A overhangs was ligated into the cloning vector pGEM®-T Easy 
(Promega, UK) (Section 2.9.7) and the resulting plasmid pGEM:685 was digested with 
HindIII and dephosphorylated (Section 2.9.4) with thermostable alkaline phosphatase 
(TSAP) to avoid plasmid recircularisation. The kanr cassette was amplified by PCR 
from pMA24 using the KNHD-F and KNHD-R primers that harbour HindIII restriction 
sites near their 5’ends. The HindIII digested kanr PCR products were then ligated with 
linearised pGEM:685. E. coli TOP10 cells were transformed with the resulting plasmid 
pGEM:685::kan and colonies were selected on LB agar supplemented with kanamycin 
(50 µg/ml) and ampicillin (100 µg/ml). Plasmid was extracted (Section 2.11.2) from 
those colonies that had grown after 24 hrs incubation and the resultant construct was 
confirmed by PCR using 685-F and 685-R primers. The PCR generated a 2.9 kbp 
Chapter 6. Mutagenesis and complementation of the genes 
 
95 
product in the plasmid having kanr inserted in the cloned cipA gene, the wildtype 
genomic DNA was used as a control in this PCR that generated an expected 1.5 kbp 
product (Figure 6.1). The mutation construct was also confirmed by nucleotide 
sequencing of pGEM:685::kan with SP6 and T7 primers. pGEM:685::kan was used to 
transform C. jejuni 01/51. 
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Figure 6.1 PCR analysis of pGEM:685::kan. 
PCR with 685-F and 685-R primers generated a 1.5 kbp product in 01/51 wildtype genomic DNA (lane 2) 
and a 2.9 kbp product in pGEM:685::kan (lane 3 and 4) and) that confirmed the insertion of kanr cassette 
in the cloned cipA. 1.0 kbp DNA markers (Promega, UK) were loaded in lane 1.  
 
C. jejuni 01/51 cells were made electrocompetent (Section 2.10.3) and electroporation 
was done to transform 01/51 (Section 2.10.4) with pGEM:685::kan and colonies were 
selected on blood agar supplemented with kanamycin (50 µg/ml). Three out of fifteen 
colonies grown after 72 hours incubation were sub-cultured and genomic DNA was 
extracted (Section 2.11.1). PCR of the genomic DNA of C. jejuni 01/51 wildtype and 
potential mutants was done using 685-F and 685-R primers. PCR products showed a 
single 1.5 kbp band in the wildtype and 2.9 kbp bands in the mutants (Figure 6.2) that 
confirmed the replacement of the wildtype cipA with the interrupted cipA by 
homologous recombination. Another PCR using M13-F and M13-R primers was also 
done to check if the PCR products were from the replicating suicide vector rather than 
recombination crossover. PCR using M13-F and M13-R primers did not generate a 
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product in mutants confirming that the suicide vector was not replicating in the 
C. jejuni∆cipA mutant and that the gene had been mutated as a result of crossover (not 
shown). C. jejuni∆cipA mutant was tested in the gentamicin protection assay to 
reconfirm the cipA involvement in invasion in cultured eukaryotic cells. 
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Figure 6.2 PCR analysis of the cipA mutation in C. jejuni 01/51.  
PCR with 685-F and 685-R primers generated a 1.5 kbp product in 01/51 wildtype (lane 2) and a 2.9 kbp 
product in three cipA mutants (lane 3, 4 and 5) that confirmed the successful mutation of cipA in C. jejuni 
01/51. Lane 1 shows 1.0 kbp DNA markers (Promega, UK). 
 
6.1.2 Mutagenesis of a putative restriction/modification enzyme (Cj0690c)  
6.1.2.1  Introduction 
DNA sequence obtained from transposon mutant 6A9 showed the inactivation of a 
putative restriction/modification enzyme (Cj0690c) of Campylobacter species. Cj0690c 
is 3753 bp (1250 amino acids) in size and the actual function of this gene is not yet 
known. This gene contains an N-6 adenine-specific DNA methylase signature and a 
type I restriction enzyme domain was identified within the coding sequence so it might 
be involved in the methylation/restriction of DNA. The DNA methyltransferases of C. 
jejuni and some other enteric pathogens have been reported to play a role in their 
virulence (Balbontin et al., 2006; Falker et al., 2005; Heusipp et al., 2007; Kim et al., 
2008). Cj0690c was mutated by insertional inactivation to reconfirm its involvement in 
invasiveness in C. jejuni 01/51. 
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6.1.2.2  Cloning and generation of the mutant 
A targeted mutation was generated in Cj0690c to further investigate its role in invasion. 
This gene has a BclI site at 1578 bp in the CDS that was selected to insert the kanr 
cassette and inactivate the gene. Initially, a 1.9 kbp DNA fragment from 586 bp to 2483 
bp inside the gene was amplified using 690-F and 690-R primers. The PCR product 
with A overhangs was ligated with the pGEM®-T Easy vector and the resulting plasmid 
pGEM:690, carrying the cloned DNA fragment, was confirmed by PCR and restriction 
digest (not shown).  
Then pGEM:690 was digested with BclI to generate the mutation construct by inserting 
the kanr cassette; BclI generates compatible ends to BamHI whose restriction sites were 
flanking the amplified kanr cassette. The kanr cassette was amplified by PCR from 
pMA24 using KCN-F and Kan-Fex primers that harbour BamHI restriction sites near 
their 5’ends. Kanr amplicons were digested with BamHI and ligated with BclI linearised 
pGEM:690. E. coli TOP10 cells were transformed with ligation products and colonies 
were selected on LB agar supplemented with kanamycin (50 µg/ml) and ampicillin (100 
µg/ml). Plasmids were extracted from four out of more than one hundred colonies that 
grew after 24 hour incubation and were tested for the correct construct by PCR with 
Cj0690c specific (690-F and 690-R) and plasmid specific (M13-F and M13-R) primers. 
PCR generated a 3.3 kbp product in plasmid extracted from two of the colonies which 
confirmed that Cj0690c was interrupted with the kanr cassette (Figure 6.3). The 
mutation construct was also confirmed by EcoRI restriction analysis that released the 
3.3 kbp band of the interrupted Cj0690c from the 3.0 kbp plasmid vector. On a 1% 
agarose gel the insert and vector bands co-migrated and appeared as single band in the 
correct construct (Figure 6.3). PCR using M13 primers generated no product in reaction 
without a DNA template which was used as a negative control; an expected 3.3 kbp 
product in the successful construct (pGEM:690::kan) confirmed interruption of cloned 
Cj0690c. Two bands of 3.3 and 1.9 kbp in one of the plasmids indicated that the E. coli 
cell might had been transformed with two plasmids one carrying interrupted insert and 
the other intact Cj0690c. Lane 6  in the figure showed a 1.9 kbp PCR product indicating 
that it was not the correct construct and the plasmid carried intact Cj0690c. PCR using 
Cj0690c specific primers showed a 1.9 kbp product in the wildtype 01/51 genomic 
DNA used as PCR reference positive control; the PCR product band pattern in the 
plasmids carrying right construct was same as shown by M13 PCR reconfirming those 
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plasmids in lane 8 and 9 of figure 6.3 were correct constructs. These constructs were 
also tested by restriction digest with EcoRI that generated two products of 3.3 kbp and 
3.0 kbps that co-migrated in the gel and a single band was observed in the correct 
constructs; while two bands of 1.9 kbp and 3.0 kbp were observed in those plasmids in 
which cloned Cj0690c was not interrupted by kanr. So the plasmid extracted from the 
colony which was shown in lane 3, 8 and 12 was selected for transformation of C. jejuni 
01/51. 
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Figure 6.3 Analysis of the pGEM:690::kan.  
PCR using M13-F and M13-R primers as expected generated no product in PCR negative control (lane 2), 
a 3.3 kbp product in plasmids carrying interrupted Cj0690c insert (lane 3 and 4) but the PCR products 
generated in plasmids from other two clones (lane 5 and 6) were not of right size so they were discarded. 
PCR using Cj0690c specific primers 690-F and 690-R generated an expected 1.9 kbp product in 01/51 
genomic DNA (lane 7), a 3.3 kbp product in the plasmid having the correct construct (lane 8 and 9) but 
products generated in other two plasmid preps were again not right (lane 10 and 11) so they were 
discarded. PCR results were verified by EcoRI restriction analysis that generated co-migrating products 
of 3.0 kbp (vector) and 3.3 kbp (insert) in the correct constructs (lane 12 and 13) while products from two 
other plasmids (lane 14 and 15) confirmed that they were not the correct constructs, so the construct from 
lane 12 was used further for generating mutation in C. jejuni 01/51.  Lane 1 shows the 1.0 kbp DNA 
markers (Promega, UK) 
 
Electrocompetent C. jejuni 01/51 cells were transformed with the suicide vector 
carrying the mutation construct of Cj0690c and the colonies that grew on BA plates 
supplemented with kanamycin were sub-cultured and genomic DNA was extracted. 
PCR using 690-F and 690-R primers showed a 3.3 kbp band in eight selected colonies 
that corresponds to the Cj0690c gene interrupted with kanr cassette (Figure 6.4). PCR 
with pGEM®-T Easy vector specific M13-F and M13-R primers generated no product 
(not shown) that confirmed the Cj0690c mutation took place by allelic exchange and the 
vector was lost in the event. 
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Figure 6.4 PCR analysis of Cj0690c mutation in C. jejuni 01/51.  
PCR using 690-F and 690-R primers generated a 1.8 kbp product in 01/51 wildtype genomic DNA (lane 
2) and a 3.3 kbp product in all the eight presumptive mutants (lane 2 – 10) that corresponds to interrupted 
Cj0690c. It confirmed that Cj0690c had been replaced by interrupted Cj0690c thus the mutation had been 
generated in all the eight tested mutants. Lanes: L1: 1.0 kbp DNA markers (Promega); L2: PCR product 
in wildtype strain 01/51; L3 to L10: PCR products in C. jejuni 01/51∆Cj0690c.  
 
6.1.3 Mutagenesis of a putative galactosyltransferase (Cj1136) 
6.1.3.1  Introduction 
DNA sequence obtained from transposon mutant 10E9 showed a match with a putative 
galactosyltransferase (Cj1136) of Campylobacter species. Cj1136 is a 1173 bp (390 
amino acids) gene that was part of LOS biosynthesis locus in C. jejuni NCTC11168, 
however, its role has not yet been characterised.  
6.1.3.2  Cloning and generation of the mutant 
A suicide vector was generated to mutate Cj1136 in C. jejuni 01/51. Initially, a 1.3 kbp 
DNA fragment, from 66 bp upstream of the Cj1136 start codon to 90 bp down stream of 
the termination codon, was amplified using primers 1136-F and 1136-R. The PCR 
product with A overhangs was ligated with pGEM®-T Easy and the resulting plasmid 
pGEM:1136 carrying the cloned DNA fragment was confirmed by restriction digest 
with EcoRI, which cut the 1.3 kbp insert from the vector (Figure 6.5).  
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Figure 6.5 Restriction analysis of pGEM:1136. 
 EcoRI digest released the 1.3 kbp insert from 3.0 kbp vector (lanes 6, 7 and 8) that confirmed the cloning 
of Cj1136 in pGEM®-T Easy.  Lanes: L1: DNA markers; L2, L3, and L4: untreated plasmid; L5: PCR 
product of Cj1136; and L6, L7, and L8: EcoRI digested plasmid. 
 
Cj1136 does not have a suitable restriction site that could be used for inserting the kanr 
cassette. Previously, the development of the plasmid based inverse PCR technique has 
aided the construction of insertional mutants when no suitable restriction site was 
present within the gene sequence for insertion of an antibiotic resistance cassette (Wren 
et al., 1994). The length of the flanking sequences on either side of the insertion site is 
of prime importance for recombination of the mutant gene with its wildtype 
chromosomal counterpart (Wassenaar et al., 1993). Recombination integration events 
have been  possible with as little as 202 bp of homologous DNA sequence, however, the 
frequency of recombination increased  with longer homologous sequences (Wassenaar 
et al., 1993). For that reason, a BamHI restriction site was introduced ~0.6 kbp from the 
start codon of the Cj1136, using primers 1136-INF and 1136-INR. Inverse PCR 
generated a 4.3 kbp PCR product flanked by BamHI restriction sites and it also deleted 
a 57 bp sequence in Cj1136. The inverse PCR product (5 µl) was run on a 1.0% agarose 
gel to check the size and the remaining volume (95 µl) was purified using PCR 
purification kit (Sigma, UK), digested with BamHI and treated with TSAP to avoid self-
ligation. The digestion mixture was purified again before ligation with the kanr cassette. 
The kanr cassette was PCR amplified as above and BamHI digested; kanr PCR products 
were ligated with BamHI digested and dephosphorylated inverse PCR product of 
pGEM:1136. E. coli TOP10 cells were transformed and colonies were selected on 
kanamycin (50 µg/ml) and ampicillin (100 µg/ml). Colony PCR using 1136-F and 
1136-R primers was performed to look for those colonies carrying the pGEM:1136::kan 
plasmid, the mutation construct was also confirmed by restriction analysis (not shown). 
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Then the suicide vector pGEM:1136::kan was introduced into C. jejuni 01/51 as 
mentioned above. Eight out of more than a hundred colonies that grew on BA 
supplemented with kanamycin (50µg/ml) were checked by colony PCR using 1136-F 
and 1136-R primers. PCR products showed a single 1.3 kbp band in the wildtype and 
three of the selected colonies and a 2.7 kbp band in five other colonies that confirmed 
the replacement of the wildtype gene with interrupted Cj1136 by recombination in these 
five out of eight tested colonies (Figure 6.6). PCR using M13-F and M13-R primers was 
also done and again no product was present in any of mutant lanes confirming that the 
suicide vector was not replicating in C. jejuni and that the gene had been mutated as a 
result of a double crossover event (not shown). 
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Figure 6.6 PCR analysis of Cj1136 mutation in C. jejuni 01/51.  
PCR using 1136-F and 1136-R primers generated a 1.3 kbp product in 01/51 genomic DNA (lane 2) and 
three presumptive mutants (lane 3, 4 and 5) that confirmed that Cj1136 was not mutated in these three 
colonies but a 2.7 kbp product was generated in five other colonies of presumptive mutants (lane 6, 7, 8, 9 
and 10) that confirmed the successful mutation of Cj1136 in these five colonies. Lanes: L1: DNA 
markers; L2: PCR product of C. jejuni 01/51 wildtype; L3 - L10: PCR products of eight of presumptive 
mutant colonies. 
 
6.1.4 Mutagenesis of a putative membrane protein (Cj1245c) 
6.1.4.1  Introduction 
DNA sequence obtained from transposon mutant 10H1 showed a match with a putative 
membrane protein (Cj1245c) of Campylobacter species. Cj1245c is 1197 bp (398 amino 
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acids) long gene of Campylobacter jejuni NCTC11168 and is conserved in other strains 
of Campylobacter jejuni. Cj1245c has not yet been further characterised. 
6.1.4.2  Cloning and generation of the mutant 
The transposon insertion mutation in the possible membrane protein (Cj1245c) gene of 
Campylobacter jejuni 01/51 showed poor invasion of INT-407 and Caco-2 cells. A 
targeted mutation was generated in Cj1245c to confirm its role in invasion. This gene 
has a BglII site at 781 bp in the CDS that was selected for insertion of the kanr cassette 
to inactivate the gene. Initially, a 1.1 kbp DNA fragment from 69 bp to 1151 bp inside 
the Cj1245c CDS was amplified using aj1-FOR and aj1-REV primers. The PCR product 
was ligated with the vector pGEM®-T Easy and the resulting plasmid pGEM:1245 
carrying the cloned DNA fragment was confirmed by PCR and restriction digest (not 
shown). 
 pGEM:1245 was digested with BglII to generate the mutation construct by inserting the 
kanr cassette. BglII generates compatible ends to BamHI whose restriction sites were 
flanking the kanr cassette. The kanr cassette (1.4 kbp) was PCR amplified from the 
pMA24 template using KCN-F and Kan-Fex primers harbouring BamHI restriction sites 
near 5’ends and was digested with BamHI. The kanr PCR product was ligated with 
linearised pGEM:1245. E. coli TOP10 cells were transformed with the ligation products 
and colonies were selected on LB agar supplemented with kanamycin (50 µg/ml) and 
ampicillin (100 µg/ml). Colony PCR using aj1-FOR and aj1-REV primers was done to 
find colonies carrying pGEM:1245::kan. The mutation construct was also confirmed by 
restriction analysis with EcoRI which cuts the vector on both sides of the insert and 
release it. EcoRI digested products were run on an agarose gel and two bands of 3.0 kbp 
and 2.5 kbp sizes corresponding to the vector and Cj1245c with kanr insert respectively, 
were observed. A PCR product of 2.5 kbp and restriction analysis confirmed that the 
mutation construct was correct (Figure 6.7).   
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Figure 6.7 The confirmation of pGEM:1245::kan. 
 Mutation construct of Cj1245c was analysed by restriction digestion with EcoRI that released a 2.5 kbp 
insert from the 3.0 kbp vector (lane 3) and confirmed the construct was correct. PCR using aj1-FOR and 
aj1-REV generated a 1.1 kbp product in 01/51 genomic DNA (lane 4) and 2.5 kbp product in 
pGEM:1245::kan (lane 5) that verified that Cj1245c mutation construct was correct. Lanes: L1: 1.0 kbp 
DNA markers (Promega); L2: untreated plasmid; L3: EcoRI digested plasmid; L4: Cj1245c PCR product 
from 01/51 genomic DNA; L5: PCR product from pGEM:1245::kan. 
 
The suicide vector pGEM:1245::kan was introduced into electrocompetent C. jejuni 
01/51 by electroporation in order to disrupt the wildtype Cj1245c. After a 5 hour 
recovery on BA plates, the transformants were selected by plating onto BA plates 
supplemented with kanamycin (50 µg/ml). After 48 hours, there were no colonies 
observed on the negative control plates, however the test plates gave tens of colonies. 
Three colonies were sub-cultured and their genomic DNA was extracted. PCR of the 
genomic DNA extracted from the C. jejuni 01/51 wildtype and its (Cj1245c) mutants 
was done using aj1-FOR and aj1-REV primers. PCR products showed a single 1.1 kbp 
band in the wildtype and 2.5 kbp bands in the mutant lanes that confirmed the 
replacement of the wildtype gene with interrupted Cj1245c by homologous 
recombination (Figure 6.8). PCR products with M13 primers did not give a product in 
the C. jejuni mutant DNA template but it gave the expected 1.1 kbp size band with 
pGEM:1245 template, which was used as PCR control (not shown), suggesting the 
Cj1245c mutation by a double crossover event and that the vector was lost. 
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Figure 6.8 PCR analysis of Cj1245c mutation in C. jejuni 01/51.  
PCR using aj1-FOR and aj1-REV primers generated a 1.1 kbp product in 01/51 wildtype genomic DNA 
(lane 2) and a 2.5 kbp product in three of the presumptive Cj1245c mutants (lane 3, 4 and 5) that 
confirmed that the wildtype Cj1245c gene was replaced by allelic exchange with the interrupted Cj1245c 
in the mutants. Lanes: L1: 1.0 kbp DNA markers; L2: PCR product of C. jeuni 01/51 wildtype; L3, L4 
and L5: PCR products of three C. jejuni 01/51∆Cj1245c colonies. 
 
6.1.5 Mutagenesis of a hypothetical protein (Cj1305c) 
6.1.5.1  Introduction  
DNA sequence obtained from transposon mutant 10H12 showed a match with a 
hypothetical protein (617 family) of Campylobacter species. Cj1305c is a 1218 bp (405 
amino acids) long gene of Campylobacter jejuni NCTC11168. The actual function of 
this gene is not known yet. It shows similarity with Cj1306c (78.1%), Cj0617 (38.9%), 
Cj0618 (37.1%), Cj1310c (63.7%), Cj1342c (38.9%) and hypothetical proteins of other 
bacteria including Aeromonas hydrophila (27%). It is a member of the 617 family of C. 
jejuni proteins. This 617 family of proteins contains homopolymeric tracts and are part 
of C. jejuni O-linked glycosylation locus (Cj1293 – Cj1342); no homologues of this 
family are found in other bacterial species (Szymanski and Wren, 2005). Mutation of 
the Cj1305c homologue in C. jejuni 81-176 resulted in fully motile bacteria with no 
effect on flagellin glycosylation (Guerry et al., 2006). The targeted mutation was 
generated in this gene to further characterise its involvement in invasion. 
6.1.5.2  Cloning and generation of the mutant 
Cj1305c has a BglII site at 531 bp in the CDS that was selected to insert the kanr 
cassette and inactivate the gene. Initially, a 1.4 kbp DNA fragment from 188 upstream 
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of the start codon to 1198 bp inside the Cj1305c was amplified using 1305-F and 1305-
R primers. The PCR product was ligated with the pGEM®-T Easy vector and the 
resulting plasmid pGEM:1305 was confirmed by PCR and restriction digest analysis. 
There was no BglII restriction site in pGEM®-T Easy vector but BglII cuts at 531 bp 
inside Cj1305c CDS so one BglII restriction product of 4.4 kbp was observed. 
pGEM:1305 was also digested with EcoRI that cut the vector on flanking sides of the 
insert and released the insert; there were EcoRI restriction sites in the Cj1305c CDS as 
well where it cut 378 bp in the CDS and three expected restriction products of 3.0 kbp, 
0.84 kbp and 0.56 kbp were obtained (Figure 6.9). The correct sized products of 
restriction digest were observed confirming the cloning of Cj1305c into the pGEM®-T 
Easy vector (Figure 6.9). 
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Figure 6.9 Restriction analysis of pGEM:1305. 
The plasmid carrying Cj1305c gene was analysed by BglII restriction digestion that linearised the vector 
and a 4.4 kbp band was observed in digest pGEM:1305 (lane 5, 6 and 7). EcoRI restriction of 
pGEM:1305 generated three bands of 3.0 kbp, 0.8 kbp and 0.5 kbp (lane 10, 11 and 12). Restriction 
analysis confirmed the cloned Cj1305c in pGEM®-T Easy in all the three tested plasmid extracts.  Lanes: 
L1 and 8: DNA markers; L2, L3 and L4: untreated plasmid; L5, L6 and L7: BglII cut pGEM:1305; L9: 
PCR product of Cj1305c; and L10, L11 and L12: EcoRI digested pGEM:1305. 
 
 pGEM:1305 was digested with BglII in order to generate the mutation construct by 
inserting the kanr cassette. The kanr cassette PCR product having BamHI restriction 
sites near the 5’ends was digested with BamHI and was ligated with linearised 
pGEM:1305. E. coli TOP10 cells were transformed with the resulting plasmid 
pGEM:1305::kan and colonies were selected on LB agar supplemented with kanamycin 
(50 µg/ml) and ampicillin (100 µg/m). Colony PCR using 1305-F and 1305-R primers 
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was done to select the colonies carrying the pGEM:1305::kan plasmid. The mutation 
construct was also confirmed by restriction analysis (not shown). 
The suicide vector pGEM:1305::kan was introduced into electrocompetent C. jejuni 
01/51. Colony PCR indicated one of the five checked mutants was correct and it was 
sub-cultured and genomic DNA was extracted. PCR of the genomic DNA of the 
C. jejuni 01/51 wildtype and the Cj1305c mutant was done using 1305-F and 1305-R 
primers. PCR products showed a single 1.4 kbp band in the wildtype and a 2.8 kbp band 
in the mutant lane that confirmed the mutation of Cj1305c (Figure 6.10). PCR using 
M13-F and M13-R primers did not show a product in the mutant lane confirming that 
the suicide vector was not replicating in the C. jejuni∆Cj1305c and the gene had been 
mutated as a result of a double crossover event (not shown). 
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Figure 6.10 PCR analysis of Cj1305c mutation in C. jejuni 01/51.  
PCR using 1305-F and 1305-R primers generated a 1.4 kbp band in 01/51 wildtype genomic DNA (lane 
2) and a 2.8 kbp product in the Cj1305c mutant (lane 3) that confirmed that Cj1305c was mutated in C. 
jejuni 01/51. Lanes: L1: DNA markers; L2: PCR product of C. jejuni 01/51 wildtype; L3: PCR product of 
C. jejuni 01/51∆Cj1305c. 
 
6.1.6 Mutagenesis of a putative anion-uptake ABC-transport system 
permease protein (Cj1539c) 
6.1.6.1  Introduction 
Cj1539c is a 720 bp (239 amino acids) long gene of C. jejuni NCTC11168. Its 
translation product is similar to many involved in anion uptake including the sulphate 
transport system permease protein and the ABC-transport permease protein It is 
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established that ABC transport system components are involved in virulence in 
Mycobacterium species (Collins et al., 2003; Peirs et al., 2005), Streptococcus 
pneumoniae (Dintilhac et al., 1997), Yersinia pestis (Bearden and Perry, 1999) and 
many other micro-organisms . It would be interesting to study how the ABC transport 
permease plays a role in C. jejuni pathogenesis. 
 
6.1.6.2  Cloning and generation of mutant 
Cj1539c does not have a suitable restriction site and so one was generated using the 
inverse PCR technique. Initially, a 1.0 kbp DNA fragment, from 188 bp upstream of the 
Cj1539c start codon to 126 bp down stream of the termination codon, was amplified 
using primers 1539-F and 1539-R. The PCR product was ligated with the vector and the 
resulting plasmid pGEM:1539 was confirmed by PCR and restriction digest analysis 
with EcoRI. Restriction products were run on the agarose gel and two bands of 3.0 kbp 
and 1.0 kbp were observed corresponding to the cloning vector and the insert, 
respectively (Figure 6.11). 
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Figure 6.11 Restriction analysis of pGEM:1539. 
 Cloning of Cj1539c was confirmed by restriction with EcoRI that released 1.0 kbp insert from 3.0 kbp 
vector (lane 5, 6 and 7) and confirmed the Cj1539c cloning in pGEM®-T Easy. Lanes: L1: DNA 
markers; L2, L3 and L4: untreated plasmid; L5, L6 and L7: EcoRI digested pGEM:1539. 
 
A BamHI restriction site was introduced ~0.3 kbp from the start codon of Cj1539c, 
using primers 1539-INF and 1539-INR. Inverse PCR generated a 4.0 kbp PCR product 
flanked by BamHI restriction sites and it also deleted a 21 bp sequence in Cj1539c. The 
inverse PCR product was purified, digested with BamHI and treated with TSAP to 
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dephosphorylate and avoid self-ligation. The digestion mixture was purified again 
before ligation with the kanr cassette. 
The kanr cassette was PCR amplified and the BamHI digested kanr PCR products were 
then ligated with the BamHI digested inverse PCR product of pGEM:1539. E. coli 
TOP10 cells were transformed with the resulting plasmid and colonies grown on LB 
agar supplemented with kanamycin and ampicillin. Colony PCR using 1539-F and 
1539-R primers was done to select colonies carrying pGEM:1539::kan plasmid. The 
mutation construct was also confirmed by restriction analysis (not shown).  
The homologue of Cj1539c in C. jejuni 01/51 was mutated by transforming C. jejuni 
01/51 with pGEM:1539::kan. The colonies grown on blood agar plates supplemented 
with kanamycin (50 µg/ml) after 48 hour incubation were analysed by PCR using 
C1539-F and C1539-R primers. The PCR generated a 1.3 kbp product in the wildtype 
strain and a 2.7 kbp product in the three selected mutant colonies corresponding to 
Cj1539c interrupted with the kanr cassette along with an unexpected 4.3 kbp band; there 
was no 1.3 kbp band corresponding to intact Cj1539c in the mutants (Figure 6.12). PCR 
using the KCN-F and Kan-Fex primers was also done to check if the kanr cassette was 
inserted in the chromosome of the mutants and this showed a 1.4 kbp band 
corresponding to the kanr cassette in all the three mutants (Figure 6.12). The colony 
PCR of the mutants using M13 primers did not generate a product (not shown). These 
mutants were further investigated by PCR using kanr specific and Cj1539c specific 
primers to confirm the kanr insertion in Cj1539c. Both ends of mutated Cj1539c were 
tested using primer combinations comprising of Cj1539c specific primer and kanr 
specific primer. The PCRs generated expected size products and confirmed the Cj1539c 
mutation in C. jejuni 01/51 (Figure 6.13). 
The mutant in cipA, Cj0690c, Cj1136, Cj1245c, Cj1305c and Cj1539c were 
successfully generated. These mutants were tested in the gentamicin protection assays 
for adhesion and invasion phenotype. 
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Figure 6.12 PCR analysis of Cj1539c mutation in C. jejuni 01/51.  
A: PCR using C1539-F and C1539-R primers generated a 1.3 kbp band in 01/51 wildtype genomic DNA 
(lane 1) and a 2.7 kbp product corresponding to interrupted Cj1539c along with an unexpected 4.3 kbp 
band in the mutants (lanes 2 to 4) suggesting the mutation of Cj1539c which was further investigated. B: 
PCR using kanr cassette specific primers KCN-F and Kan-Fex showed an expected 1.4kbp product in 
pMA24 (lane 1) and the same sized product in three mutants (lane 2, 3 and 4) that confirmed that the kanr 
cassette was inserted into the mutant’s chromosome.  Lane M shows the DNA markers. 
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Figure 6.13 Schematic diagram and PCR confirmation of Cj1539c mutation in C. jejuni 01/51.  
The schematic diagram (left) shows the postions of the primers and expected size of the PCR products 
used in the analysis of Cj1539c mutation. The right image shows the PCR products using Kan-F and 
1539-F which generated 1.9 kbp product in Cj1539c mutant (lane 2) and PCR using Kan-R and 1539-R 
primers also generated a 1.9 kbp product in mutant (lane 3) that confirmed the generation of C. 
jejuni∆Cj1539c. Lane 1 shows DNA markers. 
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6.2 Adhesion and invasion assays using Caco-2 cells 
C. jejuni 01/51 was previously known to be hyperinvasive in INT-407 cells (Fearnley et 
al., 2008) and a transposon mutant library was generated in this strain to study the 
molecular basis of hyperinvasiveness. Mutants that showed reduced invasion of INT-
407 and Caco-2 cells were selected and genes interrupted by transposon insertion were 
identified. Transposons are known to have polar effects (Dymov et al., 2004) and to 
check if the genes identified in the mutants were responsible for the reduced invasion 
phenotype or it was due to a polar effect,  targeted mutations were generated in the 
selected genes. 
Adhesion to the epithelial cell layer (Konkel et al., 1992a) can be followed by invasion 
of epithelial cells, but this has been reported to be strain-dependent, since some strains 
adhered to cultured eukaryotic cells without invasion, while the capacity of others for 
invasion was 102–104 times higher (Everest et al., 1992; Oelschlaeger et al., 1993). The 
ability of the targeted mutants to adhere and invade Caco-2 cells was therefore tested. 
The mutants showed variable levels of attachment to Caco-2 cells and interestingly 
some of the mutants showed higher adhesion than the parent strain C. jejuni 01/51 
(Figure 6.14). The change in adhesion efficiency was statistically significant in mutants 
of cipA (P = 0.01) and Cj1539c (P = 0.008) but the adhesion efficiency was not 
significantly different in other mutants i.e. Cj0690c (0.08), Cj1136 (0.09), Cj1245c 
(0.19) and Cj1305c (0.57). All the six mutants showed reduction in invasion in Caco-2 
cells (Figure 6.15). The invasion efficiency of C. jejuni 01/51 was 0.068 while mutants 
in cipA (0.014), Cj0690c (0.033), Cj1136 (0.010), Cj1245c (0.025), Cj1305c (0.04) and 
Cj1539c (0.007) showed statistically significant reduced invasion compared with the 
parent strain 01/51. The probability value in all the mutants was <0.001 except mutant 
of Cj1305c which showed a value of P = 0.001. C. jejuni 81116∆flaA/B was used as 
negative control that as expected showed very low invasion efficiency (P = <0.001). 
This targeted mutagenesis followed by gentamicin protection assays reconfirmed the 
invasion-related role of the selected six genes that were previously identified in 
transposon mutants of C. jejuni 01/51. On the basis of these observations it can be 
inferred that other genes identified by transposon mutagenesis are likely to be involved 
in the invasiveness in 01/51, however, further characterisation is needed to confirm this 
assumption. C. jejuni 01/51 mutants in cipA, Cj0690c, Cj1136, Cj1245c and Cj1539c 
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were selected for complementation studies to rule out any effect of kanr cassette 
insertion on transcription of flanking genes and to further discount any polar effects. 
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Figure 6.14 Adhesion of C. jejuni 01/51 and mutants to Caco-2 cells. 
The adhesion assay was performed in triplicate and the mean efficiency of adhesion (Y-axis) shows the 
percent of initial inoculum that had attached to the Caco-2 cells over the course of three hours. C. jejuni 
81116∆flaA/B was used as the negative control. 
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Figure 6.15 Invasion of C. jejuni 01/51 and mutants in Caco-2 cells. 
The invasion potential of C. jejuni 01/51 and mutants generated by targeted mutagenesis was tested by 
gentamicin protection assay using Caco-2 cells; all the six mutants showed reduction in invasion as 
compared to parent strain 01/51. C. jejuni 81116∆flaA/B was used as negative control in the assays and it 
showed very low invasion efficiency that confirmed the validity of the assay.  
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6.3 Complementation of mutated genes 
In total 12 genes were identified that potentially play a role in enhancing the invasion in 
Caco-2 cells by C. jejuni 01/51. Generation of targeted mutations in six of the selected 
genes followed by observation of reduced invasion in Caco-2 cells by the mutants 
further strengthened the initial finding that these genes were involved in the 
hyperinvasive phenotype. Mutated genes were complemented to satisfy Koch’s 
molecular postulates, to firmly establish a gene as a virulence factor (Falkow, 1988) 
which states the complementation of the mutated gene should reverse the reduced 
virulence-related phenotype in the mutant. Moreover, insertion of an antibiotic cassette 
into the gene may have terminated transcription of the flanking genes and the observed 
reduced invasion phenotype might be a result of lack of expression of those other genes 
rather than the mutated gene itself. Thus in order to prove that the mutated genes were 
responsible for the reduced invasion, the wildtype copy of the mutated gene was 
expressed in the mutant and if the reduced invasion was restored, it could be confirmed 
that the mutated gene was responsible for the loss of the phenotype in C. jejuni 01/51.  
 
6.3.1 Complementation strategies 
Two strategies have commonly been used to complement mutated genes in C. jejuni; 
one is trans-complementation in which the wildtype copy of the mutated gene is 
expressed extra-chromosomally in a plasmid, and other is cis-complementation in which 
the wildtype copy of the mutated gene is expressed at such a place in the mutant’s 
chromosome where insertion of the gene does not affect the transcription of its flanking 
genes. Complementation in trans is an easy and quick way and is especially suitable 
when many genes are to be complemented as was the case in this study but the higher 
copy number of the gene complement is an issue. On the other hand complementing the 
mutated gene with its wildtype copy on the chromosome of the mutant is time 
demanding but the difference in expression levels of the wildtype copy due to higher 
copy number is not a problem with this method. For its ease of use complementation of 
the mutated genes in C. jejuni 01/51 was initially attempted using the trans-
complementation method.     
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6.3.1.1 Trans-complementation using pUOA18 
Initially, complementation of the genes mutated in this study was attempted in trans 
using pUOA18, a 7.4 kbp plasmid, that can replicate in both E. coli and Campylobacter 
species (Wang and Taylor, 1990) and had successfully been used to express genes in C. 
jejuni (Abuoun et al., 2005; Lin et al., 2003; Whitehouse et al., 1998). This method was 
not successful in this study so will be described briefly. The mutated genes i.e. cipA, 
Cj0690c, Cj1136, Cj1245c, Cj1305c and Cj1539c that were interrupted by insertion of 
the kanamycin resistance cassette in this study (Section 6.1) were PCR amplified using 
gene specific primers. A BamHI cloning site in pUOA18 was used to clone the inserts 
and all the primers (Table 2.3) used to amplify the mutated genes were designed to 
contain an additional BamHI site near their 5’ ends. BamHI digested PCR products were 
ligated with BamHI cut and dephosphorylated pUOA18. Cloning of the genes in 
pUOA18 was confirmed by restriction digest analysis (Figure 6.16). Transformation of 
the mutants of C. jejuni 01/51 with their respective complementation constructs was 
attempted by both electroporation and natural transformation methods. Unfortunately, 
transformation was not successful in any of the six mutants. To test if the failure in 
transformation was due to the inability of pUOA18 to replicate inside the mutants or 
whether it was due to loss of the competence in the mutants, C. jejuni 01/51 wildtype 
strain, a known transformation efficient strain, was transformed with pUOA18 but this 
was not successful either. It confirmed that pUOA18 was not an efficient vector for use 
in C. jejuni 01/51 derived mutants. This finding was similar to another report in which 
Karlyshev and Wren (2005) previously reported that the use of the shuttle vectors was 
Campylobacter strain specific. They found that shuttle vectors including pRY112 (Yao 
et al., 1993), pMW10 (Wösten et al., 2004), pMEK91 (Mixter et al., 2003) and 
pGUO0202 (Alfredson and Korolik, 2003) which had previously been successfully used 
in some Campylobacter strains did not replicate in other strains of C. jejuni  (Karlyshev 
and Wren, 2005). 
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Figure 6.16 Restriction digest analysis of genes cloned in pUOA18. 
Wildtype copies along with presumptive native promoters of the cipA, Cj0690c, Cj1136, Cj1245c, 
Cj1305c and Cj1539c were cloned in pUOA18 to complement the mutated alleles of these genes in the 
respective mutants of C. jejuni 01/51 and cloning of the genes in PUOA18 was confirmed by restriction 
digest with BamHI. BamHI digest which released the cloned cipA (2.0 kbp), Cj0690c (4.3 kbp), Cj1136 
(1.7 kbp), Cj1245c (1.8 kbp), Cj1305c (1.9 kbp) and Cj1539c (1.3 kbp) from pUOA18 (7.4 kbp) 
confirmed cloning of the genes in this vector. Lane 1: 1.0 kbp DNA marker (Promega); lane 2: undigested 
pUOA18-cipA; lane 3: digested products of pUOA18-cipA; lane 4: undigested pUOA18-Cj0690c; lane 5: 
digested products of pUOA18-Cj0690c; lane 6: undigested pUOA18-Cj1136; lane 7: digested products of 
pUOA18-Cj1136; lane 8: undigested pUOA18-Cj1245c; lane 9: digested products of pUOA18-Cj1245c; 
lane 10: undigested pUOA18-Cj1305c; lane 11: digested products of pUOA18-Cj1305c; lane 12: 
undigested pUOA18-Cj1539c; and lane 13: digested products of pUOA18-Cj1539c. 
 
6.3.1.2 Cis-complementation 
The mutated genes in C. jejuni 01/51 were then complemented in the bacterial 
chromosome by allelic crossover following a method suggested by Dr. Neil Oldfield, 
University of Nottingham (Dr. Oldfield, personal communications). In the first genome-
sequenced C. jejuni strain NCTC11168 two adjacent genes Cj0652 that encodes a 
putative penicillin-binding protein and Cj0653c that encodes a putative aminopeptidase 
sit tail-to-tail and there is a 121bp intergenic spacer region between them; a gene of 
interest can be inserted in this spacer region without affecting the transcription of the 
flanking genes. Previous studies have demonstrated that as little as 202 bp of 
homologous sequence are required for the allelic crossover integration of transformed 
DNA into the Campylobacter genome (Baillon et al., 1999; Richardson and Park, 1997; 
Wassenaar et al., 1993). A 2.3 kbp DNA molecule consisting of ~1 kbp from each of 
Cj0652 and Cj0653c along with the intergenic spacer region was PCR amplified from 
01/51 genomic DNA using 652-F and 653-F primers (Table 2.3) and high fidelity Pfu 
DNA polymerase (Promega, UK). The purified PCR products were cloned into 
pGEM®-T Easy (Promega, UK) by TA cloning and pAJ20 was generated. The 
nucleotide sequence of the cloned DNA fragment was checked by sequencing of the 
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pAJ20 plasmid using T7 and SP6 primers that bind pGEM®-T Easy vector in the 
flanking region of the insert and sequence towards the insert (Figure 2.2). Sequencing 
confirmed that the nucleotide sequence of this region in 01/51 was homologous to 
NCTC11168. There was not a suitable restriction site for cloning in the intergenic 
region between Cj0652 and Cj0653c and so a BamHI restriction site was then 
introduced in the middle of the intergenic region by inverse PCR of pAJ20 using 
IN652-R and IN653-R primers (Table 2.3). The amplicons were digested with BamHI 
and then self-ligated using T4 DNA ligase (Promega, UK). The self-ligation products 
were transformed into E. coli Top10 (Invitrogen, UK) and the resulting plasmid pAJ21 
was then confirmed by nucleotide sequencing using 652Seq-F primer which binds near 
the 3’ end of Cj0652 and the resulting sequence reads through the intergenic region 
between Cj0652 and Cj0653c.  
Two pAJ21 derived shuttle vectors carrying either the chloramphenicol resistance 
cassette (Cmr) or the kanamycin resistance cassette (kanr) were generated for 
complementing genes in targeted mutants of 01/51 which harbour the kanr cassette or 
transposon mutants that carry Cmr, respectively. The Cmr cassette, originally identified 
in C. coli plasmid pNR9589 (Sagara et al., 1987), was PCR amplified from pUOA18 
using CML-F and CML-R primers (Table 2.3). CML-F harbours a BamHI and CML-R 
had BglII restriction sites near their 5’ends; these restriction sites were added to the Cmr 
primers to allow the BamHI/BglII double digested PCR products of Cmr to ligate with 
BamHI digested pAJ21. BamHI/BglII double digest PCR products of Cmr were ligated 
with BamHI digested and dephosphorylated pAJ21 and the ligation products were used 
to transform E. coli TOP10 (Invitrogen, UK). Colonies were selected on LB agar 
supplemented with ampicillin (100 µg/ml) and chloramphenicol (15 µg/ml). The 
resulting plasmid pAJ22 was extracted from colonies and cloning of the Cmr cassette in 
the vector was confirmed by PCR (Figure 6.17), restriction analysis (Figure 6.20) and 
nucleotide sequencing. As expected the restriction site at the 3’end of the Cmr gene was 
lost and a BamHI site was left at the 5’end to allow cloning of the genes in pAJ22 
(Figure 6.18). This was done to express the cloned gene under its native promoter and to 
avoid the effect of the constitutive Cmr promoter on the transcription levels of the 
cloned genes. pAJ22 was used in complementing the C. jejuni genes mutated by kanr 
cassette. 
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Figure 6.17 PCR analysis of pAJ22. 
pAJ22 extracted from two of the colonies was analysed by PCR using 652-F/653-F primers that generated 
a 3.2 kbp product (lane 2 and 3) and confirmed that Cmr was cloned in both of them; no PCR products 
were generated by 652-F/CML-F primers (lane 4 and 5) as expected but primers 653-F/CML-F generated 
~2 kbp bands (lane 6 and 7) that confirmed the orientation of Cmr in pAJ22 was directed towards 
Cj0653c. Sizes of the bands were compared with 1.0 kbp DNA markers (lane 1).   
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Figure 6.18 Schematic diagram of complementation suicide vectors pAJ22 and pAJ23. 
pAJ22 (upper) and pAJ23 (bottom) have a pGEM®-T Easy backbone shown as a double circle and it can 
replicate in E. coli but not C. jejuni. A DNA molecule can be cloned at the BamHI site near 5’end of the 
antibiotic resistance cassette and cloning can be confirmed by BamHI restriction analysis as well as 
nucleotide sequencing using 652Seq-F and CML-Frev or KCN-Frev primers. Cj0652 and Cj0653c 
(C. jejuni genomic DNA fragments) help in the integration of the cloned DNA molecule along with Cmr 
antibiotic selection marker in the C. jejuni chromosome by allelic exchange.  
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A kanr carrying suicide vector pAJ23 was generated the same way as pAJ22 except that 
the Cmr cassette was replaced by the kanr cassette that was amplified from pMA24 
using KCN-F and KanBgl-R primers (Table 2.3); KCN-F had BamHI while KanBgl-R 
had BglII sites near their 5’ends. kanr PCR products were double digested using BamHI 
and BglII and were ligated with BamHI digested and dephosphorylated pAJ21. 
Chemically competent E. coli Top10 were transformed with the ligation products and 
colonies were selected on LB agar supplemented with ampicillin (100 µg/ml) and 
kanamycin (50 µg/ml). Five out of more than hundred colonies obtained after overnight 
incubation were tested by colony PCR using 652-F/653-F primers. All the five colonies 
showed a 3.7 kbp product confirming the insertion of the kanr cassette in pAJ21 and 
pAJ23 was generated. PCR results of two selected plasmids are shown in Figure 6.19; 
construct of pAJ23 was also confirmed by nucleotide sequencing with 653Seq-F 
primers and restriction with BamHI analysis (Figure 6.20). pAJ23 was used to 
complement those mutants in C. jejuni 01/51 in which Cmr was used to inactivate the 
gene. 
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Figure 6.19 PCR analysis of pAJ23. 
The pAJ23 construct was confirmed by PCR using 652-F/653-F primers which showed a 2.3 kbp product 
in the pAJ21 control (lane 2) and 3.7 kbp products in two of pAJ23 minipreps (lane 3 and 4) confirming 
that the kanr cassette (1.4 kbp) was cloned in pAJ21 and pAJ23 was constructed. PCR with 652-F/KCN-F 
primers showed no products (lane 5 and 6) but primers 653-F/KCN-F showed 2.5 kbp products (lane 7 
and 8) that confirmed the orientation of kanr cassette was towards C0653c in the plasmid. Lane 1 shows 
1.0 kbpDNA markers (Promega).  
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Figure 6.20 Restriction analysis of pAJ22 and pAJ23. 
The pAJ22 and 23 were digested with BamHI to test the presence of a BamHI cloning site at the 5’ of the 
Cmr and kanr cassettes. Restriction analysis confirmed the presence of the restriction site in both the 
vectors as single bands of 6.2 kbp (lane 2) and 6.7 kbp (lane 5) were observed in restricted pAJ22 and 
pAJ23, respectively. Lane 1 was 1.0 kbp DNA markers, lane 2 and 3 were undigested pAJ22 and 23, 
respectively. 
  
6.3.2 Complementation of cipA (Cj0685c) 
In this study, cipA was identified in transposon insertion mutant 3A10 and was found to 
play a role in the invasiveness in C. jejuni 01/51. Targeted mutation of this gene by 
insertion of kanr cassette verified the initial findings from the transposon mutant studies 
that this gene promotes the invasion of C. jejuni 01/51 in cultured human intestinal 
epithelial cells. The interrupted cipA was complemented with its wildtype allele along 
with presumptive promoter to confirm that the reduced invasion phenotype in the cipA 
mutant was not due to a polar effect of transposon or the kanr cassette. 
Complementation of cipA was done by inserting its wildtype allele on the chromosome 
of the targeted mutant using the complementation suicide vector pAJ22. cipA along with 
its presumptive promoter was amplified from C. jejuni 01/51 genomic DNA by PCR 
using C685-F/C685-R primers (Table 2.3) and high fidelity Pfu DNA polymerase; these 
primers had BamHI restriction sites near their 5’ ends and the purified PCR products 
were digested with BamHI. The digested cipA amplicons were ligated with BamHI 
digested and dephosphorylated pAJ22. Chemically competent E. coli TOP10 were then 
transformed with ligation products and colonies were selected on LB agar supplemented 
with ampicillin and chloramphenicol. Twelve out of more than three hundred colonies 
grown after overnight incubation were screened for the successfully transformed clone 
by colony PCR using 652Seq-F and 653Seq-F primers and two colonies generated the 
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expected 3.0 kbp product. Further testing by PCR confirmed that cipA was cloned at the 
expected site in pAJ22 and its orientation in the resulting plasmid pAJ22-685 was 
directed towards the Cmr cassette (Figure 6.21). The PCR using C6854-F and C685-R 
primers generated ~1.9 kbp product while the expected size was 2.0 kbp but nucleotide 
sequencing of pAJ22-685 with 652Seq-F and CML-Frev primers confirmed that the 
whole expected product was cloned.  
Electrocompetent C. jejuni 01/51∆cipA was transformed with pAJ22-685 and colonies 
were selected on blood agar supplemented with kanamycin (50 µg/ml) and 
chloramphenicol (15 µg/ml). PCR based analysis confirmed the successful integration 
of the wildtype cipA allele in the mutant’s chromosome (Figure 6.22) in the only colony 
grown after 72 hours of incubation. PCR with 685-F and 685-R primers generated a 1.5 
kbp product in both the wildtype 01/51 and complemented mutant. With these primers a 
3.0 kbp product from the kanr interrupted cipA was also expected in addition to the 
observed 1.5 kbp product from complemented mutant, however this was not observed 
which may have been due to the biased preference of PCR towards smaller products. To 
confirm that the mutated cipA was not replaced by its wildtype copy in the 
complemented mutant, another PCR with primers specific to the kanr cassette and the 
cipA gene was performed which confirmed that the mutated cipA was not replaced in 
the complemented mutant (Figure 6.23). The cipA complemented C. jejuni 01/51∆cipA 
was characterised further in the adhesion and invasion assays to test if complementation 
of the gene had reversed the reduced invasion phenotype.  
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Figure 6.21 Schematic diagram and PCR analysis of cipA cloning in pAJ22. 
The schematic diagram (upper) shows the position of primers used in the analysis of cipA cloning and 
complementation. The bottom image shows the PCR of pAJ22-685 with C685-F/C685-R primers that 
generated ~1.9 kbp product (lane 2) that confirmed the cipA cloning; no product was generated with 
C685-F/652Seq-F primers (lane 3) and a 2.0 kbp product was generated with C685-R/652Seq-F primers 
(lane 4) that confirmed the orientation of cipA in pAJ22-685 was directed towards Cmr. 
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Figure 6.22 PCR confirmed the complementation of cipA in C. jejuni 01/51∆cipA. 
A: PCR with 652Seq-F/653Seq-F primers generated a 250 bp product in the 01/51 wildtype (lane 2), a 
3.0 kbp product was generated in the pAJ22-685 control (lane 3) and the same size product was generated 
in complemented mutant (lane 4) confirming the integration of cipA in the expected site of the bacterial 
chromosome. B: PCR with 685F/685-R primers generated the expected 1.5 kbp products in both 01/51 
wildtype (lane 2) and complemented mutant (lane 3) that confirmed the presence of the wildtype copy of 
cipA in the complemented mutant but further investigation was needed to confirm the presence of the 
mutated copy of the gene in the complemented mutant. C: PCR with vector specific primers M13-
R/CML-F generated a 2.0 kbp product in pAJ22-685 (lane 2) and as expected no product was generated 
in the complemented mutant (lane 3) that confirmed the simultaneous allelic exchange and loss of vector 
lead to the integration of wildtype cipA in intergenic spacer region between Cj0652 and Cj0653c in C. 
jejuni 01/51∆cipA. Lane 1 shows the 1.0 kbp DNA marker (Promega). 
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Figure 6.23 Mutated cipA was not replaced by its wildtype allele in complemented mutant. 
PCR with Kan-F and 685-F primers generated a 1.9 kbp product in 01/51∆cipA (lane 2) and 
complemented mutant (lane 3) while PCR with Kan-R/685-R primers generated 2.4 kbp product in both 
the mutant (lane 4) and complemented mutant (lane 5). It confirmed that mutated cipA was not replaced 
by its wildtype allele during complementation. Lane 1 shows the 1.0 kbp DNA marker (Promega). 
 
6.3.3 Complementation of Cj0690c 
The reduced invasion phenotype observed in the transposon and targeted mutant of 
Cj0690c in C. jejuni 01/51 was verified by complementing the mutation. Cj0690c along 
with its presumptive promoter was PCR amplified with C690-F and C690-R primers 
and the amplicon (4.3 kbp) was initially cloned in pAJ22 (Figure 6.24) to complement 
the targeted mutant of this gene but complementation was not successful despite many 
attempts. Few colonies appeared each time on blood agar supplemented with kanamycin 
and chloramphenicol but each time the mutated Cj0690c was replaced with its wildtype 
allele (not shown). This failure might be due to the large size (4.3 kbp) of Cj0690c 
along with its presumptive promoter sequence that provided at least 2.0 kbp sequence 
on each side of the kanr cassette in the targeted mutant thus increasing the chance of 
crossover in this region rather than the region between Cj0652 and Cj0653c. Cj0690c 
was then cloned in the other complementation vector pAJ23 so that complementation 
could be attempted in the transposon mutant 6A9 in which Cj0690c was mutated by 
transposon insertion. So Cj0690c was PCR amplified along with its presumptive 
promoter and BamHI digested PCR products were ligated with BamHI digested and 
dephosphorylated pAJ23. E. coli Top10 was transformed with these ligation products 
and colonies were selected on LB agar supplemented with ampicillin and kanamycin. 
After 24 hours incubation ten colonies were tested by colony PCR with 652Seq-F and 
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653Seq-F primers and two of them generated a product of the expected size (4.5 kbp). 
The resulting plasmid pAJ23-690 was extracted from one of these colonies and tested 
by PCR using gene specific primers C690-F and C690-R that generated a 4.3 kbp 
product (Figure 6.25) confirming the Cj0690c complementation vector was constructed; 
plasmid pAJ23-690 was also confirmed by nucleotide sequencing. The 
electrocompetent transposon mutant 6A9 was transformed with pAJ23-690 by 
electroporation and colonies were selected on blood agar supplemented with 
chloramphenicol and kanamycin. All the twelve colonies that appeared after 72 hours of 
incubation were tested by colony PCR with 652Seq-F and 653Seq-F primers and one 
colony that showed the expected 5.9 kbp product was further confirmed by PCR. PCR 
analysis confirmed that the Cj0690c wildtype allele was integrated in the region 
between Cj0652 and Cj0653c of C. jejuni 01/51 mutant 6A9 (Figure 6.26). This 
Cj0690c complemented mutant was further characterised in adhesion, invasion, 
motility, growth curve and different stress survival assays. 
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Figure 6.24 Cj0690c was cloned in pAJ22. 
PCR using C690-F and C690-R primers generated expected 4.3 kbp product in 01/51 wildtype genomic  
DNA (lane 2) and the plasmid extracted from E. coli transformed with ligation products of pAJ22 and 
Cj0690c (lane 3). PCR confirmed that Cj0690c was cloned in pAJ22 and the complementation vector 
(pAJ22-690) was constructed which was also confirmed by nucleotide sequencing. pAJ22-690 was used 
to transform C. jejuni 01/51∆Cj0690c. Lane 1 shows the 1.0 kbp DNA marker (Promega). 
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Figure 6.25 Cj0690c was cloned in complementation vector pAJ23. 
PCR using C690-F and C690-R primers generated 4.3 kbp products in 01/51 wildtype genomic DNA 
(lane 2), pAJ23-690 extracted from colony-2 (lane 4) and a slightly smaller product was generated from 
the plasmid extracted from colony-1 (lane 3). pAJ23-690 extracted from colony-2 was further tested by 
nucleotide sequencing and was used to complement the mutated Cj0690c. Lane 1 shows the 1.0 kbp DNA 
markers (Promega). 
 
 
 
 
 
 
 
Chapter 6. Mutagenesis and complementation of the genes 
 
125 
 
 
   
1 kbp
1.5 kbp
2 kbp
4 kbp
3 kbp
1 2 3 4
1 2 3
1 kbp
2 kbp
1.5 kbp
4 kbp
6 kbp
5 kbp
1 2 3
250 bp
A B
C
       
Figure 6.26  Cj0690c mutation was complemented in transposon mutant 6A9. 
A: PCR using 652Seq-F and 653Seq-F primers generated an expected 250 bp product in the 01/51 
wildtype (lane 2) and a 5.9 kbp product in the complemented mutant (lane 3) that confirmed the 
integration of Cj0690c in the spacer region between Cj0652 and Cj0653c. B: PCR with Cj0690c specific 
(690-F and 690-R) primers generated a 3.8 kbp product in the 6A9 transposon mutant control template 
(lane 2) and a 1.8 kbp product in both the 01/51 wildtype (lane 3) and complemented mutant (lane 4) that 
confirmed the complementation of Cj0690c in the mutant. There should have been two PCR products of 
1.8 kbp and 3.8 kbp in the complemented mutant but the appearance of a 1.8 kbp band demanded further 
investigation to confirm that the mutated copy of Cj0690c was also present in the complemented mutant. 
C: PCR with transposon specific (Transeq) and Cj0690c specific (690-F) primers generated a ~1.5 kbp 
product in both the mutant 6A9 (lane 2) and complemented mutant (lane 3) that confirmed the presence of 
mutated Cj0690c gene in the complemented mutant. 1.0 kbp DNA markers (lane 1) were used for size 
comparison in all the gels. The PCR confirmed the successful complementation of Cj0690c in its mutant 
and it was also confirmed that mutated Cj0690c was not replaced by its wildtype allele and the wildtype 
allele was integrated in the intergenic region between Cj0652 and Cj0653c.                                                                                                                                                   
                                              
                                                                                                                             
                   
 
Chapter 6. Mutagenesis and complementation of the genes 
 
126 
6.3.4 Complementation of Cj1136 
The mutated Cj1136 was complemented with a wildtype copy of the gene to rule out 
any polar effects of the kanr cassette on the downstream genes. Complementation was 
accomplished using suicide vector pAJ22. Cj1136  along with its presumptive promoter 
was amplified by PCR using C1136-F and C1136-R primers (Table 2.3) and high 
fidelity Pfu DNA polymerase (Promega, UK). Primers C1136-F and C1136-R had 
additional BamHI site near their 5’ ends, therefore, purified PCR products were digested 
with BamHI and were ligated with BamHI digested and dephosphorylated pAJ22 to 
generate pAJ22-1136. Chemically competent E. coli TOP10 cells were transformed 
with pAJ22-1136 and colonies were selected on ampicillin (100 µg/ml) and 
chloramphenicol (15 µg/ml). Twelve out of more than a hundred colonies were screened 
by colony PCR with 652Seq-F and 653Seq-F primers (Table 2.3) and one colony 
showed an expected 2.8 kbp product which was further tested by PCR using gene 
specific primers that confirmed the successful cloning of Cj1136 in the vector pAJ22. 
PCR of the resulting vector pAJ22-1136 with C1136-F and C1136-R primers generated 
a 1.7 kbp product confirming that Cj1136 was successfully cloned in pAJ22 (Figure 
6.27); cloning was also confirmed by nucleotide sequencing using 652seq-F and CML-
Frev primers.  
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Figure 6.27 Schematic diagram and PCR analysis of Cj1136 cloning in pAJ22. 
The schematic diagram (left) shows the binding positions of primers used in the analysis of Cj1136 
cloning and complementation. The right image shows the PCR using C113-F and C1136-R primers that 
generated a 1.7 kbp product in 01/51 genomic DNA (lane 2) and pAJ22-1136 (lane 3) confirming that 
Cj1136 was cloned in pAJ22. PCR with C1136-F/652seq-F did not generate a product (lane 4) but 
C1136-R/652Seq-F primers generated a 1.8 kbp product (lane 5) that confirmed that the orientation of 
Cj1136 in pAJ22-1136 was directed towards the Cmr cassette. Lane 1 shows 1.0 kbp DNA marker 
(Promega).   
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Following confirmation of the construct C. jejuni 01/51∆Cj1136 was made 
electrocompetent following protocol described in Section 2.10.3 and were transformed 
with pAJ22-1136. Colonies were selected on blood agar supplemented with kanamycin 
(50 µg/ml) and chloramphenicol (15 µg/ml) and the only two colonies grown after 48-
72 hours of incubation were picked and genomic DNA was extracted and analysed by 
PCR. PCR with 652Seq-F and 653Seq-F primers generated a 2.8 kbp band in both the 
colonies tested while an expected 250 bp band was observed in 01/51 genomic DNA 
that was used as control (Figure 6.28). Thus confirming the integration of Cj1136 in the 
intergenic region between Cj0652 and Cj0653c. PCR with C1136-F/C1136-R and 1136-
F/1136-R primer sets generated 1.8 kbp and 1.3 kbp products, respectively, which were 
correct for the wildtype (complement) copy of Cj1136 but bigger bands of 2.7 kbp and 
2.2 kbp from the mutated Cj1136 were missing (Figure 6.28). The generation of only 
smaller bands was most probably due to PCR bias because easy (smaller) templates are 
preferentially amplified in multitemplate PCR (Hori et al., 2007). PCR with Kan-
F/1136-R and Kan-R/1136-F sets was performed separately that generated 2.0 kbp and 
1.9 kbp products respectively to the primer set used in the mutant and both 
complemented mutants (Figure 6.29). It was confirmed by PCR that mutated Cj1136 
was not replaced by its wildtype copy in the complemented mutants. The kanr cassette 
was in the same orientation as that of the mutated Cj1136. The Cj1136 mutant in C. 
jejuni 01/51 and its complemented mutant were further studied in the assays of adhesion 
and invasion to test if complementation had restored the invasion phenotype.    
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Figure 6.28 PCR analysis of Cj1136 complementation in C. jejuni 01/51∆Cj1136. 
A: PCR using 652Seq-F and 653Seq-F generated a ~250 bp product in 01/51 genomic DNA (lane 2), 2.9 
kbp products in pAJ22-1136 control template (lane 3) and both complemented mutants (lane 4 and 5) 
confirming that the wildtype copy of Cj1136 was integrated in the intergenic region between Cj0652 and 
Cj0653c. B: PCR with C1136-F and C1136-R  generated a 1.7 kbp product in 01/51 wildtype genomic 
DNA (lane 2) and both the complemented mutants (lane 3 and 4) that confirmed the presence of the 
wildtype copy of Cj1136 in the complemented mutants but further investigation was needed to confirm 
the presence of the mutated copy. C: PCR with 1136-F and 1136-R generated 1.3 kbp products in 01/51 
control (lane 2) and both complemented mutants (lane 3 and 4) that reconfirmed the results shown by 
C1136-F/R primers (B). D: PCR with Cmr specific CML-F and pGEM®-T Easy specific M13-F primers 
generated ~2.0 kbp product in the pAJ22 control template (lane 2) but no product was generated in the 
complemented mutant genomic DNA templates (lane 3 and 4) that confirmed the simultaneous 
homologous cross over and loss of vector resulting in the integration of Cj1136 in C. jejuni 
01/51∆Cj1136 chromosome. Lane1 in all the blocks shows 1.0 kbp DNA marker (Promega).  
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Figure 6.29 PCR confirmed the presence of mutated Cj1136 in complemented mutant. 
A: PCR using Kan-F and 1136-R primers generated a ~2.0 kbp product in 01/51∆Cj1136 mutant (lane 2) 
and both of its complemented mutants (lane 3 and 4) confirming that the mutated Cj1136 was present in 
the complemented mutants. B: PCR with Kan-R and 1136-F primers which binds in the Cj1136 and the 
kanr cassette also generated ~1.9 kbp products in 01/51∆Cj1136 control template (lane 2) as well as in 
both the complemented mutants (lane 3 and 4) which reconfirmed that the interrupted Cj1136 was not 
replaced by the wildtype copy and also confirmed that both parts of the gene flanking kanr were present in 
the complemented mutants. Lane 1 in A and B blocks in the above figure were 1.0 kbp DNA markers.                              
                                                                                                                                                              
Chapter 6. Mutagenesis and complementation of the genes 
 
129 
6.3.5 Complementation of Cj1245c 
Interruption of Cj1245c, a putative membrane protein encoding gene in C. jejuni 01/51 
resulted in reduced invasion in its transposon insertion mutant 10H1 and the invasion-
related role of Cj1245c observed in the transposon mutant was then reconfirmed by 
inactivating the gene by kanr insertion. To verify the involvement of Cj1245c in C. 
jejuni virulence, mutated Cj1245c was complemented by expressing the wildtype allele 
of this gene under its presumptive native promoter and the complemented mutant was 
tested for the restoration of invasion.  
Cj1245c was PCR amplified from 01/51 with C1245-F and C1245-R primers and high 
fidelity Pfu DNA polymerase and the BamHI cut PCR products were ligated with 
BamHI digested and dephosphorylated pAJ22. E. coli TOP10 was transformed with 
ligation products and colonies that were grown on LB agar supplemented with 
ampicillin and chloramphenicol were screened by PCR for the resulting plasmid pAJ22-
1245. PCR with C1245-F and C1245-R primers generated a 1.8 kbp product in both the 
01/51 wildtype control and plasmid extracted from E. coli transformed with pAJ22-
1245 (Figure 6.30). PCR with C1245-F/652Seq-F and C1245-R/652Seq-F primers 
confirmed that the orientation of Cj1245c in the plasmid was directed towards Cmr. 
Cloning of Cj1245c in plasmid pAJ22 was also confirmed by nucleotide sequencing 
with CML-Frev and 652Seq-F primers and the complementation vector pAJ22-1245 
was used to transform and complement the mutated Cj1245c in C. jejuni 
01/51∆Cj1245c. Transformation of C. jejuni 01/51∆Cj1245c with pAJ22-1245 was not 
successful despite many attempts as no colonies were observed on blood agar 
supplemented with ampicillin and chloramphenicol. Transformation was attempted by 
both electroporation of electrocompetent, and natural transformation of normally 
growing C. jejuni 01/51∆Cj1245c. It was possible that mutation of Cj1245c in 01/51 
might have affected its transformation efficiency or ability. 
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Figure 6.30 Cj1245c along with its presumptive promoter was cloned in pAJ22. 
PCR with C1245-F and C1245-R primers generated a 1.8 kbp product in the 01/51 wildtype control (lane 
2) and pAJ22-1245 (lane 3) confirming that Cj1245c was cloned in pAJ22. PCR with C1245-F and 
C652Seq-F primers generated no product in pAJ22-1245 (lane 4) but primers C1245-R and 652Seq-F 
generated a 1.9 kbp product in pAJ22-1245 (lane 5) that confirmed the orientation of Cj1245c in pAJ22-
1245 was directed towards Cmr. Lane 1 shows the 1.0 kbp DNA marker (Promega). 
 
 
6.3.6 Complementation of Cj1539c 
The reduced invasiveness observed in the 6A7 mutant due to transposon insertion in 
Cj1539c was reconfirmed by generating a targeted mutation in the gene in C. jejuni 
01/51. The invasion-related role of Cj1539c was verified by complementing the gene in 
C. jejuni 01/51∆Cj1539c. 
Cj1539c along with its presumptive promoter was PCR amplified from 01/51 genomic 
DNA with C1539-F and C1539-R primers and high fidelity Pfu DNA polymerase 
(Promega). Purified PCR products were digested with BamHI as the primers used to 
amplify Cj1539c had BamHI restriction site their near 5’ends. Digested PCR products 
were ligated with BamHI digested and dephosphorylated pAJ22. E. coli Top10 was 
transformed with ligation products and colonies were selected on LB agar supplemented 
with ampicillin and chloramphenicol. Twenty four colonies grown after overnight 
incubation were screened for the presence of the resulting plasmid pAJ22-1539 by 
colony PCR using 652Seq-F and 653Seq-F primers. Three of the colonies generated 
expected 2.4 kbp products (not shown) and plasmid extracted from one of them was 
further analysed by PCR. PCR with C1539-F and C1539-R primers generated a 1.3 kbp 
product that confirm that whole the gene along with promoter had been cloned; PCR 
with C1539-F/652Seq-F and C1539-R/652Seq-F primers confirmed that Cj1539c was 
cloned at the expected BamHI cloning site and the orientation of the gene in pAJ22-
1539 was directed towards the Cmr cassette (Figure 6.31). Cj1539c cloning in pAJ22-
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1539 was also confirmed by nucleotide sequencing with 652Seq-F and C1539-R 
primers. pAJ22-1539 was used to complement mutated Cj1539c in C. jejuni 
01/51∆Cj1539c. 
C. jejuni 01/51∆Cj1539c was transformed with pAJ22-1539 and a single colony grown 
on blood agar supplemented with kanamycin and chloramphenicol was tested by PCR 
for successful complementation. PCR with 652Seq-F/653Seq-F and 1539-F/1539-R 
primers generated 2.4 kbp and 1.3 kbp products, respectively and confirmed that 
Cj1539c was integrated at the expected place in the bacterial chromosome by 
homologous recombination (Figure 6.32). The complemented C. jejuni 01/51∆Cj1539c 
was characterised further in gentamicin protection, growth, motility, autoagglutination 
and different stress assays.  
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Figure 6.31 Schematic diagram and PCR confirmation of the Cj1539c cloning in pAJ22. 
The schematic diagram (left) shows the binding positions of primers used in the analysis of Cj1539c 
complementation. The image on the right side shows the PCR with C1539-F/C1539-R primers that 
generated a 1.3 kbp product in both the 01/51 wildtype control (lane 2) and vector pAJ22-1539 (lane 3) 
that confirmed the Cj1539c cloning in the vector. PCR with C1539-F/652Seq-F primers did not show a 
band of 1.5 kbp (lane 4), a faint band of ~1 kbp was probably a single primer PCR product. PCR with 
C1539-R/652Seq-F showed a 1.5 kbp product (lane 5) and confirmed that orientation of Cj1539c in the 
vector was directed towards Cmr.  
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Figure 6.32 Confirmation of Cj1539c complementation in C. jejuni 01/51∆Cj1539c by PCR. 
A: PCR with 652Seq-F and 653Seq-F primers generated ~250 bp product in the 01/51 (lane 2) and 2.4 
kbp in the complemented mutant (lane 3) that confirmed the integration of Cj1539c in the expected site 
between Cj0652 and Cj0653c in the mutant’s chromosome. B: PCR with C1539-F and C1539-R primers 
generated a 1.3 kbp product in 01/51 (lane 2), Cj1539c mutant control generated 2.7 kbp and ~4.0 kbp 
products (lane 3) and the complemented mutant generated 1.3 kbp product (lane 4) that reconfirmed the 
Cj1539c complementation but the expected higher size band of the mutated Cj1539c was not generated in 
the complemented mutant. C: PCR with pGEM®-T Easy specific M13-F and Cj1539c specific C1539-R 
primers generated a 2.3 kbp product from the pAJ22-1539 template (lane 2) but no product was generated 
from the complemented mutant (lane 3) that confirmed that the vector was not replicating in the 
complemented mutant. D: PCR with Kan-F/1539-F generated a 1.9 kbp product in Cj1539c mutant (lane 
2) and the complemented mutant (lane 3) and Kan-R/1539-R primers also generated a 1.9 kbp product in 
mutant (lane 4) and complemented mutant (lane 5) that confirmed the presence of the mutated Cj1539c in 
the complemented mutant. Lane 1 in the above images was 1 kbp DNA markers.    
 
6.4 Summary and conclusions 
A transposon mutant library was screened for mutants showing reduced invasion and 
the genes mutated in thirteen selected mutants were identified. The role in invasion in 
C. jejuni 01/51 of six selected genes (cipA, Cj0690c, Cj1136, Cj1245c, Cj1305c and 
Cj1539c) was reconfirmed by generating insertion mutations using a kanr cassette which 
does not have transcription termination sequences thus was unlikely to have polar 
effects. These six mutants of C. jejuni 01/51 were tested for adhesion and invasion in 
cultured Caco-2 cells using gentamicin protection assays; all the six targeted mutants 
showed statistically significant reduction in invasion in Caco-2 cells compared to the 
wildtype strain 01/51 but interestingly adhesion was variable with some of the mutants 
showing a higher level of adhesion as compared to the wildtype strain C. jejuni 01/51.  
Complementation of the mutated genes was attempted in five of the mutants and four of 
the mutated genes (cipA, Cj0690c, Cj1136 and Cj1539c) were successfully 
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complemented. The mutants and complemented mutants were selected for adhesion and 
invasion in Caco-2 cells and further characterisation.  
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7 PHENOTYPIC CHARACTERISATION OF THE 
MUTANTS AND COMPLEMENTED MUTANTS 
 
7.1 Introduction 
Attachment to target host cells is a critical early step in the pathogenesis of many 
bacterial infections including C. jejuni, since adherent bacteria can release enzymes, 
toxins and trigger changes in the host cell cytoskeleton that may lead to invasion into 
epithelial cells (Ketley, 1997). Invasiveness in cultured eukaryotic cells has been 
correlated with virulence of C. jejuni in many previous studies (Everest et al., 1992; 
Fearnley et al., 2008; Newell et al., 1985). The use of Caco-2 cells as a model for 
studying adhesion and invasion of the intestinal epithelial cells by C. jejuni and C. coli 
was previously proposed (Everest et al., 1992). The gentamicin protection assay is a 
standard method of determining the bacterial invasion in cultured eukaryotic cells 
(Elsinghorst, 1994). There are different variables in the gentamicin protection assay and 
bacterial cells are exposed to different environmental stresses that may affect the 
bacterial survival in the assay. The adhesion and invasion ability of C. jejuni 01/51 
wildtype, selected mutants and complemented mutants was tested to verify the 
virulence-associated role of the mutated genes that were previously identified by 
transposon mutagenesis. C. jejuni 01/51 and mutants were also tested for their growth 
and resistance to different stresses to establish if the reduced invasion phenotype of the 
mutants was related to the lack of survival of mutants in different stresses encountered 
during gentamicin protection assays. 
Campylobacter jejuni generally colonises in the chicken gut which results in 
contamination of the raw poultry meat, which is considered as the major source of food-
borne campylobacteriosis (Butzler, 2004; Park, 2002). The mechanisms by which C. 
jejuni initiates colonisation, either in humans or in the avian host, are poorly understood, 
but a putative correlation between the ability of C. jejuni to invade the cultured Caco-2 
cells and colonisation of chicks was previously proposed (Hanel et al., 2004). Such a 
correlation between invasion of cell cultures and colonisation ability was also found in 
other investigations. Defined mutants of ciaB, which encodes for a Campylobacter 
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secreted protein required for the maximal invasion of C. jejuni in cultured eukaryotic 
cells were unable to colonise the chick gut (Ziprin et al., 2001). Inactivation of  an auto-
transporter protein capA in C. jejuni NCTC11168 resulted in the reduced invasion of the 
mutant in Caco-2 cells as well as reduction in colonisation in chick gut compared to 
parent strain NCTC11168 (Ashgar et al., 2007). Virulence association of some of the 
genes in C. jejuni 01/51 was confirmed in this study and three invasion-related genes 
cipA, Cj1136 and Cj1245c were tested to determine whether mutation in these genes 
impaired the organism’s ability to colonise chicks.  
Moreover, lipooligosaccharide (LOS) of C. jejuni has previously been found to be 
important for invasion in cultured eukaryotic epithelial cells (Marsden et al., 2009) and 
chicken intestine colonisation (Gilbert et al., 2002). The Cj1136 homologue in C. jejuni 
01/51 was found to be important for invasion in Caco-2 cells in this study and this gene 
is part of the LOS biosynthesis locus (Cj1131c – Cj1152c) in first genome-sequenced C. 
jejuni, NCTC11168. LOS from C. jejuni 01/51, the Cj1136 mutant and the 
complemented mutant was also analysed to determine if Cj1136 was involved in LOS 
biosynthesis in 01/51, and whether an altered LOS biosynthesis pathway in the mutant 
led to the reduced invasion and chick colonisation phenotypes. 
 
7.2 Gentamicin protection assay with complemented mutants 
The reduced invasion phenotype observed in transposon mutants of C. jejuni 01/51 
(Section 4.3) was reconfirmed by generating targeted mutations in the selected genes 
(cipA, Cj0690c, Cj1136, Cj1245c, Cj1305c and Cj1539c) that confirmed the invasion-
related role of these genes (Section 6.2). The four targeted mutants (∆cipA, ∆Cj0690c, 
∆Cj1136 and ∆Cj1539c) showed lowest levels of invasion in Caco-2 cells (Section 6.2) 
and thus were selected for complementation (Section 6.3) to verify the involvement of 
these genes in invasion by C. jejuni 01/51. The complementation of the mutated genes 
was attempted to rule out a polar effect of kanr cassette insertion on the transcription of 
downstream genes. After complementing these genes, the C. jejuni 01/51 wildtype, 
mutants and complemented mutants were tested in the adhesion and gentamicin 
protection assays (Section 2.7 and 2.8) to determine if complementation of the mutated 
genes had restored the reduced invasion phenotype in mutants.  
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The complementation of all mutated genes increased adhesion to Caco-2 cells (Figure 
7.1). C. jejuni 01/51-CML, the 01/51 wildtype strain with the Cmr cassette integrated in 
the intergenic gap between Cj0652 and Cj0653c, was used as a control to test if the 
change in adhesion levels was affected by the Cmr cassette. C. jejuni 01/51-CML 
showed similar results to the 01/51 wildtype confirming that the increase in adhesion 
phenotype was due to complementation of the mutated gene and that Cmr insertion had 
no effect on the adhesion phenotype. The change in adhesion to Caco-2 of mutants in 
cipA, Cj0690c (mutant 6A9), Cj1136 as well as complementation of these mutated 
genes was not statistically significant. Reduction in adhesion of the Cj1539c mutant 
compared to parent strain 01/51 remained statistically significant (P <0.001) as was 
observed in the previous assays (Section 6.2) and the increase in adhesion by 
complementation of the mutated Cj1539c significantly restored adhesion (P <0.05). 
However, the level of restoration was far below the parent strain 01/51 which might be 
due to low levels of expression of Cj1539c in the complemented mutant compared to 
wildtype strain.  C. jejuni 81116∆flaA/B mutant (Wassenaar et al., 1991) was used as 
negative control in the adhesion assays and it showed very low levels of adhesion as 
was expected. 
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Figure 7.1 Adhesion of C. jejuni 01/51, mutants and complemented mutants to Caco-2 cells. 
Adhesion of C. jejuni 01/51 wildtype (01/51) and Cj0690c transposon insertion mutant (6A9 Mut), 
complemented mutant 6A9 (6A9 Comp), targeted cipA mutant (cipA Mut), complemented cipA mutant 
(cipA Comp), targeted Cj1136 mutant (1136 Mut), complemented Cj1136 mutant (1136 Comp), targeted 
Cj1539c mutant (1539 Mut), complemented Cj1539c mutant (1539 Comp), C. jejuni 01/51 with Cmr 
inserted in the intergenic gap between Cj0652 and Cj0653c (01/51CML) and a double mutant of C. jejuni 
81116 in flaA and flaB (flaA/B cont) was tested in Caco-2 cells. Complemented mutants showed higher 
levels of adhesion than their respective mutants. 01/51CML was used as a control in the adhesion assay 
that confirmed that integration of Cmr in the 01/51 chromosome had no affect on the adhesion potential. 
C. jejuni 81116∆flaA/B was also used as negative control in the assay and it showed very low adhesion 
that confirmed the validity of the adhesion assay. 
 
Complementation of the mutated genes in C. jejuni 01/51 partially restored the invasion 
phenotype in the complemented mutants (Figure 7.2). The levels of invasion restored in 
the complemented mutants were statistically significant as compared to their respective 
mutants but the invasion phenotype was not fully restored as compared to the 01/51 
wildtype strain. This might be due to lower levels of expression of the complemented 
genes in the complemented mutants. C. jejuni 01/51-CML had a similar invasion 
efficiency to the 01/51 wildtype which confirmed that the change in invasion levels 
observed in the complemented mutants was not due to Cmr cassette insertion but was 
due to complementation of the mutated genes. A non-invasive C. jejuni 81116∆flaA/B 
was used as control in the gentamicin protection assay and it showed very low levels of 
invasion that confirmed the validity of the assay.  
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Figure 7.2 Invasion of C. jejuni 01/51, mutants and complemented mutants to Caco-2 cells. 
The invasion phenotype of C. jejuni 01/51 wildtype strain (01/51) and Cj0690c transposon insertion 
mutant (6A9 Mut), complemented mutant 6A9 (6A9 Comp), targeted cipA mutant (cipA Mut), 
complemented cipA mutant (cipA Comp), targeted Cj1136 mutant (1136 Mut), complemented Cj1136 
mutant (1136 Comp), targeted Cj1539c mutant (1539 Mut), complemented Cj1539c mutant (1539 
Comp), C. jejuni 01/51 with Cmr inserted in intergenic gap between Cj0652 and Cj0653c (01/51 CML) 
and a double mutant of C. jejuni 81116 in flaA and flaB (flaA/B cont) was tested in Caco-2 cells. 
Complemented mutants showed higher levels of invasion than their respective mutants. 01/51 CML was 
used as control in the gentamicin protection assay that confirmed the invasion potential was not affected 
by the integration of Cmr in 01/51 chromosome. C. jejuni 81116∆flaA/B was also used as negative 
control in the assay and it showed very low level of invasion that confirmed the validity of the gentamicin 
protection assay. 
 
Both adherence and invasion are multifactorial and motility-dependent processes 
(Wassenaar et al., 1991) but a strong correlation between them has not been established. 
A previous study found that all investigated C. jejuni strains were able to adhere to 
Caco-2 cells but some strains were deficient in invasion (Hanel et al., 2004). Adherence 
is most likely a prerequisite for invasion of epithelial cells by any bacterial pathogen. 
However, the pathogen may bind to an epithelial cell membrane without subsequent 
internalization and the number of adherent bacteria does not correlate with the number 
of intracellular bacteria (Hanel et al., 2004). Non-viable and metabolically inactivated 
campylobacters were still able to adhere to host cells (Konkel and Cieplak, 1992) while 
Campylobacter invasion did require nascent protein synthesis (Konkel and Cieplak, 
1992; Oelschlaeger et al., 1993). This means that the factors required for adhesion 
might be different from those needed for invasion. A gene involved in invasion may not 
necessarily be important for adhesion as well. This study showed that mutation in cipA, 
Cj0690c, Cj1136, Cj1245c and Cj1305c resulted in reduced invasion in cultured human 
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intestinal epithelial cells without significant reduction in adhesion potential but Cj1539c 
was found to be involved in both adhesion and invasion since inactivation of Cj1539c 
reduced adhesion and invasion in this mutant.  
 
7.3 Further phenotypic characterisation of the mutants 
Further studies of the C. jejuni 01/51 wildtype, mutants and complemented mutants 
were done to test if the observed changes in invasion potential in the mutants were due 
to differences in their atmospheric oxygen tolerance, intracellular survival, sensitivity to 
Triton X-100, growth rates or motility. 
 
7.3.1 Methods for phenotypic characterisation 
7.3.1.1 Atmospheric stress assay 
During gentamicin protection assays, bacterial cells have to go through different 
atmospheric conditions including 5% CO2 and air. Atmospheric stress assays were 
performed to check whether the change in invasiveness in cultured eukaryotic cells 
shown by mutants and complemented mutants of C. jejuni 01/51 was due to a difference 
in their survival under atmospheric oxygen concentration. For the assay, bacterial 
growth was harvested from blood agar plates as above, and suspended in 2.5 ml sterile 
PBS. The bacterial suspension was inoculated into pre-warmed complete cell culture 
media (Eagle’s minimal essential medium supplemented with 10% foetal calf serum and 
1% non-essential amino acids) to an optical density (570 nm) of 0.1 and this suspension 
was incubated at 37oC in the cell culture incubator supplied with 5% CO2. Samples 
were taken at 0, 1, 2, 3, 4 and 5 hour time points and serial dilutions were plated out for 
viable cell count. The assay was carried out in duplicate.  
 
7.3.1.2 Hydrogen peroxide sensitivity assay 
The toxic reactive oxygen species including hydrogen peroxide are released in the 
eukaryotic cells as a result of oxidative metabolism. C. jejuni 01/51, selected mutants 
and complemented mutants were also tested for hydrogen peroxide sensitivity to check 
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if the change in hydrogen peroxide sensitivity was responsible for the observed changed 
in their interaction with INT-407 and Caco-2 cells. For the hydrogen peroxide 
sensitivity assay, bacterial growth was harvested from blood agar plates as above and 
suspended in 2.5 ml sterile PBS. The bacterial cells were resuspended in 1 ml of pre-
warmed Mueller-Hinton (MH) broth (Merck, UK) to an optical density (570 nm) of 0.1 
in a 24-well cell culture plate. The plate was placed in an airtight plastic container with 
Campygen pack and incubated at 37oC on a shaker with 150 rpm agitation. After taking 
a zero hour sample for viable count, hydrogen peroxide was added to a final 
concentration of 0.5 mM (calculation given below) to each well. The plate was again 
placed on the shaker with agitation at 150 rpm under microaerobic conditions and 
further samples were taken at 0.5, 1, 1.5, 2 and 3 hours for serial dilutions and viable 
cell count. The assay was carried out in duplicate. 
Calculation of H2O2 concentration for the assay:  
Molarity of the 30% hydrogen peroxide solution (Sigma, UK) was calculated using the 
formula 
Molarity= % x density x 1000 
     100 x Mol. Weight 
Molarity of 30% H2O2 was 9.7 M. 
A fresh stock of hydrogen peroxide was prepared every time by diluting 30% H2O2 
1000-fold in water (10 µl of 30% H2O2 in 10 ml water made it 9.7 mM solution) and for 
making 0.5 mM H2O2, 52 µl of H2O2 stock solution was diluted in 950 µl of MH broth. 
 
7.3.1.3 Survival in Triton X-100 
The Triton X-100 (1% v/v) was used in gentamicin protection assays to release 
internalised bacteria from the cultured epithelial cells. C. jejuni 01/51, selected mutants 
and complemented mutants were also tested for Triton X-100 (1% v/v) sensitivity to 
check if the change in sensitivity to the detergent was responsible for the observed 
changed in their interaction with INT-407 and Caco-2 cells. For the Triton X-100 
sensitivity assay, bacterial growth was harvested from blood agar plates as above and 
suspended in 2.5 ml sterile PBS. The bacterial cells were resuspended in 1 ml of 
distilled water to an optical density (570 nm) of 0.1 in 24-well plate. The sterile Triton 
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X-100 (10 µl) was added to each well and after taking a zero hour sample for viable 
count, the bacterial cell suspension was incubated at room temperature and further 
samples were taken after 30 minutes and 1 hour incubation for serial dilutions and 
viable cell count. The assay was carried out in triplicate. 
 
7.3.1.4 Measurement of bacterial growth by spectrophotometer 
 To check if the reduction in the levels of invasion in C. jejuni mutants was due to a 
change in their growth as compared to parent strain C. jejuni 01/51, growth of the 
mutants was measured overtime by a spectrophotometric method in a 96-well plate. For 
the assay bacterial strains were grown for 48 hours on blood agar with appropriate 
antibiotics added where needed. The bacterial growth was harvested from the plates and 
resuspended in 2.5 ml sterile PBS. An appropriate volume of this suspension was added 
to Mueller-Hinton (MH) broth in a 96-well plate to make a final volume of 100 µl in a 
well and an absorbance of ~ 0.1 (OD 570nm).  The plate was then placed in an air-tight 
container with a Campygen gas pack (Oxoid, UK) and incubated on a shaker at 37oC 
and 150 rpm agitation. Absorbance was read at 570 nm using an ELISA plate reader. 
Regular absorbance readings were taken at 1, 2, 3, 4, 5, 6, 7, 8, 23, 26, 28 and 30 hrs. 
Each mutant was tested in triplicate and the mean of these values was plotted. 
 
7.3.1.5 Motility assay 
The C. jejuni 01/51 and its mutants were tested for their motility to check if a reduction 
in motility was responsible for the low invasion. Motility of the bacterial strains was 
tested as described earlier (Section 4.2.2). The assay was carried out in triplicate and the 
mean of these values was plotted. 
 
7.3.1.6 Autoagglutination assay  
The autoagglutination assay was performed following the protocol described elsewhere 
(Golden and Acheson, 2002). Briefly, the growth of each strain was harvested from 
blood agar plates as above and suspended in 2.5 ml sterile phosphate buffered saline 
(PBS). The absorbance of the solution was adjusted to ~1.0 at 600 nm in PBS and the 
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actual absorbance was measured again. The bacterial suspension (2.0 ml) was 
transferred into sterile bijoux tubes with caps and left standing undisturbed at 37oC in 
microaerobic conditions for 24 hrs. One millilitre of the upper aqueous phase formed 
was then taken gently with a micropipette and the absorbance was again measured at 
600 nm. The level of autoagglutination was calculated by subtracting the absorbance 
shown by the upper aqueous phase collected after 24 hour incubation from the initial 
absorbance measured at the start of incubation. The assay was carried out in triplicate. 
 
7.3.1.7 Chick colonisation 
The chick colonisation experiment with C. jejuni 01/51 and its mutants in cipA, Cj1136 
and Cj1245c were carried out at the Veterinary Laboratories Agency, Weybridge, 
United Kingdom. The chick colonisation assay was performed using a quantitative oral 
chick-colonisation model as previously described (Wassenaar et al., 1993). Briefly, 
groups of 10 specific pathogen-free chicks used in this study, hatched from eggs 
obtained from Charles River SPAFAS Inc., Hanover, Germany, were housed in 
isolators and were dosed at day 1 of age. Two doses of each of C. jejuni 01/51 wildtype, 
C. jejuni 01/51∆cipA, C. jejuni 01/51∆Cj1136 and C. jejuni 01/51∆Cj1245c at 3.4 ± 0.9 
x 104 and 3.4 ± 0.9 x 106 CFU in 100 µl 0.1M PBS pH 7.2 were given by oral gavage. 
Doses were prepared by harvesting bacteria grown overnight on blood agar plates into 
sterile PBS and the actual doses were determined retrospectively by viable count. At 5 
days post-inoculation the chicks were sacrificed by cervical dislocation and the levels of 
colonisation into the caeca were determined by plating out dilutions of caecal contents 
onto blood agar plates that were supplemented with kanamycin (50 µg/ml) in the case of 
the mutants. The degree of chick colonisation was determined as CFU per gram of 
caecal contents, for individual birds. The minimal level of detection was 100 CFU/gram 
caecal contents. The chick colonisation assays were performed in accordance with the 
local ethics committee and UK home office licence guidelines. Statistical analysis of the 
data was carried out using Minitab software and the data was analysed by using 
nonparametric Mann-Whitney (two-tailed) test to assess statistical significance and a 
statistical P value of <0.05 was statistically significant.    
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7.3.1.8 Lipooligosaccharide analysis 
7.3.1.8.1 Extraction of lipooligosaccharide by phenol-water extraction method 
Lipooligosaccharide was extracted from C. jejuni 01/51, C. jejuni 01/51∆Cj1136 and C. 
jejuni 01/51∆Cj1136:Cj1136 using a modification of the phenol-water extraction 
procedure described elsewhere (McNally et al., 2007; Prendergast et al., 2001). Briefly, 
confluent bacterial growth from blood agar plates was washed three times in sterile PBS 
(Sigma, UK). After the last wash cells were resuspended in sterile distilled water to an 
optical density (600 nm) of 1.0. One millilitre of the bacterial cell suspension was added 
to an equivalent volume of phenol (pre-heated to 65oC; Sigma, UK) in an eppendorf 
tube and mixed for one minute using a vortex mixer. Then samples were incubated at 
65oC for 10 minutes, during which the samples were mixed at regular intervals. After 
cooling on ice, the samples were centrifuged (12000 X g for 3 min). At this stage 
separated layers were visible and the upper aqueous layer containing LOS was removed 
to a new tube. The LOS preparation was purified by adding 0.1 x vols of 20% sodium 
acetate (pH 4.5) plus 5 x vols of absolute alcohol and LOS was allowed to precipitate at 
4oC overnight. Precipitated LOS was harvested by centrifugation (5000 x g) for 10 
minutes and the pellet was washed with ice-cold 70% ethanol. Dried LOS was 
resuspended in 500 µl distilled water. 
7.3.1.8.2 Sodium dodecyl sulphate polyacrylamide electrophoresis 
The LOS extracts were fractionated by sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis (SDS-PAGE). LOS samples (20 µl) were mixed with an equivalent 
volume of 2x sample loading buffer (100 mM Tris-HCl [pH 8.0], 2% β-
mercaptoethanol, 4% SDS, 0.02% bromophenol blue, 20% glycerol) and mixtures were 
boiled for 10 minutes before loading (20 µl) onto an SDS-PAGE gel consisting of a 
stacking gel of 4% (v/v) acrylamide and a separating gel of 15% (v/v) acrylamide; 
composition of the gels is shown in Table 7.1. The gel was run in SDS-Tris-glycine 
buffer (0.025 M Tris base, 0.192 M glycine and 0.1% SDS, pH 8.3) at 200 V constant 
and 30 mAmp per gel until the dye front reached the bottom of the gel (BIO-RAD, 
Protean II system).  
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Table 7.1 Components for preparation of SDS-PAGE gels. 
Reagents Volume for stacking 
gel (4%) 
Volume for separating 
gel (15%) 
Acrylamide/bis-acrylamide 30%, 29:1 650 µl 5 ml 
Sodium dodecyl sulphate 10% (w/v) 50 µl 100 µl 
1.5M Tris-HCl  (pH 8.8) - 2.5 ml 
0.5M Tris-HCl (pH 6.8) 1.25 ml - 
Distilled water 3.0 ml 2.5 ml 
Ammonium persulphate 10% (w/v) 50 µl 50 µl 
Tetramethylethylenediamine (TEMED) 5 µl 10 µl 
   
7.3.1.8.3 Silver staining of lipooligosaccharide SDS-PAGE gel 
The LOS SDS-PAGE gel was stained by a sensitive LPS silver staining method (Tsai 
and Frasch, 1982). The silver staining was done in glass trays that were soaked in 2% 
(v/v) nitric acid overnight and were washed with plenty of distilled water before use. 
After running, the gel was washed once with fixative solution (40% isopropanol and 5% 
glacial acetic acid) then was fixed overnight in the fixative solution. The LOS was 
oxidised by soaking the gel in periodic acid solution (0.7% periodic acid, 40% 
isopropanol and 5% acetic acid) for 5 minutes. Then the gel was washed with distilled 
water on an orbital shaker for two hours and the water was changed every ten minutes. 
The gel was stained by shaking for 10 minutes in a freshly prepared staining solution (2 
ml concentrated ammonium hydroxide [fresh frozen stock], 28 ml 0.1 N NaOH, 115 ml 
distilled water and 5 ml of 20% silver nitrate [freshly prepared silver nitrate solution 
was added drop-wise to the above with vigorous stirring and the staining was done in 
the dark). After staining, the gel was washed 3 times in distilled water (15 min/wash). 
Then the gel was transferred to a new tray and pre-warmed (37oC) developer (citric acid 
10 mg, 30% formaldehyde 0.1 ml and distilled water 200 ml) was added. The tray was 
agitated by hand for few minutes until the LOS bands became visible, then it was 
washed with distilled water and the staining reaction was stopped by adding 0.35% 
acetic acid.  
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7.3.2 Results and discussion of phenotypic characterisation of mutants 
The selected mutants and complemented mutants of C. jejuni 01/51 were characterised 
further to check whether the change in invasiveness was due to other factors that can 
potentially affect invasion including atmospheric stress, survival in hydrogen peroxide 
and Triton X-100, growth and motility. Selected mutants were also tested for their chick 
gut colonisation ability and role in LOS biosynthesis.  
 
7.3.2.1 Atmospheric stress 
C. jejuni has to go through a diversity of atmospheric conditions during the gentamicin 
protection assay. The bacterial cell survival and growth was determined under the 
conditions encountered in the gentamicin protection assay to assess the effects of these 
diverse environmental conditions on the invasion potential of C. jejuni 01/51 and its 
mutants in genes Cj0690c (6A9), Cj1245c, cipA (Cj0685c), Cj1136 and Cj1539c. The 
number of wildtype cells recovered over the course of 5 hours was comparable to those 
of the initial number of cells tested (0 hours) and mutants showed survival very similar 
to parent strain 01/51 (Figure 7.3). This suggested that the survival rate under 
atmospheric conditions was similar for the parent strain and its tested mutants. It also 
confirmed that the cell numbers of C. jejuni 01/51 and its tested mutants did not 
significantly change by growth or death in the complete cell culture media over the 5 
hours time period. A posttranslational regulator csrA was found to be important for 
oxidative stress resistance and virulence of C. jejuni (Fields and Thompson, 2008) and 
H. pylori (Barnard et al., 2004). The invasion-related genes in C. jejuni 01/51 that were 
tested in this stress assay do not seem important for the atmospheric stress in this 
bacterium.  
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Figure 7.3 Atmospheric stress in C. jejuni 01/51 and mutants. 
Effect of atmospheric stress on C. jejuni 01/51 wildtype (01/51), mutants: transposon insertion mutant in 
Cj0690c (6A9 Mut), targeted Cj1245c mutant (1245 Mut), targeted cipA mutant (685 Mut), targeted 
Cj1136 mutant (1136 Mut) and targeted Cj1539c mutant (1539 Mut) was determined by incubating the 
bacteria in complete cell culture media in 5% CO2 at 37oC and determining the viable bacterial cell 
number (CFU/ml). There was no significant effect of atmospheric stress on the survival of C. jejuni 01/51 
wildtype and its tested mutants. 
 
7.3.2.2 Hydrogen peroxide sensitivity 
Intracellular (internalised) bacteria may be exposed to hydrogen peroxide (H2O2) which 
is a by-product of oxidative metabolism in aerobic organisms (Alvarez-Peral et al., 
2002). Hydrogen peroxide resistance in C. jejuni may play a role in the intracellular 
survival of the bacteria after invading the host cells. Mutation of γ-glutamyl 
transpeptidase in C. jejuni strain 81116 resulted in increased H2O2 resistance and higher 
invasion of INT-407 cells by the mutant compared to its wildtype strain  (Barnes et al., 
2007). Resistance to hydrogen peroxide was tested in C. jejuni 01/51 and its mutants in 
Cj0690c (mutant 6A9), Cj1245c, cipA (Cj0685c), Cj1136 and Cj1539c to establish if 
reduced intracellular survival of the mutants was responsible for the reduced invasion 
phenotype shown by the mutants in this study. Resistance to hydrogen peroxide in C. 
jejuni 01/51 and its mutants was tested in 0.5 mM H2O2 solution in MH broth and 
bacterial cell numbers were determined every 30 minutes for three hours. The C. jejuni 
01/51 wildtype strain and its mutants showed similar levels of resistance to H2O2 
(Figure 7.4) confirming that the reduction in invasion in cultured human epithelial cells 
shown by the mutants was not due to an increased sensitivity to H2O2 thus reducing 
intracellular survival of the mutants.  
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Some studies suggested that C. jejuni can survive within eukaryotic cells for several 
days (Babakhani and Joens, 1993; Black et al., 1988). Inside host cells, organisms may 
be exposed to a variety of host killing mechanisms, including reactive oxygen species 
like hydrogen peroxide (Alvarez-Peral et al., 2002). To circumvent the harmful reactive 
oxygen species, like many organisms C. jejuni has evolved specific defence 
mechanisms including the ability to remain bound in an endosome inside the cell (De 
Melo et al., 1989) and/or synthesise protective enzymes like catalase encoded by katA 
(Day et al., 2000), alkyl hydroperoxide reductase encoded by ahpC, superoxide 
dismutase encoded by sodB (Iovine, 2008) and cytochrome C peroxidase (Bingham-
Ramos and Hendrixson, 2008). Therefore resisting hydrogen peroxide stress and 
subsequently interrupting the formation of the toxic intermediate products may allow 
improved persistence and survival of C. jejuni within eukaryotic cells. The genes 
encoding for catalase (katA) and cytochrome c peroxidase are present in C. jejuni 
(Bingham-Ramos and Hendrixson, 2008; Day et al., 2000; Parkhill et al., 2000; Purdy 
and Park, 1994) and intracellular survival of a C. jejuni mutant in katA was reduced 
compared to parent strain (Day et al., 2000). Catalase activity in C. jejuni 01/51 and its 
mutants was also tested by dipping a part of bacterial colony with a plastic loop into 
30% H2O2 and the appearance of bubbles indicated catalase activity. The wildtype strain 
01/51 and mutants were all positive for catalase activity so they were less likely to be 
sensitive to 0.5 mM hydrogen peroxide which was supported by the results (Figure 7.4). 
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Figure 7.4 Sensitivity of C. jejuni 01/51 and mutants to hydrogen peroxide. 
C. jejuni 01/51 wildtype (01/51) and mutants: transposon insertion mutant in Cj0690c (6A9 Mut), 
targeted Cj1245c mutant (1245 Mut), targeted cipA mutant (685 Mut), targeted Cj1136 mutant (1136 
Mut) and targeted Cj1539c mutant (1539 Mut) were tested for their sensitivity to H2O2 by incubating the 
bacteria in 0.5 mM H2O2 and determining the viable bacterial cell count (CFU/ml) at different time points. 
C. jejuni 01/51 wildtype and its tested mutants showed similar levels of resistance to 0.5 mM H2O2. 
 
7.3.2.3 Survival in 1% Triton X-100 
Triton X-100 (4-octylphenol polyethoxylate) is a non-ionic detergent which has a 
hydrophilic polyethylene oxide group and a hydrocarbon lipophilic group. Though 
Triton X-100 has no antimicrobial properties (Sigma, product information guide), 
commercial preparations of Triton X-100 have been found to contain peroxides up to 
0.22% hydrogen peroxide equivalents (Ashani and Catravas, 1980) which may interfere 
with biological reactions. Moreover, Triton X-100 can solubilise lipids and proteins, 
and the membrane of Gram-negative bacteria is made up of lipoproteins that can be 
affected by the detergent. Sensitivity of C. jejuni to sodium deoxycholate and Triton X-
100 was increased in cbrR, a response regulator, mutant of C. jejuni strain F38011 
(Raphael et al., 2005). Triton X-100 (1% v/v) was used in the gentamicin protection 
assays in this study to lyse eukaryotic cells and release internalised C. jejuni. Therefore 
the C. jejuni 01/51 wildtype and its mutants in Cj0690c, Cj1245c, Cj0685c, Cj1136 and 
Cj1539c were tested for survival in Triton X-100 (1% v/v) to determine if mutation in 
the genes rendered them sensitive to Triton X-100 and the observed reduction in 
invasion in Caco-2 cells observed in mutants was due to their inability to survive in the 
detergent. 
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C. jejuni 01/51 and its mutants were suspended in 1% Triton X-100 and incubated for 
one hour at room temperature. The viable count (CFU/ml) was determined at the start, 
30 minutes and 60 minutes of incubation. There was no significant reduction in the 
bacterial cell numbers in first 30 minutes in wildtype and all the mutants but the 
Cj1539c mutant showed a one log reduction in viable cell numbers in second half of the 
one hour incubation (Figure 7.5). This increased sensitivity of C. jejuni 01/51∆Cj1539c 
to Triton X-100 (1%, v/v) is unlikely to have an effect on their invasiveness in Caco-2 
cells determined by the gentamicin protection assay because generally bacteria are 
diluted and plated out within 30 minutes after eukaryotic cell lysis in the detergent, 
during which period the survival of Cj1539c mutant was not affected. The translational 
product of Cj1539c, a putative anion-uptake ABC-transport system permease protein, 
has five transmembrane helices and is expected to be a membrane protein. It is possible 
that the inactivation of this protein might have reduced the bacterial cell membrane 
permeability allowing Triton X-100 to enter the cell and cause cell lysis; however, this 
process seems very slow as there was no reduction in bacterial cell numbers in first half 
an hour of challenge with the detergent and there was only one log reduction after one 
hour incubation in 1% (v/v) Triton X-100.  
A previous study found that C. jejuni 81-176 mutants in putative glycosyltransferases 
encoded by waaF, lgtF and galT had reduced INT-407 cells invasion potential as 
compared to wildtype strain, and this reduction in invasiveness was due to increased 
sensitivity to Triton X-100 used for lysis of the cultured cell monolayer. When invasion 
capability of the mutants was determined using a modified invasion assay in which the 
monolayer was lysed with water rather than detergent, there was no statistically 
significant difference in the invasion levels of wild-type strain 81-176 and mutants 
(Kanipes et al., 2008). The mutant in a putative glycosyltransferase encoded by Cj1136 
did not show higher levels of sensitivity to the detergent used in this study that 
confirmed the reduction in invasion levels exhibited by the mutant was not due to 
killing of the mutant cell in 1% Triton X-100. 
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Figure 7.5 Survival of C. jejuni 01/51 and mutants in Triton X-100. 
Survival of C. jejuni 01/51 wildtype (WT), Cj0690c transposon insertion mutant (6A9Mut), targeted 
Cj1245c mutant (1245Mut), targeted cipA mutant (685Mut), targeted Cj1136 mutant (1136Mut) and 
targeted Cj1539c mutant (1539Mut) was determined in Triton X-100 (1%, v/v) by viable cell count 
(CFU/ml). There was not a decrease in bacterial cell numbers in first 30 minutes but Cj1539c mutant 
showed a log decrease in viable cells between 30 and 60 minutes incubation in the detergent.    
 
7.3.2.4 Growth curves of mutants and complemented mutants 
Growth curves of C. jejuni 01/51 wildtype, its mutants in Cj0690c (6A9Mut), cipA 
(Cj0685c), Cj1136, Cj1245c and Cj1539c, and the complemented mutants of Cj0690c, 
Cj0685c, Cj1136 and Cj1539c were carried out to check if the change in their growth 
was responsible for the observed changes in their invasion phenotype. Growth was 
tested in Mueller-Hinton (MH) broth by measuring optical density at different time 
intervals. The wildtype strain 01/51 and tested mutants showed similar growth curves 
(Figure 7.6) though lag phase in mutants of Cj0685c, Cj1539c and Cj0690c was slightly 
longer than C. jejuni 01/51 wildtype. This suggested that the mutation of Cj0685c, 
Cj0690c, Cj1136, Cj1245c or Cj1539c in C. jejuni 01/51 did not have a detrimental 
effect on growth. Growth of complemented mutants of Cj0685c, Cj0690c, Cj1136 and 
Cj1539c was also determined and they showed similar results to wildtype strain (not 
shown). 
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Figure 7.6 Growth curves of C. jejuni 01/51 and its mutants. 
Growth curves of C. jejuni 01/51 and its mutants in invasion-related genes were determined in MH broth 
by measuring optical density (OD) at different time intervals. 01/51 Wildtype strain and mutants showed 
similar growth curves. Legends: WT: C. jejuni 01/51 wildtype; 6A9Mut: transposon insertion mutant in 
Cj0690c; 685Mut: targeted mutant in cipA (Cj0685c); 1136Mut: targeted mutant in Cj1136; 1245Mut: 
targeted mutant in Cj1245c; 1539Mut: targeted mutant in Cj1539c. 
 
7.3.2.5 Motility 
Motility in C. jejuni and other enteric pathogens has been implicated in intestinal 
colonisation and invasion by several classical studies (Schmitt et al., 1994; Wassenaar 
et al., 1993; Yao et al., 1994; Young et al., 2000a). Motility of the C. jejuni 01/51 
wildtype strain and transposon mutants was measured earlier and those mutants selected 
for transposon insertion site localisation, were having at least 75% motility as compared 
to the wildtype strain (Section 4.3). The motility of the mutants in cipA, Cj0690c 
(mutant 6A9), Cj1136, Cj1245c, Cj1305c and Cj1539c, and complemented mutants was 
tested to re-confirm the previous findings but with targeted mutants. All the tested 
mutants and complemented mutants showed motility similar to the wildtype strain 01/51 
confirming that a change in the invasion phenotype in these mutants and complemented 
mutants was not due to a change in motility (Figure 7.7).  
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Figure 7.7 Motility of C. jejuni 01/51, mutants and complemented mutants. 
Motility of C. jejuni 01/51 wildtype (01/51), mutants: transposon insertion mutant in Cj0690c (6A9 Mut), 
complemented mutant 6A9 (6A9 Comp), targeted cipA mutant (685 Mut), complemented cipA mutant 
(685 Comp), targeted Cj0690c mutant (690 Mut), targeted Cj1136 mutant (1136 Mut), complemented 
Cj1136 mutant (1136 Comp), targeted Cj1245c mutant (1245 Mut), targeted Cj1305c mutant (1305 Mut), 
targeted Cj1539c mutant (1539 Mut), complemented Cj1539c mutant (1539 Comp) and a non-motile C. 
jejuni 81116∆flaA/B (flaA/B) control was determined in MH broth supplemented with 0.4% agar. All the 
C. jejuni 01/51 mutants and complemented mutants showed a level of motility similar to the 01/51 
wildtype. C. jejuni 81116∆flaA/B was used as a negative control in the test that showed very low levels of 
motility. 
 
7.3.2.6 Autoagglutination 
The ability of C. jejuni to autoagglutinate has been associated with changes in invasion 
and/or adherence (Golden and Acheson, 2002; Misawa and Blaser, 2000) and C. jejuni 
81-176 mutants defective in autoagglutination showed a modest reduction in invasion of 
INT-407 cells. So the autoagglutination ability of the C. jejuni 01/51 and its mutants 
used in this study was tested to determine if the reduced invasion in Caco-2 cells shown 
by mutants was related to their inability to autoagglutinate. Interestingly, a statistically 
significant inverse correlation between the ability to autoagglutinate and invasion 
potential was found in this study (Figure 7.8). The autoagglutination in C. jejuni 01/51 
was lower than its mutants and complemented mutants which was statistically 
significant (P = <0.05). 
Previously, a transposon mutant library generated in C. jejuni 480 was studied to find 
those mutants with reduced motility and autoagglutination; a link between expression of 
functional flagella and autoagglutination was suggested as 20 mutants that lost motility, 
were not able to autoagglutinate (Golden and Acheson, 2002). Four of the mutants 
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having lost their ability of motility and autoagglutination expressed FlaA, and two out 
of these four mutants were unable to invade cultured INT-407 cells (Golden and 
Acheson, 2002). Motility was not reduced in any of the mutants tested in this study that 
may account for a lack of reduction in autoagglutination in these mutants. 
Moreover, Cj1333 (pseD) was mutated in one of the autoagglutination mutants in which 
invasion in INT-407 cells was abolished (Golden and Acheson, 2002). The pseD is part 
of glycosylation locus (Cj1293- Cj1342) in C. jejuni NCTC11168 (Parkhill et al., 2000) 
and is involved in attachment of PseAm (pseudaminic acid) to flagellin during 
glycosylation (Guerry et al., 2006). Glycosylation in C. jejuni is important for 
autoagglutination (Guerry et al., 2006) and host cell invasion (Karlyshev et al., 2004) 
and the loss of invasion and autoagglutination was most probably due to impaired 
glycosylation in pseD mutant. No glycosylation related genes were mutated in any of 
the mutants in which autoagglutination was tested in this study so autoagglutination was 
not affected. A non-motile double mutant C. jejuni 81116∆flaA/B was also used in the 
autoagglutination assay, interestingly it did not show a reduction in autoagglutination 
(Figure 7.8) which was contrary to a previous report that motility is important for 
autoagglutination (Golden and Acheson, 2002). 
 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Strain
01/51
6A9
Mutant
6A9
Comp
cipA
Mutant
cipA
Comp
1136
Mutant
1136
Comp
1539
Mutant
1539
Comp
flaA/B
Mutants
A
u
to
a
gg
lu
tin
a
tio
n
 
Figure 7.8 Autoagglutination in C. jejuni 01/51 and mutants. 
The ability to autoagglutinate in C. jejuni 01/51 wildtype (strain 01/51), transposon insertion mutant in 
Cj0690c (6A9 mutant), complemented 6A9 mutant (6A9 comp), targeted cipA mutant (cipA mutant), 
complemented cipA mutant (cipA comp), targeted Cj1136 mutant (1136 mutant), complemented Cj1136 
mutant (1136 comp), targeted Cj1539c mutant (1539 mutant), complemented Cj1539c mutant (1539 
comp) and non-motile C. jejuni 81116∆flaA/B was tested. No strong correlation between 
autoagglutination and invasion was found.   
Chapter 7. Phenotypic characterisation of the mutants and complemented mutants 
 
155 
7.3.2.7 Chick colonisation 
Chicken colonisation potential of C. jejuni 01/51 wildtype and targeted mutants in cipA 
(Cj0685c), Cj1136 and Cj1245c was tested in the chick colonisation model. 
Colonisation results showed that the cipA mutant colonised the birds at the similar 
levels (2.62 x 108 CFU/gram of caecal contents) to the parent strain 01/51 whose mean 
level of colonisation was 2.44 x 108 (Figure 7.9). This suggests that the inactivation of 
cipA (Cj0685c) does not affect colonisation potential of C. jejuni 01/51. The mutants of 
Cj1245c showed a reduction in chick colonisation potential as compared to parent strain 
01/51 (Figure 7.9) but this was not statistically significant (P >0.05) suggesting that this 
gene does not play a role in chick colonisation by C. jejuni 01/51. C. jejuni 01/51 
wildtype strain colonised 100% of the birds and colonisation level was high but the 
mutant in Cj1136 showed a significantly (P <0.001) low level of chick colonisation as 
30% of birds (n = 3/10) infected with the lower dose (4.3 x 104 CFU) of the Cj1136 
mutant were not colonised. The colonisation levels in those birds infected with higher 
dose (4.3 x 106 CFU) of the mutant were significantly reduced compared to the lower 
dose of the wildtype strain 01/51 (Figure 7.9), which strongly suggests that Cj1136 is 
important for the chick colonisation by C. jejuni.  
Successful colonisation of the chicken gut is a multifactorial process. Mutations in 
genes of RacR-RacS, a two component regulatory system involved in temperature 
regulation (Bras et al., 1999), dnaJ involved in the heat shock response (Ziprin et al., 
2001), cbrR, a gene involved in bile tolerance (Lin et al., 2003; Raphael et al., 2005), 
iron transport and regulation (Cawthraw et al., 1996a; van Vliet et al., 2002), serine 
catabolism (Velayudhan et al., 2004), and glycosylation (Karlyshev et al., 2004; Kelly 
et al., 2006) have all been shown to reduce or abolish the ability of C. jejuni to colonise 
the chicken gut. Flagella have been shown to be required for passage through the 
gastrointestinal tract but not for caecal colonisation (Wösten et al., 2004). Mutations in 
the pldA gene and the ciaB gene (Ziprin et al., 2001) also lead to a noncolonising 
phenotype. In Salmonella species, a reduction in the ability to colonise chickens 
correlated with changes in the lipopolysaccharide profile (Craven et al., 1993; Turner et 
al., 1998). Like many other pathogens LOS is important for invasion in C. jejuni and 
deletion of the LOS biosynthesis locus in C. jejuni NCTC11168 abolished invasion of 
the mutant in Caco-2 cells however chicken colonisation of this mutant was not tested 
(Marsden et al., 2009). Cj1136 is part of the LOS biosynthesis locus in C. jejuni 
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NCTC11168 (Parkhill et al., 2000) and is potentially involved in LOS biosynthesis. The 
impaired ability of colonisation in chicks shown by the Cj1136 mutant might be due to 
altered LOS biosynthesis in this mutant. Cj1136 encodes for a putative 
galactosyltransferase and the importance of this enzyme for chicken colonisation in C. 
jejuni has previously been reported. Mutation of cgtB that encodes for a putative 
galactosyltransferase in C. jejuni 81-176 reduced the invasion in INT-407 cell and chick 
colonisation in the mutant (Gilbert et al., 2002).  
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Figure 7.9 Colonisation of chicks by C. jejuni 01/51 WT and mutants. 
The C. jejuni 01/51 wildtype, its mutants in cipA (Cj0685c), Cj1136 and Cj1245c were tested for their 
ability to colonise gut of chicks. A low and a high dose of the wildtype strain or mutants was given to 10 
birds in each group. Numbers of bacteria that had colonised the birds were determined in caecal contents 
five days after infection. The C. jejuni 01/51 wildtype colonised to ~ 108 (cfu/g) and cipA (Cj0685c) 
mutants showed a similar level of colonisation to wildtype strain. C. jejuni 01/51 mutant in Cj1245c 
showed a reduction in colonisation but it was not statistically significant. Both low and high doses of the 
mutant in Cj1136 showed significantly lower levels of chick colonisation compared to the lower dose of 
the wildtype strain 01/51 confirming that Cj1136 plays a role in chick colonisation in C. jejuni 01/51.  
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7.3.2.8 Lipooligosaccharide analysis 
Lipooligosaccharide (LOS) structures are generally important for invasion in many 
pathogenic bacteria  (Kanipes et al., 2004; Lambotin et al., 2005; Marsden et al., 2009; 
Preston et al., 1996; Swords et al., 2000). LOS biosynthesis genes are clustered in a 
locus (Cj1131c – Cj1152c) in C. jejuni NCTC11168 (Parkhill et al., 2000). Sequencing 
and microarray analysis of the LOS biosynthesis locus in the C. jejuni genome have 
shown that this locus is highly variable (Gilbert et al., 2002; Parker et al., 2008), which 
may contribute to the phenotypic variation in C. jejuni. 
In this study, a transposon insertion in a gene (Cj1136 homologue) encoding for a 
putative glycosyltransferase resulted in reduced invasion in Caco-2 cells compared to C. 
jejuni 01/51 wildtype strain. LOS is important for invasion in C. jejuni (Marsden et al., 
2009). The Cj1136 is part of the LOS biosynthesis locus in C. jejuni NCTC11168 and 
Cj1136 has yet not been characterised and its role in LOS biosynthesis is not known. 
Our hypothesis was that Cj1136 might be involved in LOS biosynthesis and inactivation 
of Cj1136 would have altered the LOS structure that consequently resulted in reduced 
invasion in cultured Caco-2 cells and chick colonisation in the mutant. So LOS was 
extracted from C. jejuni 01/51 wildtype, its mutant in Cj1136 and complemented 
Cj1136 mutant and analysed by SDS-Tricin polyacrylamide gel electrophoresis and 
silver staining. LOS extracted from the mutant gave a band with higher electrophoretic 
mobility compared to that extracted from the 01/51 wildtype stain, LOS from the 
complemented mutant showed an electrophoretic mobility similar to that from the 
wildtype strain (Figure 7.10). It confirmed that Cj1136 is involved in LOS biosynthesis 
in C. jejuni 01/51 as the Cj1136 mutant appeared to have generated a truncated LOS, it 
also confirmed that normal LOS biosynthesis was restored on complementation of the 
mutation.  
Lipopolysaccharide (LPS) and lipooligosaccharide (LOS) are the major surface antigens 
of Gram-negative bacteria and play an important role in the interaction of these bacteria 
with their host and/or the environment (Caroff et al., 2002). These surface 
polysaccharide molecules in C. jejuni also serve as host mucosal adherence factors. 
LOS is made up of two covalently linked domains: a hydrophobic lipid A moiety and 
non-repeating unit of inner and outer core oligosaccharide (Aspinall et al., 1995). The 
LOS core oligosaccharides are synthesised by adding sugar moieties by 
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glycosyltransferases and modifying enzymes. The LOS is important for virulence of C. 
jejuni. 
Inactivation of cgtB encoding for a putative galactosyltransferase in C. jejuni 81-176 
reduced the invasion in INT-407 cells and chick colonisation (Gilbert et al., 2002) while 
a site-specific insertional mutant of C. jejuni strain 81-176 in cgtA gene which encodes 
for an N-acetylgalactosaminyltransferase, showed a significant, more than twofold, 
increase in invasion of INT-407 cells compared to the wildtype (Guerry et al., 2002). 
Previously in an attempt to correlate the colonisation and invasion ability of C. jejuni 
strains with PCR-based presence or absence of selected LOS biosynthesis genes it was 
found that cgtB and wlaN were present in 68% of C. jejuni strains with strong 
colonisation and invasive ability compared to 20% in weak or non-invasive strains 
(Muller et al., 2007). In our laboratory, the presence of Cj1136 was checked in C. jejuni 
strains with hyper and low invasion potentials (Fearnley et al., 2008) and some evidence 
of a correlation between Cj1136 presence and invasion potential was found as the gene 
was present in 67% (n = 4/6) hyperinvasive and 25% (n = 1/4) low-invasive C. jejuni 
strains (Appendix 5), however, the screen of a large number of hyperinvasive and low-
invasive strains is needed. This data is in contrast to a previous report in which PCR 
detection of Cj1136 and other genes encoding for putative galactosyltransferases 
(except wlaN and cgtB) in 40 C. jejuni isolates indicated no correlation between the 
occurrence of the genes and the colonisation and invasion ability of the strains (Muller 
et al., 2007). 
 There are other genes as well as Cj1136 that encode for putative galactosyltransferase 
including cgtB in C. jejuni 81-176 (Gilbert et al., 2002), and eight genes encode 
putative galactosyltransferases (wlaH, wlaG, Cj1136, Cj1138, wlaN (Cj1139c), 
Cj1434c, Cj1438c and Cj1440c) in C. jejuni NCTC11168 (Parkhill et al., 2000). 
Sequencing of C. jejuni RM1221 resulted in the annotation of two putative 
galactosyltransferases (CJE1278 and CJE1280) with no similarity to genes of 
NCTC11168 (Fouts et al., 2005). Apart from Cj1136, those genes encoding for putative 
galactosyltransferases in C. jejuni 01/51 are not known but if there are any others they 
were unable to compensate for the lack of Cj1136 gene products in C. jejuni 
01/51∆Cj1136. 
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Figure 7.10 Comparison of LOS extracted from C. jejuni 01/51 with that from Cj1136 mutant and 
complemented mutant. 
LOS extracted from C. jejuni 01/51, Cj1136 mutant and complemented mutant were electrophoresed on 
15% SDS-PAGE gel and silver stained. LOS from the Cj1136 mutant showed a higher electrophoretic 
mobility compared to that extracted from the 01/51 wildtype or complemented mutant. Lane 1: 01/51 
wildtype; lane 2: Cj1136 mutant; lane 3: complemented Cj1136 mutant.  
 
7.4 Summary and conclusions 
After confirming the virulence-associated role of selected genes identified in C. jejuni 
01/51 transposon insertion mutants with reduced invasion phenotype by generating 
targeted mutagenesis and the mutated genes were complemented. The adhesion and 
invasion ability of C. jejuni 01/51 wildtype, selected mutants and complemented 
mutants were tested to verify the involvement of the mutated genes in virulence. 
Complementation of the mutated genes partially but significantly restored the invasion 
in Caco-2 cells. C. jejuni 01/51 and mutants showed similar growth in MH broth and 
there was no significant difference in motility, resistance to atmospheric oxygen, H2O2 
and triton X-100 stress between the 01/51 wildtype strain and mutants which confirmed 
that the reduced invasion phenotype in the mutants was not affected by growth, motility 
or the survival of mutants in different stresses encountered during the gentamicin 
protection assays. 
C. jejuni 01/51 and mutants in cipA, Cj1245c and Cj1136 were tested for their ability to 
colonise the avian gut in a chick colonisation model. The cipA mutant showed 
colonisation levels similar to the wildtype strain and Cj1245c mutant showed some 
reduction in colonisation but it was not statistically significant suggesting that these 
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genes were not involved in chick colonisation by C. jejuni 01/51. The Cj1136 mutant 
showed significantly reduced colonisation in the chick gut compared to the wildtype 
strain highlighting a role for this gene in chick colonisation.  
Analysis of lipooligosaccharides extracted from C. jejuni 01/51, the Cj1136 mutant and 
complemented mutant showed that Cj1136 was involved in LOS biosynthesis in 01/51, 
and the altered LOS biosynthesis in the mutant was most probably responsible for the 
reduced invasion and chick colonisation phenotypes in the Cj1136 mutant.  
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8 GENERAL DISCUSSION AND FUTURE DIRECTIONS 
 
C. jejuni is the most common cause of bacterial food-borne diarrhoea worldwide, but its 
pathogenic mechanisms are not clear. However, previous studies showed that toxin 
production, invasion and motility are important for Campylobacter pathogenesis 
(Ketley, 1997). Invasion of host epithelial cells is believed to be an important virulence 
mechanism of C. jejuni and not all strains have the same virulence potential (Everest et 
al., 1992). C. jejuni strain dependent variability in invasion in eukaryotic cells has been 
reported by many researchers (Everest et al., 1992; Konkel and Joens, 1989; Malik-Kale 
et al., 2007; Newell et al., 1985). The differences in invasiveness in C. jejuni isolates of 
human, poultry and environmental origin  and the identification of hyperinvasive strains 
of C. jejuni were recently reported (Fearnley et al., 2008). This research project aimed 
to investigate the molecular basis of this hyperinvasiveness in Campylobacter jejuni by 
identifying and characterising invasion-associated genes in the hyperinvasive strain 
01/51. 
The variability in invasiveness in C. jejuni strains might be due to differences in their 
genetic content and the presence of novel virulence-associated genes might be 
responsible for the hyperinvasive phenotype observed in some C. jejuni strains. Genetic 
differences in bacterial strains have been determined by whole genome sequencing, 
comparative genomic microarrays and/or subtractive hybridisation techniques (Ahmed 
et al., 2002; Dorrell et al., 2001; Fouts et al., 2005; Hinchliffe et al., 2003; Hofreuter et 
al., 2006; Howard et al., 2006; Poly et al., 2007b). These methods are powerful tools to 
determine the similarity or variation in genetic content among strains and may provide 
the basis for some of the phenotypic variations observed. However, the differences in 
genomic content do not account for all the phenotypic diversity observed. Different 
phenotypes could be exhibited by genetically matched strains and the phenotypic 
variation might be contributed by small changes in nucleotide sequence of the gene 
including point mutation and/or nucleotide deletions or insertions leading to frame shifts 
(Malik-Kale et al., 2007). Whole genome sequencing can reveal these minor changes in 
the genes but it is an expensive and demanding procedure, moreover, whole genome 
sequence is less likely to reveal the phenotypic variations that are due to gene 
regulation/expression differences. Transposon mutagenesis is an excellent and relatively 
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cost effective tool to determine the phenotypic variation and functions of the genes. 
Transposon mutagenesis has successfully been used to identify virulence associated 
genes in many bacterial species (Autret et al., 2001; Shah et al., 2005); this technique 
has also previously been used in C. jejuni to determine the bacterial factors that 
contribute to chicken colonisation ability, motility and autoagglutination in the 
organism (Golden and Acheson, 2002; Grant et al., 2005; Hendrixson et al., 2001; 
Hendrixson and DiRita, 2004). A transposon mutant library was constructed in a 
hyperinvasive, clinical isolate of C. jejuni strain 01/51 in order to investigate at the 
molecular level the hyperinvasive phenotype observed in this organism. The 
hyperinvasive strains exhibit a significant difference in invasion potential from poor 
invasive strains (Fearnley et al., 2008). Thus generation of a mutagenesis library in a 
hyperinvasive strain was expected to provide a good opportunity to identify the genes 
that promote the ability of the organism to invade the host cells. The mutant library was 
screened to find the mutants with reduced invasion in the human intestinal epithelial cell 
line, INT-407 cells and results were also confirmed using an alternative human colonic 
cell line, Caco-2. A screen of 768 mutants in an in vitro assay of invasiveness revealed 
174 mutants with a reduction in invasion compared to the parent strain and these were 
subsequently checked for their motility. Motility is an important virulence factor in 
Campylobacter jejuni and previous studies with nonmotile mutants demonstrated that 
motility is essential for C. jejuni invasion in intestinal epithelial cells (Grant et al., 1993; 
Wassenaar et al., 1991; Yao et al., 1994). Location of the transposon insertions was 
determined in only those mutants that were more than 75% motile as compared to the 
parent strain 01/51 to focus the effort on identifying those genes with a role in invasion 
rather than motility. Eleven genes that were potentially involved in the invasion 
phenotype in C. jejuni were identified in this study. All but two of the mutants had 
transposon insertions in genes shared with the genome sequenced strain NCTC11168; 
one of the genes did not show match to available genome sequence databases and it 
might be unique to strain 01/51. None of the transposons had inserted into orthologues 
of any of known invasion-related genes found in other bacteria, such as in Salmonella or 
Yersinia. This is not too surprising, as from the numerous genome sequences that are 
now available it is apparent that C. jejuni does not contain any such invasion-related 
genes (Champion et al., 2008), however this does not preclude there being novel 
invasion-related genes present in strain 01/51. Genes previously recognised for invasion 
in cultured epithelial cells by other C. jejuni strains, including cadF, ciaB, galE and 
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csrA (Fields and Thompson, 2008; Fry et al., 2000; Konkel et al., 1999; Monteville et 
al., 2003) were not identified in this study indicating that our screen was not exhaustive.  
This study identified 11 genes that are potentially important for the invasion of C. jejuni 
into intestinal epithelial cells. Most of the genes have previously not been characterised 
and their role in invasion was not known. Two genes, Cj1020c encoding for a 
cytochrome C and Cj1503c encoding for a putative proline dehydrogenase, identified in 
this study are potentially involved in energy generation and metabolism. It is possible 
that the virulence-associated role of these factors is as yet not known. Moreover, 
invasion of C. jejuni in host cells requires the synthesis of nascent proteins (Konkel and 
Cieplak, 1992), an energy dependent process, and as energy is generated from metabolic 
activity these two genes may have an indirect role in the invasion process. 
Metabolically active C. jejuni were capable of invading cultured eukaryotic cells. C. 
jejuni fixed with bacteriostatic chemical sodium azide, or when these bacteria were 
tested in the presence of chloramphenicol which blocks protein synthesis, C. jejuni lost 
their ability to invade the cultured epithelial cells (Konkel et al., 1992a). So 
metabolically efficient strains should show higher invasiveness compared to 
metabolically impaired strains. Further characterisation of these genes especially in 
terms of the growth characteristics of the mutants may give more details about the role 
of these genes.  
The mutants selected for transposon localisation exhibited very low levels of invasion in 
INT-407 and Caco-2 cells (Section 4.3.3). The role of six potentially invasion-
associated genes (cipA, Cj0690c, Cj1136, Cj1245c, Cj1305c and Cj1539c) mutated by 
transposon insertion was reconfirmed by targeted mutagenesis. All the mutants showed 
a reduction in invasion in cultured human intestinal epithelial cells but the levels of 
adherence to host cells were variable in mutants; however, inactivation of Cj1539c 
encoding for a putative anion-uptake ABC-transport system permease protein abolished 
both the invasion and adhesion potential of the mutant (Section 6.2).  Adherence to host 
cells is considered a prerequisite for invasion but the adherence and invasion processes 
may involve different proteins (Konkel et al., 1999). It seems that the genes i.e. 
Cj0690c, Cj1136, Cj1245c and Cj1305c identified in this study are important in 
invasion in INT-407 and Caco-2 cells but they are not crucial for adhesion to the host 
cells used. A reduction in invasion without adhesion has also previously been reported 
by others. Inactivation of ciaB in C. jejuni resulted in reduced invasion in INT-407 cells 
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but not adhesion (Konkel et al., 1999); a mutation in a putative DNA methyltransferase 
(Cj1461) showed higher adhesion to INT-407 cells but only a 50-fold reduced invasion 
compared to wildtype C. jejuni strain 81-176 (Kim et al., 2008).  
In aerobic growing organisms, reactive oxygen species (ROS) including superoxide 
anion and hydrogen peroxide are formed during oxidative metabolism (Alvarez-Peral et 
al., 2002). The toxic effects of ROS are crucial in the destruction of intracellular 
pathogens by macrophages and reflect the ability to damage essential cellular 
components such as nucleic acids, lipids and proteins (Jamieson, 1998; Storz et al., 
1987). To circumvent the harmful nature of ROS, many organisms have evolved 
specific defence mechanisms, which involve the synthesis and/or activation of 
protective molecules or enzymes including catalase and superoxide dismutase 
(Jamieson, 1998), and methionine sulfoxide reductase (Mintz et al., 2002). Ferritin in 
C. jejuni is involved in iron storage and protection from intracellular oxidative stress, a 
C. jejuni mutant of ferritin-encoding gene (cft) was more sensitive to H2O2 killing than 
parent strain (Wai et al., 1996). The mutants in cipA, Cj0690c, Cj1136, Cj1245c and 
Cj1539c were tested for sensitivity to hydrogen peroxide to determine if the reduced 
invasion potential of the mutants was due to intracellular killing by ROS. Results 
confirmed that the reduced invasiveness in the mutants was not due to increased 
sensitivity to hydrogen peroxide which is generated in the eukaryotic cells. The catalase 
activity was determined in these mutants and all of them possessed a catalase activity 
which might be responsible for their resistance to H2O2.    
Most of the genes identified in this study are also present in the first C. jejuni genome 
sequenced strain NCTC11168. The prevalence of six invasion-associated genes (cipA, 
Cj0690c, Cj1136, Cj1245c, Cj1305c and Cj1539c) that were further characterised by 
targeted mutagenesis in this study, was screened in six hyperinvasive and four poor 
invasive C. jejuni strains using PCR. All the genes showed random distribution but 
Cj1245c and Cj1539c were present in all the hyperinvasive and poor invasive strains 
tested (Appendix 5). The distribution of cipA, Cj0690c and Cj1136 was higher among 
the hyperinvasive strains. Cj1305 encoding for a hypothetical protein was found only in 
hyperinvasive C. jejuni strains (5/6) which suggest that this gene might be important for 
the hyperinvasive phenotype however a screening of a higher number of hyperinvasive 
and poor invasive strains is needed to strengthen the evidence. Cj1305c was identified 
as part of Campylobacter jejuni O-linked glycosylation locus (Cj1293 - Cj1342); 
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however, a previous study reported that flagellin glycosylation was not affected in a 
mutant of Cj1305c in C. jejuni 81-176 (Guerry et al., 2006). A strong correlation 
between the presence or absence of known virulence-associated genes of C. jejuni with 
virulence potential of the strains could not be established in previous PCR based studies 
(Fearnley et al., 2008; Muller et al., 2006) which suggests that many molecules play a 
role in this phenotype and the absence of one bacterial determinant might be 
complemented by another in a different strain. Alternatively more than one mechanism 
of invasion might be used by C. jejuni strains and different invasion-related 
determinants might be involved in these different mechanisms.  
It has been suggested that genetic content and diversity is dictated by the environment 
in which an organism lives (Konstantinidis et al., 2006). It has also been observed that 
phenotype including invasiveness and ability of the same C. jejuni strain to colonise the 
chicken gut changes depending upon the environments in which they had been prior to 
the experiments. A poor invasive strain may become hyperinvasive on repeated passage 
through host cells (van Alphen et al., 2008); on the other hand, the same strain might 
lose invasion potential on repeated passage through laboratory culture media (Konkel et 
al., 1990). Host colonisation ability of the C. jejuni strains has also been shown to 
increase on passage in vivo (Cawthraw et al., 1996b). The increased invasiveness or 
ability to colonise the host gut by passage in vivo is more likely due to changes in 
bacterial gene expression levels (Konkel et al., 1990). Thus the strain dependent 
hyperinvasive phenotype in C. jejuni may also be due to differences in expression of 
invasion-associated genes. Further studies of expression of the virulence-associated 
genes identified in this study along with previously known virulence genes may help 
understand the contribution of gene expression to hyperinvasiveness. However, a 
previous study found that the relative chick colonisation ability of C. jejuni strains 
NCTC11168 and 81116 that were passaged in vivo was still different (Ahmed et al., 
2002); this relative difference among the strains is more likely to be dictated by genetic 
content of the strains rather than gene expression levels. The difference in genetic 
content and its contribution to differences in strain dependent phenotypes therefore can 
not be ignored.  
This study showed that the putative galactosyltransferase encoded by Cj1136 is 
involved in lipooligosaccharides (LOS) biosynthesis in C. jejuni. Inactivation of Cj1136 
in C. jejuni 01/51 resulted in a significant reduction in invasion in INT-407 and Caco-2 
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cell and production of truncated LOS. The reduced invasion phenotype observed in the 
Cj1136 mutant is most probably an indirect effect due to the abolished biosynthesis of 
intact and functional LOS, however, a more direct role of this determinant in the 
invasion process other than LOS biosynthesis can not be ruled out. LOS might be 
involved in the activation of some host cell bacterial uptake processes. Further 
gentamicin protection assays using the wildtype strain 01/51 and the Cj1136 mutant in 
the presence of purified LOS from a wildtype strain may reveal whether the reduced 
invasion phenotype was due to altered LOS or some other reasons. Many previous 
studies have shown the implication of bacterial LOS in invasion of host cells by the 
organism (Guerry et al., 2002; Kanipes et al., 2004; Lambotin et al., 2005; Muller et al., 
2007; Perera et al., 2007; Swords et al., 2000). The structure of LOS in strain 01/51 and 
the polysaccharide units introduced by the galactosyltransferase (Cj1136) are not yet 
known and mass spectrometry and nuclear magnetic resonance analysis of purified LOS 
would help our understanding of the structure. After genome sequencing of C. jejuni 
NCTC11168, eight genes encoding putative galactosyltransferases (wlaN, wlaH, wlaG, 
Cj1136, Cj1138, Cj1434c, Cj1438c and Cj1440c) were annotated (Parkhill et al., 2000). 
Besides Cj1136, the genes encoding for a putative galactosyltransferase in C. jejuni 
01/51 are not known; it will be interesting to know the virulence-related roles of other 
galactosyltransferases, if any, in strain 01/51.  Furthermore, in addition to LOS 
biosynthesis, a putative galactosyltransferase encoded by Cj1136 might also be involved 
in the production of other surface polysaccharides or protein glycosylation in C. jejuni. 
A previous report suggested that the mutation of wlaK, a member of the LOS 
biosynthesis genes cluster, resulted in the production of altered LOS as well as impaired 
O-linked glycosylation in C. jejuni 81116 (Wood et al., 1999).  
The molecular mechanisms through which the genes identified in this study contribute 
to hyperinvasiveness in C. jejuni are not known and further characterisation of other 
genes which have not been characterised in this study by mutagenesis and 
complementation and functional analysis, is needed to understand their particular role in 
this phenotype.    
In this study transposon insertion sites were localised in only those mutants that were 
highly motile and showed less than 20% invasion compared to wildtype strain 01/51. It 
does not mean that other mutants with reduced invasion potential in which the 
transposon insertion site was not determined were unlikely to reveal the genes involved 
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in hyperinvasiveness; identification and characterisation of the genes mutated in other 
transposon insertion mutants with reduced invasion and good levels of motility would 
likely reveal other genes that contribute to invasion potential in C. jejuni.  
In summary, eleven invasion-associated genes were identified in this study using 
transposon mutagenesis (Table 5.1). The virulence-associated role of all the genes 
identified, apart from cipA, was previously unknown and this study revealed their 
importance in the invasion process. Six selected genes were mutated by targeted 
mutagenesis to reconfirm their contribution to invasiveness in C. jejuni and four of them 
were successfully complemented which partially restored invasion potential of the 
mutants. Also confirmed was the fact that the reduced invasion observed in C. jejuni 
mutants in cipA, Cj0690c, Cj1136, Cj1245c and Cj1539c was not due to reduced growth 
or motility, atmospheric air stress, killing in complete cell culture media, intracellular 
survival or killing of the mutants with detergent used in the gentamicin protection 
assays. A putative galactosyltransferase encoded by Cj1136 was found crucial for chick 
gut colonisation by C. jejuni. Chick colonisation potential of the mutant in cipA was 
similar to the wildtype strain 01/51. The mutant in Cj1245c showed a reduction in chick 
colonisation but this was not statistically significant. This study also showed that the 
translation product of Cj1136 is involved in LOS biosynthesis in C. jejuni which was 
previously not confirmed.  
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APPENDICES 
Appendix 1. The levels and efficiency of invasion of C. jejuni strain 01/51 into Caco-2 cells with 
different bacterial multiplicities of infection (MOI).  
MOIa Inoculumb Invasionc Invasion efficiency 
25 8.25E+06 2.79E+04 0.34 
50 1.72E+07 5.30E+04 0.31 
100 3.52E+07 9.55E+04 0.27 
150 5.05E+07 1.36E+05 0.27 
200 7.50E+07 2.34E+05 0.31 
300 9.75E+07 2.29E+05 0.23 
500 1.55E+08 2.24E+05 0.14 
650 2.00E+08 2.40E+05 0.12 
850 2.55E+08 2.28E+05 0.09 
a The number of bacteria per eukaryotic cell that were added to the cell monolayer. 
b The number of bacteria in the initial inoculum added to each well of cell monolayer. 
c The bacterial CFU count that were recovered from each well after invasion assay. 
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Appendix 2. Results of transposon mutant library screening for invasion in INT-407 cells. 
 1 2 3 4 5 6 7 8 9 10 11 12 
3A +++ ++ +++ +++ +++ ++ +++ + +++ 2 + NG 
3B +++ +++ +++ +++ ++ +++ ++ +++ ++ 3 NG NG 
3C X + + ++ + +++ ++ ++ ++ X NG NG 
3D +++ ++ ++ +++ ++ ++ +++ X ++ ++++ NG NG 
3E + +++ + ++ +++ ++ X ++ + +++ +++ NG 
3F +++ + +++ +++ X +++ +++ ++ X NG NG NG 
3G ++ + ++ X ++ ++ + +++ + NG NG NG 
3H ++ +++ X X X 2 X X X NG +++ NG 
4A +++ +++ 3 +++ ++ ++ ++ +++ +++ + ++ ++ 
4B + ++ +++ +++ +++ +++ +++ ++ +++ ++ +++ +++ 
4C + +++ +++ + +++ ++ ++ ++ +++ +++ +++ ++ 
4D ++ ++ ++ +++ ++ +++ ++ ++ ++ +++ ++ +++ 
4E +++ 3 +++ + +++ +++ +++ +++ + +++ ++ +++ 
4F +++ ++ ++ +++ ++ + +++ + + +++ +++ ++ 
4G ++ ++ + + +++ +++ +++ +++ ++ + 3 +++ 
4H X + ++ +++ +++ + + ++ +++ +++ ++ + 
5A + ++ +++ +++ + +++ +++ +++ ++ +++ + NG 
5B 3 +++ +++ + X ++ + +++ +++ X +++ NG 
5C +++ + 2 ++ +++ +++ + ++ +++ + NG NG 
5D +++ ++ +++ +++ +++ +++ +++ +++ +++ ++ X NG 
5E ++ +++ +++ +++ ++ +++ ++ ++ X + + X 
5F ++ +++ ++ +++ +++ +++ +++ ++ +++ X +++ X 
5G ++ ++ ++ +++ +++ +++ +++ ++ +++ +++ ++ +++ 
5H +++ +++ +++ + +++ +++ +++ ++ + X +++ X 
6A X X X +++ NG + X X X + +++ + 
6B + +++ X +++ +++ 3 3 +++ 2 2 X X 
6C ++ + + +++ +++ +++ +++ +++ +++ +++ +++ +++ 
6D +++ + ++ ++ ++ +++ + +++ +++ +++ +++ X 
6E + +++ ++ +++ +++ NG ++ ++ + + NG X 
6F + + +++ ++ ++ + +++ +++ + + +++ 3 
6G + ++ X +++ + ++ +++ ++ +++ ++ +++ X 
6H +++ ++ X + +++ +++ +++ +++ ++ X + + 
7A +++ +++ ++ +++ +++ +++ ++ ++ +++ +++ +++ +++ 
7B +++ ++ +++ ++ ++ +++ +++ + +++ +++ +++ +++ 
7C +++ +++ ++ +++ +++ ++ +++ +++ +++ +++ ++ ++ 
7D +++ + + + +++ +++ +++ +++ +++ +++ +++ +++ 
7E +++ +++ ++ ++ +++ +++ +++ +++ +++ +++ +++ +++ 
7F +++ +++ +++ +++ ++ +++ + +++ +++ +++ +++ +++ 
7G +++ +++ +++ +++ + ++ +++ ++ ++ +++ 2 + 
7H + ++ +++ ++ + 3 ++ +++ +++ +++ +++ + 
8A +++ +++ ++ +++ +++ +++ ++ + ++ +++ ++ ++ 
8B +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ ++ + 
8C +++ +++ +++ ++ +++ +++ +++ +++ +++ +++ +++ +++ 
8D +++ ++ +++ +++ +++ +++ +++ +++ ++ ++ ++ +++ 
8E ++ +++ +++ +++ ++ +++ +++ ++ ++ +++ +++ ++ 
8F +++ +++ ++ ++ +++ +++ +++ ++ +++ +++ +++ +++ 
8G +++ +++ +++ +++ +++ +++ ++ +++ ++ +++ +++ +++ 
8H +++ +++ +++ +++ ++ ++ ++ +++ +++ + +++ +++ 
9A NG +++ NG +++ NG +++ ++ +++ 
9B NG X +++ NG NG ++ +++ +++ 
9C NG NG +++ +++ +++ NG +++ +++ 
9D X X +++ + +++ NG +++ NG 
9E NG X NG X NG +++ X NG 
9F NG +++ +++ +++ NG NG NG NG 
9G +++ +++ NG +++ ++ +++ +++ +++ 
9H NG +++ +++ NG ++ +++ 3 NG 
There was no bacterial 
growth in these wells. 
10A +++ ++ +++ X + + +++ 2 + +++ +++ NG 
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10B ++ +++ +++ ++ 2 +++ + 3 2 +++ + 2 
10C + ++ ++ ++ +++ ++ X NG + +++ +++ +++ 
10D ++ + + 2 + NG + NG ++ 2 3 2 
10E 3 +++ +++ 2 +++ +++ ++ NG 1 2 3 3 
10F +++ + + X + ++ ++ ++ +++ +++ +++ +++ 
10G NG NG ++ + +++ ++ +++ +++ ++ + NG + 
10H X 3 1 +++ ++ ++ +++ +++ +++ NG ++ X 
01/51: +++ N/C: X 
A random transposon insertion library generated in C. jejuni 01/51 was screened to identify mutants in 
which their ability to invade INT-407 cells was reduced. Screening assays were repeated three times 
independently and results were combined from three sets of invasion screening assays. The results show 
the average levels of invasion of a mutant in three assays, for example if a certain mutant had shown ++ 
invasion in two assays and + in the third assay, it was reported as ++. Key: NG: no growth in inoculum; 
X: no colony seen in undiluted lysate; 1, 2 or 3: exact number of colonies counted; +: 4 to 6 colonies 
counted; ++: 7 to 9 colonies counted; +++: more than 9 colonies per spot. 
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Appendix 3. Combined motility and invasion results of selected transposon mutants. 
Mutant Invsna
 
Dia(cm)b %motilec Mutant Invsn Dia(cm) %motile Mutant Invsn Dia(cm) %motile 
3A8  + 0.5 10.2 5C7  + 5.4 110.2 7F7  + 3.4 69.4 
3A10  2 4.3 87.8 5C10  + 6 122.4 7G5  + 4.6 93.9 
3A11  + NA NAd 5D11  X 3.8 77.6 7G11  2 3.5 71.4 
3B10  2 3.6 73.5 5E9  X 4.4 89.8 7G12  + 4.5 91.8 
3C1  X 3.5 71.4 5E10 +  6 122.4 7H1  + 2.8 57.1 
3C2  + 3 61.2 5E11  + 5.4 110.2 7H5  + 4.5 91.8 
3C3  + NA NA 5E12  X 4.9 100 7H6  3 3.6 73.5 
3C5  + 4.4 89.8 5F10 X  2.6 53.1 7H12  + 3.8 77.6 
3C10  X 2.8 57.1 5F12  X 4.6 93.9 8A8 +  5.1 104.1 
3D8  X 3.4 69.4 5H4 +  4 81.6 8B12  + NA NA 
3E1  + NA NA 5H9  + 4.8 98 8H10  + 4.2 85.7 
3E3  + 4.2 85.7 5H10  X 2.9 59.2 9B2  X 1 20.4 
3E7  X 2.5 51 5H12  X 3.7 75.5 9D1  X NA NA 
3E9  + 4.1 83.7 6A1 X  2.5 51 9D2  X 4.5 91.8 
3F2  + NA NA 6A2  X 1.7 34.7 9D4  + 3.7 75.5 
3F5  X 1.8 36.7 6A3  X 3 61.2 9E2  X 3.5 71.4 
3F9  X NA NA 6A6  + 5.5 112.2 9E4  X NA NA 
3G2  + 3.7 75.5 6A7  X 4.2 85.7 9E7  X 4.7 95.9 
3G4  X 0.5 10.2 6A8  X 4.2 85.7 9H7 3 5 102 
3G7  + 5.1 104.1 6A9  X 4 81.6 10A4 X  4.8 98 
3G9  + 3.7 75.5 6A10  + NA NA 10A5  + 1.2 24.5 
3H3  X 3.5 71.4 6A12  + 4.2 85.7 10A6  + 3 61.2 
3H4  X NA NA 6B1  + 3.5 71.4 10A8  2 4.1 83.7 
3H5 X 3.3 67.3 6B3  X NA NA 10A9  + 3.5 71.4 
3H6  2 3.6 73.5 6B6  3 4.3 87.8 10B5  2 2.5 51 
3H7  X 4 81.6 6B7  3 4.2 85.7 10B7  + 3.7 75.5 
3H8  X 4 81.6 6B9  2 4.2 85.7 10B8  3 3.2 65.3 
3H9  X 0.8 16.3 6B10  2 NA NA 10B9  2 3.1 63.3 
4A3 3  4.5 91.8 6B11 X  4.5 91.8 10B11  + 4 81.6 
4A10  + 4 81.6 6B12  X 1.3 26.5 10B12  2 3.4 69.4 
4B1  + 3.8 77.6 6C2 +  NA NA 10C1  + 3.2 65.3 
4C1  + 4.7 95.9 6C3  + NA NA 10C7  X 2.9 59.2 
4C4  + 5 102 6D2  + NA NA 10C9  + 3 61.2 
4E2  3 5 102 6D7  + 4.5 91.8 10D2  + 3.7 75.5 
4E4  + 4.3 87.8 6D12  X 4.5 91.8 10D3  + 3.4 69.4 
4E9  + 4.5 91.8 6E1  + 4.6 93.9 10D4  2 NA NA 
4F6  + 4.5 91.8 6E9  + 1.5 30.6 10D5  + 2.6 53.1 
4F8  + 5.1 104.1 6E10 + NA NA 10D7  + 3.7 75.5 
4F9  + 5 102 6E12 X 5.2 106.2 10D10  2 3.7 75.5 
4G3  + 4.2 85.7 6F1 + 1.9 38.8 10D11  3 3.5 71.4 
4G4  + 4.1 83.7 6F2 + NA NA 10D12  2 3.7 75.5 
4G10  + 5 102 6F6 + 4.3 87.8 10E1  3 3.6 73.5 
4G11  3 NA NA 6F9 + 4 81.6 10E4  2 3.3 67.3 
4H1  X 4.9 100 6F10 + 4.7 95.9 10E9 1 4.3 87.8 
4H2  + 3.8 77.6 6F12 3 4.9 100 10E10 2 NA NA 
4H6  + 1.7 34.7 6G1 + 0.5 10.2 10E11 3 4.6 93.9 
4H7  + 3 61.2 6G3 X 1 20.4 10E12 3 4.6 93.9 
4H12  + 4.6 93.9 6G5 + 4.6 93.9 10F2 + 4.9 100 
5A1 +  5.2 106.1 6G12 X 5 102 10F3 + 5 102 
5A5  + 5.2 106.1 6H3 X 2.2 44.9 10F4 X NA NA 
5A11  + NA NA 6H4 + 4.3 87.8 10F5 + 5.2 106.1 
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5B1  3 5.8 118.4 6H10 X 4.4 89.8 10G4 + 4.3 87.8 
5B4  + 4.3 87.8 6H11 + 3 61.2 10G10 + NA NA 
5B5  X 5.5 112.2 6H12 + 2.2 44.9 10G12 + 5.2 106.1 
5B7 +  6 122.4 7B8 +  NA NA 10H1 X 4.3 87.8 
5B10  X 2 40.8 7D2  + 1.5 30.6 10H2 3 5.5 112.2 
5C2  + 5 102 7D3  + 0.8 16.3 10H3 1 4.3 87.8 
5C3  2 5.5 112.2 7D4  + 2 40.8 10H12 X 4.7 95.9 
01/51 +++ 4.9 100 NegCone X 0.5 10.2         
a: invasion in INT-407 cells observed in invasion screening assays. 
b: diameter of growth measured in centimetres in motility assay. 
c: percentage of motility shown by the mutants as compared to that shown by C .jejuni 01/51.  
d: result not available. 
e: results of C. jejuni 81116∆flaA/flaB used as negative control in the assays. 
One hundred and seventy four transposon mutants that showed very low invasion in the invasion 
screening assay were tested for motility. Forty mutants that showed up to three colonies in the invasion 
screening assay and more than 75% motility as compared to wildtype strain were selected (shaded) for 
confirmation of the reduced invasion phenotype in INT-407 and Caco-2 cells.  Key:  X: no colonies; 1, 2 
or 3: exact number of colonies counted; +: 4 to 6 colonies; ++: 7 to 9 colonies; +++: more than 9 colonies 
counted in 3 µl spot of undiluted sample after invasion.  
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Appendix 4. Invasion efficiencies and percentage of invasion shown by the selected mutants in the 
standard invasion assays. 
Mutant Invasion 
efficiency % invasion 
% invasion 
reduction Mutant 
Invasion 
efficiency % invasion 
% invasion 
reduction 
01/51 0.078 100 - 4H1 0.114 146.3* *Nil (-46.3) 
3A10 0.005 6.7 93.3 5B5 0.032 40.7 59.3 
3G4 0.000 .04 99.9 5C3 0.037 47.5 52.5 
3H7 0.008 10.6 89.4 5D11 0.091 117.8* *Nil(-17.8) 
3H8 0.014 17.9 82.1 5E9 0.053 68 32 
3H9 0.001 1.04 99 5E12 0.083 106.7* *Nil (-6.7) 
4A3 .070 90.8 9.2 5F12 0.123 158.5* *Nil (-58.5) 
4E2 0.018 23.4 76.6 5H12 0.095 122.1* *Nil (-22.1) 
01/51 0.248 100 - 6B11 0.194 78.6 21.4 
5B1 0.082 32.9 67.1 6D12 0.165 66.6 33.4 
6A7 0.016 6.3 93.7 6E12 0.206 83.4 16.6 
6A8 0.191 77.1 22.9 6F12 0.162 65.3 34.7 
6A9 0.049 19.6 80.4 6G1 0.001 0.2 99.8 
6B6 0.106 42.8 57.2 6G3 0.000 0.1 99.9 
6B7 0.200 80.8 19.2 6G12 0.150 60.7 39.3 
6B9 0.129 52.2 47.8 6H10 0.168 68 32 
01/51 0.403 100 - 10D12 0.003 0.8 99.2 
9B2 0.001 0.2 99.8 10E9 0.007 1.8 98.2 
9D2 0.026 6.4 93.6 10E11 0.021 5.1 94.9 
9E7 0.145 36 64 10E12 0.009 2.2 97.8 
9H7 0.140 34.7 65.3 10H1 0.019 4.7 95.3 
10A4 0.003 0.8 99.2 10H2 0.003 0.7 99.3 
10A8 0.151 37.5 62.5 10H3 0.016 4 94 
10D10 0.004 1 99 10H12 0.002 0.6 99.4 
*Mutant showed higher invasion (value shown in bracket) in INT-407 cells than parent strain in standard 
gentamicin protection assays. 
Invasiveness of the selected mutants that showed low invasion in INT-407 cells but maintained good 
motility in preliminary screening assays was checked in standard gentamicin protection assays. Invasion 
efficiencies shown in the table were the mean values of triplicate wells for each mutant and percent 
invasion and percent invasion reduction are the percentage of invasion and percentage of reduction in 
invasiveness, respectively, shown by the mutants compared to the wildtype strain C. jejuni 01/51. The 
selected mutants were tested for invasion in INT-407 cells in three independent assays which are shown 
by separated blocks in the above table. Mutants 3G4, 3H9, 9B2, 6G1 and 6G3 were motility mutants 
which were used as negative controls in the assays.  Mutants that showed less than a 20% invasion i.e. 
greater than an 80% reduction in invasion as compared to wildtype strain were selected (shaded) for 
reconfirmation of the reduced invasion in INT-407 cells and testing their invasiveness in Caco-2 cells. 
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Appendix 5. Prevalence of invasion-related genes amongst C. jejuni isolates with hyper- and low-
invasion potentials. 
A: 
Strain Source Invasion 
phenotype 
cipA Cj0690c Cj1136 Cj1245c Cj1305c Cj1539c 
01/04 Human Hyper + + - + + + 
01/10 Human Hyper + + + + + + 
01/35 Human Hyper + - - + + + 
01/41 Human Hyper + + + + + + 
01/51 Human Hyper + + + + + + 
EX114 Puddle Hyper - - + + - + 
01/39 Human Low + + - + - + 
01/40 Human Low + - + + - + 
01/42 Human Low + + - + - + 
81116 Human Low - - - + - + 
 
B: 
Phenotype cipA Cj0690c Cj1136 Cj1245c Cj1305c Cj1539c 
Hyperinvasive 
(n = 6) 
5 
(83%) 
5 
(83%) 
4 
(67%) 
6 
(100%) 
5 
(83%) 
6 
(100%) 
Low invasive 
(n = 4) 
3 
(75%) 
2 
(50%) 
1 
(25%) 
4 
(100%) 
0 
(0%) 
4 
(100%) 
Total 
(n = 10) 
8 
(80%) 
7 
(70%) 
5 
(50%) 
10 
(100%) 
5 
(50%) 
10 
(100%) 
A: The presence of invasion-related genes identified in this study was determined by PCR in hyper- and 
low-invasive C. jejuni isolates reported previously (Fearnley et al., 2008). The primers used for PCR 
amplification of cipA (685-F and 685-R), Cj0690c (690-F and 690-R), Cj1136 (1136-F and 1136-R), 
Cj1245c (aj1-FOR and aj1-REV), Cj1305c (1305-F and 1305-R) and Cj1539c (1539-F and 1539-R) are 
given in brackets with each gene and the primer details are described in Table 2.3.  
B: The percentage of hyer- and low-invasive strains carrying invasion-associated genes 
identified in this study. The prevalence of the genes was tested by Mr. G K Wilson, a 
final year research project student under my supervision.    
